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ABSTRACT 
 
 This dissertation investigates the complex regulation of IL-2 inducible T-cell 
kinase (Itk) and its related Tec family kinase members, using a combination of 
experimental and computational approaches.  Tec kinases are expressed primarily in 
hematopoietic cells and regulate key signaling events in lymphocyte activation, 
differentiation, and development.  Itk functions in immune response, fine-tuning 
signaling downstream of the T-cell Receptor (TCR), and is a putative drug target for 
allergies and autoimmune disease.  Btk, a Tec kinase found in B-cells, carries out a 
similar role to that of Itk, only downstream of B-cell Receptor (BCR) signaling.  The 
chapters of this dissertation focus on these two kinases, Itk and Btk, and share the 
common goal of improving our understanding of the molecular mechanisms that regulate 
these kinases and the immune cell signaling pathways they are a part of, primarily 
addressing two questions: 1) What is the role of the N-terminal Pleckstrin Homology 
(PH) domain in regulating Itk and Btk, in addition to its canonical role of PIP3 binding 
and consequent colocalization to the plasma membrane?  2) The isolated kinase domains 
of Tec kinases exhibit very weak activity, unlike other kinases domains, such as Src 
kinases, which have isolated kinases domains that are fully active; what are the 
sequence/structure differences responsible for rendering Tec kinase domains inactive? 
 The major contribution of this dissertation is the development of an Itk PH 
domain mutant, C96E/T110I (referred to later as ItkPHS), that overcomes the insoluble, 
aggregation-prone nature of wild-type ItkPH without affecting canonical PIP3 binding.  
This development opened the door to studying the previously intractable Itk PH domain 
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(Chapter 2), and in this dissertation, I elucidate novel functional interactions between 
ItkPH and Itk kinase domain (Chapter 3), and ItkPH and calmodulin (Chapter 4).  Using 
molecular dynamics simulations, tightly coupled with experiment, I also identify novel 
N-lobe packing motifs in the kinase domain of the Tec kinase Btk, shedding light on the 
structural features that account for the weak catalytic activity of the isolated kinase 
domains these enzymes (Chapter 6).  Cumulatively, this work provides new insight into 
the complex molecular-level regulation of the multi-domain tyrosine kinases in the Tec 
family.
 
 
 
1 
CHAPTER 1.  GENERAL INTRODUCTION 
 
 
Kinases transfer the γ-phosphate of ATP to other biological molecules, serving as 
chemical messengers that make the tight regulation of cell-signaling pathways possible.  
Non-receptor tyrosine kinases are found in the cytoplasm (not membrane-bound) and 
transfer the γ-phosphate of ATP to tyrosine residues of other proteins, often turning these 
proteins “on” or “off” in the context of their respective signaling pathway.  This notion of 
“on” or “off” can be useful to holistically conceptualize these pathways but is a gross 
oversimplification; in reality, many of these enzymes are multi-domain proteins that can 
exist in multiple conformational states, participate in multiple protein-protein 
interactions, and experience a gradient of variable activity levels depending on these 
states.  The molecular mechanisms that govern the activity of these kinases is 
extraordinarily complex, and though much has been discovered in recent years, much 
remains to be understood, especially for the Tec family of non-receptor tyrosine kinases.  
The Tec family consist of five members (Itk, Btk, Tec, Bmx, and Rlk), which play key 
roles in signaling events related to immune cell signaling, specifically lymphocyte 
activation, differentiation, and development. 
This dissertation focuses primarily on IL-2 inducible T-cell kinase (Itk), as well as 
Bruton’s tyrosine kinase (Btk).  Itk and Btk are critical for proper immune signaling and 
response, with Itk functioning in signaling downstream of the T-cell receptor (TCR), and 
Btk functioning in an analogous signaling pathway downstream of the B-cell receptor 
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(BCR).  These pathways are very sensitive and finely tuned, and slight perturbations in 
these signaling events can result in a compromised immune system.  For example, 
overactive signaling can lead to autoimmune diseases and allergies, cases where the 
immune system is attacking things that it should not.  Also, Btk is associated with the 
human disease XLA (X-linked agammaglobulinemia), in which mutations to Btk render 
the immune system severely compromised, often resulting in death.   
Itk can be thought of as a “rheostat,” or “dimmer switch” for TCR signaling, in 
that it dials activity up or down; but in the absence of Itk activity, immune response is not 
completely abolished.  These properties make Itk an attractive pharmaceutical target for 
allergies and autoimmune disease – cases where the immune system is overactive and 
needs to be dialed down, without abolishing immune response altogether.  However, 
before effective drugs can be designed to target Itk and related kinases, a better 
understanding of the molecular mechanisms governing activity is required.  This 
dissertation uses both computational and experimental techniques in a synergistic manner 
to improve our understanding of these complex molecular mechanisms, focusing on the 
N-terminal Pleckstrin Homology (PH) domain, and the C-terminal catalytic kinase 
domain, of Itk and the Tec kinases. 
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Literature Review 
 Itk in T-cell Receptor (TCR) signaling.  IL-2 inducible T-cell kinase (Itk), also 
referred to as Interleukin-2 Tyrosine Kinase (Itk) and T-cell specific kinase (Tsk), is 
involved in signaling downstream of the T-cell-receptor (TCR) and contributes to proper 
immune response and T-cell development and maturation.  The TCR signaling pathway 
is stimulated by antigen recognition at the Major Histocompatibility Complex I (MHC I), 
and the subsequent signaling is finely tuned and tightly regulated.  Slight perturbations to 
this signaling can result in a compromised immune system; overactive TCR signaling can 
be responsible for autoimmune disease and allergies.  Bruton’s tyrosine kinase (Btk), 
Itk’s homologue in B-cells, is associated with the human disease XLA (X-linked 
agammaglobulinemia)1,2, in which mutations to Btk render the immune system severely 
compromised, often resulting in death.  Furthermore, in a recent study of two girls who 
died of Epstein-Barr virus, the underlying cause was found to be mutation to Itk3.  A 
recent review coined Itk as the “rheostat” of TCR signaling in that it dials this signaling 
up or down like a light switch dimmer4.  And although Itk is necessary for a proper TCR 
response, it is not absolutely essential to this pathway; deleting Itk is not fatal and still 
allows for some basal immune response5.  These very properties make Itk an appealing 
drug target for allergies and autoimmune disease, cases where we want to dial down 
immune response without abolishing it altogether, and Itk is an active target of 
pharmaceutical efforts6,7. 
 Stimulation of the TCR upon antigen recognition at the Major Histocompatibility 
Complex (MHC) sets off a phosphorylation cascade inside the T-cell.  This cascade 
phosphorylates and activates the tyrosine kinases Zap70 and Lck, a Src family kinase.  
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Lck phosphorylates Itk, activating it, and Itk in turn phosphorylates and activates 
Phospholipase-C-γ-1 (PLCγ1), which then hydrolyzes PI(4,5)P2 into the second 
messengers IP3 and diacylglycerol (DAG)8,9, both of which play essential roles in 
downstream signaling pathways.  Of particular importance to TCR signaling is the 
calcium flux resulting from IP3 binding its receptor on the endoplasmic reticulum (ER), 
facilitating the calcium release.  Calcium release activates calmodulin (CaM) and 
subsequently calmodulin kinases (CaMKs) and calcineurin (CN), which in turn activates 
transcriptions factors, including NFAT, that regulate the expression of key genes 
involved in immune response, particularly cytokine production8,9.  Cytokines are proteins 
that are secreted into the circulatory system and serve as chemical messengers to 
formulate an immune response by binding receptors on other immune cells. 
 Tec family kinases.   The Tec family kinases are non-receptor (i.e. not membrane-
embedded) tyrosine kinases found primarily in hematopoietic cells.  They are tightly 
regulated and differentially expressed, responding to extracellular signals such as 
lymphocyte surface antigens, cytokines, and G-protein couple receptors.  The five family 
members – Itk, Btk, Tec, Rlk, Bmx – consist of the same domain architecture (Figure 1), 
with the following exceptions:  Rlk lacks a PH domain and Bmx has a non-traditional 
SH3 domain10.  Structures have been solved for all of these domains individually, but no 
multi-domain structures exist for the Tec kinases, leaving a gap in our understanding of 
the structural mechanisms that regulate their activity. 
 The research of this dissertation centers on Itk and its two closest homologues, 
Btk and Tec.  Btk has a similar role to Itk, but is expressed in B-cells and thus signals 
downstream of the B-cell Receptor (BCR)11.  B-cells, like T-cells, recognize surface 
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antigens at the Major Histocompatibility Complex (MHC), which in B-cells triggers a 
signaling cascade that results in antibody production and regulation of genes that dictate 
B-cell development, whereas the T-cell signaling cascade controls cytokine production 
and regulation of key genes for immune response and T-cell development and 
maturation.  Tec has a high sequence homology to Itk and is thought to play a role in 
triggering cell division and differentiation, especially in liver cells12-14. 
 
 
 Figure 1.  Domain Architecture of the Tec Family kinases 
 
  
 Src Family Kinases.  The Src family is the largest family of non-receptor tyrosine 
kinases, with nine members: Src, Yes, Fyn, Fgr, Lck, Hck, Blk, Lyn, and Frk.  Src 
kinases play important roles in numerous signaling pathways related to cell growth and 
differentiation.  The namesake of the family, c-Src, was first tyrosine kinase to be 
discovered, and v-Src was the first oncogene isolated15.  The Src family is closely related 
to the Tec family and possesses a similar domain architecture, consisting of a C-terminal 
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catalytic kinase domain, preceded by the following N-terminal regulatory domains: Src 
Homology 2 (SH2), SH3, and an N-terminal myristoylation site that serves to co-localize 
these kinases to plasma membrane16. 
 Full-length structures of Src kinases have been solved in both their active and 
inactive conformations, leading to a well understood mechanism of regulation for these 
kinases17-19.  Another tyrosine kinase, Csk, phosphorylates a tyrosine residue (pY505 on 
Lck) on the C-terminal tail of the kinase domain, which is then recognized by the SH2 
domain, locking the kinase domain into its inactive conformation through intramolecular 
interactions with the SH3 and SH2 regulatory domains.  Activation of Src kinases 
involves phosphatase activity to remove the phosphate on the C-terminal tail, releasing 
the SH3 and SH2 domains from the kinase domain, allowing them to interact with their 
other protein-binding partners; all of these events serve to isolate the kinase domain, 
which upon phosphorylation of its activation loop (pY394 in Lck) is fully active16,18,20.  
Why the isolated kinase domains of Src kinases are fully active, in sharp contrast to other 
kinases domains, such as those of the Tec kinases, remains an unanswered question and is 
addressed in Chapter 6 of this dissertation. 
 Pleckstrin Homology (PH) Domains.  PH domains are the 11th most prevalent 
protein domain in the human proteome21, and they are found exclusively in eukaryotes, 
although a recent study suggests protein ancestry in bacteria22.  All PH domains share a 
very similar fold (single alpha helix with a 7-stranded beta-barrel), yet PH domains have 
surprisingly low sequence homology – as low as 10%, with only a single conserved 
tryptophan residue among all PH domains23,24.  The well-established function of PH 
domains is to co-localize proteins to signaling complexes at the plasma membrane via 
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binding to phosphoinositol groups embedded in the membrane.  Lysine-Arginine motifs 
determine the specificity (PI(4,5)P2, PI(3,4,5)P3, etc.)25-27.  ItkPH, TecPH, and BtkPH, 
specifically bind PI(3,4,5)P3 10,28.  There is no solved structure for ItkPH, but structures 
BtkPH and TecPH have been solved (Figure 2)28,29.  In addition to their canonical 
phosphoinositide binding role, PH domains have been implicated in many other 
functions, such as mediating protein-protein interactions and regulating enzymatic 
activity of catalytic domains24-26.  The majority of PH domains in the proteome currently 
have poorly characterized functions. 
 
Figure 2.  Pleckstrin Homology (PH) domain structure.   (left) Structure of the Btk 
PH domain complexed with IP4, the soluble head-group of PI(3,4,5)P3 (shown in yellow), 
PDB ID 1B55. (right)  NMR structure of Tec PH domain (ensemble of 20 NMR 
structurs), PDB ID 2LUL. 
 
 
 
 Itk activation and self-association. The following steps are necessary for Itk 
activation: 1) Recruitment to the membrane via the PH domain binding PI(3,4,5)P3; 2) 
Phosphorylation of Tyr-511 on the activation loop of Itk by the Src family kinase Lck; 3) 
Binding of Itk to the SLP-76/LAT complex9.  Once activated, Itk activates PLC-γ-1 by 
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phosphorylating Tyr-783, and PLC-γ-1 then triggers diacylglycerol (DAG) and IP3 
production by hydrolysis of PIP3.  IP3 binds to IP3-sensitive channels on the endoplasmic 
reticulum initiating calcium flux, these signals ultimately lead to expression and release 
of the cytokine IL2. 
 Itk has been shown to self-associate via an intermolecular interaction between its 
SH3 and SH2 domains30-32; studies suggest that this interaction serves to down-regulate 
Itk catalytic activity32.  The SH3/SH2 interaction has been characterized by the Andreotti 
lab, and its structure solved via NMR31.   Karsten Sauer’s lab at the Scripps Institute has 
demonstrated a possible second interface of self-association in Itk, showing that PH 
domain self-associates in a coimmunoprecipitation (CoIP) assay in which transfected 
ItkPH-myc and ItkPH-YFP were pulled down with an anti-myc antibody33.   
 Early in my Ph.D. work, I aimed to characterize this ItkPH/ItkPH self-association.  
Though I was able to reproduce the CoIP results in Huang et. al. 33, my work suggests 
that this finding may be due to the aggregation-prone behavior of wild-type ItkPH in 
vitro.  In Chapter 2 of this dissertation34, I demonstrate the poor solution behavior of 
wild-type ItkPH and characterize a double mutant that rescues this poor behavior without 
altering canonical PI(3,4,5)P3 binding: ItkPH C96E/T110I (referred to hereafter as 
ItkPHS, for “solubilizing” mutant).  ItkPHS is monomeric, and the positions of the 
solubilizing mutations suggest that it is unlikely that these mutations have disrupted a 
specific ItkPH/ItkPH interaction; T110I is buried and not surface exposed (based on 
structures BtkPH and TecPH, Itk’s two closest homologues), and C96E, though partially 
surface exposed, does not appear to be highly accessible to participate in binding.  These 
observations certainly do not disprove ItkPH/ItkPH self-association.  It is possible that 
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inside the T-cell, the PH domain participates in the self-association of Itk, and in fact the 
very properties that give rise to ItkPH’s poor solution behavior in vitro may be important 
for the functioning of Itk in vivo.  However, any results obtained with wild-type ItkPH 
under in vitro conditions need to be interpreted in light of its aggregation-prone behavior. 
 
 Structural anatomy of Kinase Domains.  The active conformation of kinases is 
highly conserved across almost all non-metabolic, Eukaryotic Protein Kinases (EPKs).   
Furthermore, the equilibrium of inactive to active conformers differs between kinase 
domains, resulting in some kinase domains having higher activity levels than others.  
Numerous kinase catalytic domain structures have been solved in both their catalytically 
active and inactive conformers.  The active conformation of kinases is highly conserved 
across almost all non-metabolic Eukaryotic Protein Kinases (EPKs).   Furthermore, the 
equilibrium of inactive to active conformers differs between kinases, resulting in some 
kinases having higher activity levels than others.  Some kinases are intrinsically in the 
active conformation, whereas others require additional events (e.g. post-translation 
modification or interactions with other domains or proteins) to drive them into the active 
form.   We currently do not have a solid molecular level understanding of why certain 
kinases are more active than others.   
 Recent work has combed the PDB and established a set of structural features that 
are conserved across the active kinase domain structures of nearly all EPKs.  Susan 
Taylor and colleagues identified two sets of residues that are distant in sequence space, 
but come together to form “spines” of residues connected across three-dimensional 
space35,36.  The catalytic spine (C-spine)(Figure 3, yellow) aligns key residues in the 
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catalytic cleft that are important for catalysis and ATP binding, and the regulatory spine 
(R-spine, also referred to as the hydrophobic spine)(Figure 3, orange) serves to hold the 
αC-Helix in its active “in” position, maintaining the Lys-Glu salt bridge (K430-E445 in 
Btk), another feature that has shown to be necessary for a kinase domain to be considered 
in its active conformation.  During kinase domain transition to its inactive conformation, 
the αC-Helix swings outward, disassembling the R-spine and breaking the Lys-Glu salt 
bridge, which undergoes an “electrostatic switch”37, in which the Lys forms a salt bridge 
with the Asp of the DFG motif (K430-D539 in Btk), and the Glu forms a salt bridge with 
an Arg on the A-loop (E445-R544 in Btk)(Figure 3).  The DFG motif is a conserved 
motif in most EPKs that plays key roles in catalysis38,39.  The Asp in the DFG motif 
contacts a Mg2+, aiding in the binding and orientation of ATP.  The Phe (F540 in Btk) in 
the motif is part of the R-spine, thus aiding in stabilizing the active conformation; this 
Phe can also flip outward into the catalytic cleft, referred to as the “DFG-out” 
conformation, which an important role in inhibitor recognition: the cancer drug imatinib 
(Gleevec), which targets BCR-Abl fusion kinase and is used to treat Chronic 
Myelogenous Leukemia (CML)40, only binds to Abl in the DFG-out conformation41.  In 
the DFG-out state, the Lys-Glu salt bridge is often maintained, but the R-spine is 
disassembled due to the Phe being flipped outward away from the spine, resulting in an 
ultimately inactive conformation. 
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Figure 3.  Conserved structural features hallmark of active kinase domains for 
EPKs.  The catalytic core of Btk kinase domain is shown in its active conformation (PDB 
entry 3K54) and its inactive conformation (PDB entry 3GEN); the activation loop (A-
loop) is missing from the electron density of 3K54 and has been modeled in using 
MODELLER42 (See Chapter 6 for details).  The hydrophobic, or regulatory spine (R-
spine, shown in orange) and the catalytic spine (C-spine, shown in yellow) are aligned in 
the active conformation.  Key salt bridges are colored according to charge (red = positive, 
blue = negative).  In the active conformation, the A-loop is “open” and the αC-Helix is in 
its active αC-in position, which facilitates the alignment of the regulatory spine (R-spine).  
The in position of the αC-Helix also facilitates the formation of the conserved Lys-Glu 
salt bridge (K430-E445 in Btk), which serves to correctly orient ATP and is necessary for 
catalysis.  Upon transition to the inactive conformation, the αC-Helix moves outward to 
its inactive αC-out position, breaking the Lys-Glu salt bridge and disassembling the R-
spine; the A-loop coils inward, forming a new salt bridge characteristic of inactive 
kinases (E445-R544 in Btk). 
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Organization of this dissertation 
 This dissertation probes the molecular-level regulation of IL-2 inducible T-cell 
kinase (Itk) and its related kinases in the Tec family kinases and Src family kinases, using 
a combination of experimental and computational approaches.  Chapter 1 provides a 
general introduction and literature review of the Tec kinases, Src kinases, and their 
respective structural features and roles in immune cell signaling.  Chapters 2-5 focus on 
the N-terminal Pleckstrin Homology (PH) domain of Itk and its functional roles in 
regulating Itk catalytic activity.  Chapter 6 focuses on the C-terminal catalytic kinase 
domains of Tec kinases and Src kinases and aims to identify novel structural features that 
explain the sharp difference in baseline activity between the isolated kinase domains of 
two families. 
 In Chapter 2, I describe the discovery and characterization of ItkPHS, a double 
mutant (C96E/T110I) that overcomes the poor expression and solution behavior of wild-
type ItkPH without perturbing known functionality.  The development of ItkPHS is one of 
the most significant contributions of this dissertation, as it has opened the door to 
biophysically interrogate the previously intractable PH domain of Itk.  I was able to 
assign 1H-15N backbone chemical shifts for ItkPHS and use this tool to map binding of 
ItkPH to the kinase domain of Itk (Chapter 3), and a novel interaction between 
calmodulin (CaM) and ItkPH (Chapter 4).   In Chapter 5, I probe the mechanism by 
which BtkPH E41K confers constitutive activation; Btk E41K has been in the literature 
since 1995 as a hyper-activating, transforming mutant, but its mechanism has remained 
elusive.  In Chapter 6, using a computationally driven approach, I identify novel packing 
motifs in the N-lobe of the kinase domains of Tec and Src families that contribute to the 
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understanding of the motions and structural features that govern the catalytic activity of 
these kinases. 
 
Motivation 
  Though each chapter ventures into different biological questions, all of the work 
presented in this dissertation shares the common goal increasing our understanding of the 
complex regulation of Itk, Btk, and the Tec family kinases.  Itk and Btk are putative drug 
targets for allergies and autoimmune disease, and a necessary prerequisite to rational drug 
design is a better understanding of the structural features that regulate these kinases.  An 
obstacle in this understanding has been the absence of multi-domain structures for Tec 
kinases.  We know that the non-catalytic regulatory domains play important roles in 
regulating activity, but the structural basis for those roles remain elusive9.  The 
motivation of this dissertation is to advance the knowledge of those structural features in 
the absence of solved multi-domain crystal structures, with a synergistic approach of both 
experimental and computational methods. 
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Abstract 
IL2-inducible T-cell kinase (Itk) is a Tec family non-receptor tyrosine kinase 
involved in signaling downstream of the T-cell receptor.  Itk contains an amino-terminal 
Pleckstrin Homology (PH) domain that binds phosphatidylinositol (3,4,5)-triphosphate, 
recruiting Itk to the plasma membrane upon T cell receptor activation.  In addition to 
phosphoinositide binding, accumulating data suggest that the Itk PH domain likely 
mediates additional interactions outside of the phosphoinositide ligand binding pocket.  
The structural basis for additional PH domain functions remains elusive due to the poor 
recombinant expression and in vitro solution behavior of the Itk PH domain.  Here we 
determine that the lone α-helix in the Itk PH domain is responsible for the poor solution 
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properties and that mutation of just two residues in the Itk α-helix to the corresponding 
amino acids in Btk or Tec dramatically improves the soluble recombinant expression and 
solution behavior of the Itk PH domain.  We present this double mutant as a valuable tool 
to characterize the structure and function of the Itk PH domain.  It is also interesting to 
note that the precise sites of mutation identified in this study appear as somatic mutations 
associated with cancerous tissue.  Collectively, the findings suggest that the two helical 
residues in the Itk PH domain may serve an important and unique structural role in wild-
type Itk that differentiates this tyrosine kinase from its related family members.  
 
Introduction 
 
IL2-inducible T-cell kinase (Itk) is a member of the Tec family of non-receptor 
tyrosine kinases that plays a role in T-Cell Receptor (TCR) mediated signaling (1-3).  In 
addition to mediating numerous protein-protein interactions through its non-catalytic 
domains, Itk catalytic activity is responsible for phosphorylation, and thus activation, of 
phospholipase C γ1 (PLCγ1) (4-6).  A recent review coined Itk as the “rheostat” of the T-
cell, in that it fine-tunes the strength of the signaling cascade and subsequent immune 
response (7).  This makes Itk an appealing target for modulating the immune response in 
the context of disease states such as allergy and autoimmunity.  Detailed knowledge of 
the structures and functions of the individual domains of Itk, as well as how the different 
domains work together to control Itk function, are required steps to advance toward 
exerting control over this T cell signaling protein. 
 
 
 
20 
Itk consists of five domains; the amino-terminal Pleckstrin Homolgy (PH) 
domain, followed by the Tec Homology (TH) domain, Src Homology 3 (SH3) domain, 
Src Homology 2 (SH2) domain and the catalytic Kinase domain at the carboxy-terminus.  
We have extensively characterized the structural and functional details of the SH3, SH2 
and Kinase domains of Itk (7-13) but have not, to date, been able to investigate the Itk PH 
domain in any detail due to its extremely poor solution behavior. Numerous structures of 
PH domains from other proteins have been solved, including that of Btk, the Tec family 
kinase expressed in B-cells(14, 15) and all share a common fold consisting of a single α-
helix adjacent to a 7-stranded β-barrel. PH domains generally bind phosphatidylinositols, 
and in spite of the conserved fold, have surprisingly low sequence homology (16).  In T 
cells, the Itk PH domain binds phosphatidylinositol (3,4,5)-triphosphate (PtdIns(3,4,5)P3 
or PIP3) that is transiently produced by the action of phosphoinositide 3-kinase at the 
plasma membrane following activation of the T cell receptor (17).   
In addition to phosphoinositide binding, a subset of PH domains display a range 
of additional functions (18).   Touhara, et. al. show that nine different PH domains bind 
βγ-subunits of G Protein coupled receptors, suggesting that this might be a conserved 
feature of many PH domains (19).  The Btk PH domain has also been shown to bind βγ-
subunits (20) and another study suggests that both Btk and Itk can be activated by βγ-
subunits of G Proteins (21).  The Itk PH domain also exhibits activities beyond PIP3 
binding; specifically, kinetic data point to a role for the Itk PH domain in regulating the 
catalytic activity of the Itk kinase domain (13, 17), perhaps in a manner similar to Protein 
Kinase B (22, 23), and the Itk PH domain is thought to mediate intermolecular 
association of multiple molecules of Itk (24) forming intermolecular clusters that affect 
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Itk catalytic activity (25)  The Itk and Btk PH domains have also been shown to bind 
filamentous actin (26).  In spite of the numerous potential physiological roles of the Itk 
PH domain, efforts to elucidate the structural basis for these observations have been 
hampered by the fact that recombinant Itk PH domain is very poorly expressed in 
bacterial systems and exhibits poor solution behavior in vitro.  
Here we compare the expression and solution behavior of the PH domains of 
three Tec family kinases, Itk, Btk and Tec, and show that the poor recombinant 
expression and in vitro solution behavior of the Itk PH domain is unique among these Tec 
family kinases.  Using the well-behaved Tec PH domain as a template, we deliver 
mutations to the Itk PH domain that remedy the poor solution behavior, without adversely 
affecting the binding of the Itk PH domain to PIP3.  We aim to use this mutant Itk PH 
domain as a tool to probe the structure and function of the Itk PH domain and shed light 
on the multiple roles of this domain in controlling Itk function in T cells. 
 
Results 
Wild-type Itk PH domain, unlike Tec and Btk PH, shows poor recombinant 
expression yields.  The PH-TH domain fragments of Itk (residues 1-154), Tec (residues 
1-154), and Btk (residues 1-176) were cloned into modified pET-vectors containing N-
terminal tags of either His6-MBP or His6-GB1.  Itk PH-TH and Btk PH-TH were also 
cloned into pGEX-4T vectors, containing an N-terminal GST tag (Figure 1A). Previous 
work in Btk suggests that the TH domain (also known as the Btk motif) is necessary for a 
stably-folded PH domain (15, 27) and so in the current work we use constructs that 
include both the PH and TH domain of either Itk, Btk or Tec.  Hereafter the PH-TH 
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region from each kinase is referred to as ‘PH’.  Expression levels for all of the PH 
domain constructs were tested in BL21(DE3) cells.  Following induction with IPTG and 
overnight expression at 15°C, cells were lysed and pellet (P) and soluble (S) fractions 
were subjected to gel electrophoresis on 12% SDS-PAGE gels (Figure 1 B-D).  For all 
three solubility tags, GB1, MBP, and GST, ItkPH shows almost no soluble expression, 
whereas BtkPH, and especially TecPH are readily expressed as soluble protein regardless 
of which purification tag is used.  
Using a large culture volume (3L), we attempted to purify soluble His6-GB1-
ItkPH for preliminary NMR analysis; however, ItkPH precipitates immediately upon 
cleavage from the His6-GB1 tag.   Retaining the His6-GB1 tag we were able to purify 
and concentrate ItkPH for acquisition of a one-dimensional 1H NMR spectrum (Figure 
1E).  Purified His6-GB1-ItkPH (90 µM in 100% D2O) was compared directly to His6-
GB1-TecPH under identical conditions.  The signal intensity for the TecPH protein is 
consistent with the sample concentration while the Itk spectrum exhibits much lower 
intensity (Figure 1E).  We hypothesize that the weak signal of ItkPH is due to formation 
of large soluble aggregates that broaden the NMR signal and the fact that only a fraction 
of the Itk PH domain remains soluble during the course of the NMR experiment.  Indeed, 
the His6-GB1-ItkPH sample shows visible precipitate in the NMR tube that increases 
with time, consistent with protein aggregation.  The poor expression characteristics of the 
Itk PH domain combined with the insoluble nature of the purified domain prevent 
detailed analysis of this domain in vitro.   
The α-helix of ItkPH is responsible for its poor recombinant expression behavior.  
The contrast between the low soluble expression levels and poor in vitro behavior of 
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ItkPH, and the readily over-expressed and well-behaved TecPH led us to use the Tec 
sequence as a template to pinpoint the region of the Itk PH domain responsible for the 
poor solubility.   Using a chimeric approach, we swapped secondary structure elements of 
Itk into the Tec sequence at logical secondary-structure junctions (Figure 2A and B).  We 
expected that systematic replacement of portions of the Tec PH domain sequence with 
those of Itk would diminish the soluble expression of Tec for at least one of the chimeras.  
The expression results for this series of constructs should pinpoint the region of Itk 
responsible for the observed lack of expression.  To test this hypothesis, we screened for 
soluble expression of the Tec/Itk chimeras in BL21(DE3) cells.  Chimera “Tec/ItkHα,” in 
which the α-helix of the Tec PH domain was swapped for the α-helix of Itk, all but 
eliminated soluble expression (Figure 2C), whereas all other Tec/Itk chimeras yielded 
significant soluble expression comparable to wild-type TecPH domain (Figure 2C).  
Based on this result, we next replaced the α-helix of the ItkPH domain with that of Tec 
(Itk/TecHα) and tested the bacterial expression behavior.    The Itk/TecHα construct 
yielded substantial soluble expression compared to wild-type ItkPH (Figure 2C).  The 
data therefore show that swapping eight residues within the α-helix region of Itk PH to 
those of Tec (Figure 2D) rescues the poor expression behavior observed for wild-type Itk.  
ItkPH/TecHα binds PIP3.  We next engineered the ItkPH/TecHα mutation into 
full-length Itk to examine the effect of this sequence change on PH domain ligand 
binding.   Direct comparisons between wild-type and mutant must be made in the context 
of the full-length Itk protein since the wild-type Itk PH domain cannot be expressed.  
Flag-tagged wild-type full-length Itk and full-length Itk/TecHα baculoviral constructs 
were created and expressed in Hi-Five cells. Purification was achieved as described 
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previously for wild-type full-length Itk using the FLAG-affinity resin (28).   The purified 
full-length proteins (wild-type Itk and Itk/TecHα) were subjected to a pull-down assay 
using immobilized PIP3 ligand.  Both wild-type Itk and Itk/TecHα bind to PIP3 
suggesting that mutations within the α-helix of the PH domain do not adversely affect the 
PIP3 ligand binding pocket (Figure 2E).  
Mutation of the amino acids at each end of the a-helix, C96 and T110, is sufficient 
to rescue ItkPH expression and solubility.  Having established that the α-helix region of 
the Itk PH domain is the origin of the poor expression and solution behavior, we next set 
out to determine the minimal set of mutations necessary to generate a well behaved Itk 
PH domain construct.  Individual and pairs of amino acids in the α-helix of Itk PH 
domain were mutated to their corresponding residues in Tec and screened for soluble 
expression as before (Figure 3A &B).   The minimal sequence change that permits 
soluble expression levels of Itk PH involves mutation of residues C96 and T110 to the 
amino acids of either Tec (C96P/T110I) or Btk (C96E/T110I) (Figure 3B, arrows).  
Positions 96 and 110 are located at opposite ends of the α-helix (Figure 3C) suggesting 
helix stability may play a role in the observed soluble expression.  Moreover, the 
mutation of T110 to isoleucine likely improves side-chain packing within the PH domain; 
the modeled structure of ItkPH reveals a significant void surrounding T110, whereas the 
isoleucine side-chain at this position fills the space (Figure 3D).   Regardless of 
mechanism, mutation of C96 to either Glu (derived from Btk) or Pro (derived from Tec) 
combined with mutation of T110 to isoleucine results in robust soluble expression of 
ItkPH (Figure 3B).    
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Expression and purification of soluble ItkPH.  Having created a well-behaved 
double mutant of ItkPH, we next set out to express and purify this protein for biophysical 
characterization.   The panel of four PH domains, wild-type ItkPH, ItkPH/TecHα, wild-
type TecPH and ItkPH(C96P/T110I) were each expressed as His6-GB1 fusion proteins in 
E. coli and purified by nickel affinity chromatography.  Next, each protein was subjected 
to size exclusion chromatography prior to cleavage of the His6-GB1 tag (Figure 4A).  
The elution profile for wild-type ItkPH is consistent with the poor solution behavior and 
aggregation-prone nature of this protein, eluting over a range of fractions, indicating a 
heterogenous mixture of apparent molecular weights.  In contrast, wild-type TecPH and 
Itk/TecHα both elute from the column as a single band at fractions consistent with 
monomeric protein.  Interestingly, Itk (C96P/T110I) shows an elution profile that is 
intermediate to wild-type ItkPH and wild-type TecPH or Itk/TecHα.  A significant 
portion of Itk(C96P/T110I) elutes as a monomer while a portion of the sample elutes at 
earlier fractions in a manner that is similar to wild-type ItkPH. 
Since the double mutant ItkPH(C96E/I110I) based on the Btk amino acid 
sequence (Figure 3A) also produced soluble protein (Figure 3B), we expressed and 
purified this ItkPH mutant to assess its behavior on a sizing column. Figure 4B shows 
that the His6-GB1-ItkPH(C96E/T110I) protein elutes in a manner consistent with a 
monomeric species in contrast to the elution prolife of His6-GB1-ItkPH(C96P/T110I).    
We therefore proceeded with the ItkPH(C96E/T110I) mutant for further characterization.    
The His6-GB1-ItkPH(C96E/T110I) construct was next expressed in 3 liters of M9 
minimal media containing 15N-NH4Cl as the sole source of nitrogen and purified using 
nickel affinity (Ni-NTA) chromatography.  The His6-GB1 purification tag was cleaved 
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using the engineered Factor Xa site and separated from ItkPH(C96E/T110I) by a second 
pass through a Ni-NTA column.  The ItkPH(C96E/T110I) protein was then subjected to 
size exclusion chromatography for the final step of purification.  Unlike the uniform 
elution of His6-GB1-ItkPH(C96E/T110I) from the sizing column (Figure 4B), the 
cleaved ItkPH(C96E/T110I) protein elutes from the sizing column over a range of 
fractions primarily clustered into two peaks (Figure 4C, black trace).  SDS-PAGE 
indicates that both elutions correspond to the ItkPH(C96E/T110I) protein (see inset, 
Figure 4C) and CD spectra of the pooled fractions for each peak (fractions 24-35 and 36-
41) are nearly identical (Figure 4D).  These data suggest that the ItkPH(C96E/T110I) 
mutant forms higher molecular weight aggregates in solution (approximately 40-70 kDa 
in size) in a manner that might be similar to wild-type ItkPH. 
Unlike wild-type ItkPH, the major ItkPH(C96E/T110I) species in solution 
corresponds to the molecular weight of the monomer (Figure 4C).  Moreover, we find 
that we can concentrate the ItkPH(C96E/T110I) fractions corresponding to the 
monomeric peak and successfully acquire 2D HSQC NMR data (Figure 5A). The HSQC 
spectrum of ItkPH(C96E/T110I) is characterized by resonances with well-dispersed 
chemical shifts indicative of a folded protein domain, and average 1H line-widths of 23 
Hz consistent with that of a monomeric protein (29) (Figure 5A).  We also concentrated 
the higher molecular weight species that elutes in fractions 24-35 (Figure 4C) and find 
that NMR resonances cannot be detected for this sample (not shown).   Given the purity 
of the sample (see inset Figure 4C), the fact that both peaks run identically on SDS-
PAGE, and the presence of 2mM DTT in the buffer to disfavor formation of disulfide 
bonds, we suspect that a portion of ItkPH(C96E/T110I) aggregates to form a higher 
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molecular weight species giving rise to broad NMR lines and that exchange processes 
further broaden the NMR linewidths beyond detection.   The purified ItkPH(C96E/T110I) 
sample is stable over time without detectable formation of the larger aggregate.  Evidence 
for the stable monomeric species comes from lack of a higher molecular weight peak 
following reinjection of the purified fractions (36-41) onto the same sizing column 
(Figure 4C, red trace) and no change in the HSQC data over a period of 3 months (data 
not shown).    
Triple-resonance NMR datasets have been acquired and backbone resonance 
assignments for ItkPH(C96E/T110I) are underway.  HSQC spectra for 
ItkPH(C96E/T110I) in the absence and presence of inositol 1,3,4,5-tetrakisphosphate 
(IP4), the soluble head-group of PI(3,4,5)P3, show significant chemical shift perturbations 
for a subset of ItkPH resonances (Figure 5A&B).  The backbone amide resonances of 
several of the positively charged amino acids surrounding the ligand binding pocket of 
the PH domain have been assigned and exhibit chemical shift perturbations consistent 
with IP4 binding (Figure 5C). Together, the preliminary NMR data and the improved 
expression characteristics illustrate that introducing two amino acid sequence changes 
into the α-helix region of the ItkPH domain yields a significantly better behaved protein 
that binds the IP4 ligand (Figure 2E, Figure 5) and partially retains the propensity of the 
wild type Itk PH domain to aggregate in solution (Figure 4C).  
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Discussion 
 
Two amino acids within the single α-helix of the Itk PH domain are the origin of 
the low expression and lack of solubility observed for this protein when expressed and 
purified from bacteria.  The extremely poor solution behavior of the wild-type ItkPH 
prevents production of this protein for detailed structural and biochemical analysis. 
Indeed, in spite of evidence supporting a PIP3 binding role for the Itk PH domain in T 
cells (17, 30), the failure of ItkPH to bind IP4 in previous in vitro assays (31) has led to 
the suggestion that ItkPH does not bind inositol polyphosphates.  We suggest that these 
previously reported in vitro results were hampered by the poor behavior of ItkPH in 
solution.  In the present work, we have identified two Itk PH domain residues, C96 and 
T110, that when mutated to the corresponding Tec or Btk amino acids, alleviate the poor 
expression and solution behavior of ItkPH, providing a tool to probe structural and 
mechanistic features of the Itk PH domain that are relevant to T cell signaling.   
The specific mutations, C96E and T110I, are located at the N- and C-termini of 
the PH domain α-helix, pointing to a role for this helix in the aggregation prone behavior 
of the wild-type Itk PH domain.  We propose that poor side-chain packing interactions at 
position 110 might destabilize the PH domain (Figure 3D).  We find, however, that the 
single point mutation of T110 to isoleucine is not sufficient to produce soluble and stable 
Itk PH domain (Figure 3B).  The other mutation required to generate a well-behaved Itk 
PH domain (C96E) lies at the amino-terminal end of the same α-helix (Figure 3).   
Within the ItkPH α-helix, residue 96 occupies the N1 position, defined as the first 
residue with helical torsion angles (32).  Position specific amino acid preferences in 
 
 
 
29 
helices have been extensively examined over the years (33, 34).  Proline and glutamate 
(the amino acids in the TecPH and BtkPH N1 position, respectively) show the highest 
propensity for the N1 position of α helices, while cysteine and arginine (amino acids in 
the N1 position of mouse and human ItkPH, respectively) are significantly less favorable 
in this position. Given the intractable nature of the wild-type ItkPH protein, it is not 
possible to measure and directly compare the stability of the α-helix in the context of the 
wild-type Itk PH sequence versus the C96E/T110I mutation.  It is nevertheless tempting 
to speculate that the wild-type residues found at both positions 110 and 96 within ItkPH 
serve to destabilize the α-helix leading to unfolding and aggregation that results in the 
poor behavior observed for this domain in solution.   
The aggregation prone behavior of ItkPH may be an integral part of this domain’s 
function, and not simply an artifact of recombinant expression and purification in vitro.  
Previous work has shown that full-length Itk and the ItkPH fragment form intermolecular 
clusters both in cells (35) and in a co-immunoprecipitation assay from 293T cells (24).  
These observations, combined with intermolecular cluster formation via the SH3 and 
SH2 domains of Itk (8, 36) suggest that the entire regulatory domain region of Itk 
promotes intermolecular self-association.  Disrupting the SH3/SH2 interface results in 
increased catalytic activity suggesting the self-association may reflect a negative 
regulatory conformation of Itk (25).  The extent and manner by which the Itk PH domain 
contributes to regulation of Itk catalytic activity (and whether the PH domain mutations 
described here alter clustering of full-length Itk) remain to be determined.  Another 
regulatory model is that the overall stability of the Itk PH domain fold may be 
evolutionarily tuned to achieve appropriate levels of PIP3 binding following TCR 
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activation.  The identity of the amino acids at the ends of the ItkPH helix may have 
evolved to shift the equilibrium away from the well-folded, ligand binding competent 
conformation of the Itk PH domain thereby regulating the extent to which Itk associates 
with the membrane during T cell signaling.  Evidence for intrinsic disorder in the PH 
domain of SWAP-70 has been recently described (37) suggesting that conformational 
flexibility might be a shared mechanism for regulating the function of PH domains more 
generally.  All of the questions related to the precise mechanism by which the Itk PH 
domain contributes to and modulates T cell signaling can, with the ItkPH(C96E/T110I) 
mutant described here, be addressed in a more quantitative manner. 
In addition to the well-documented role for Itk in immune cell signaling 
processes, Itk mutations appear in the COSMIC database (Catalogue Of Somatic 
Mutations In Cancer) that records mutations in select genes sequenced from cancerous 
tissues (38, 39).  Eight of the Itk mutations in the COSMIC database are in the Itk PH 
domain; and three of the eight mutations are located within the α-helix of the Itk PH 
domain.  Remarkably, two of these mutated sites coincide exactly with the sites identified 
in this study: R96H and T110M (40), lending further support to the idea that these sites 
within the ItkPH α-helix are important for the structure and function of this domain.  
While a direct link between the Itk mutations listed in the COSMIC database and disease 
has not been firmly established, our results suggest that specific amino acid changes at 
positions 96 and 110 within the Itk PH domain can overcome an intrinsically unfolded 
and unstable domain to stabilize the structure possibly promoting Itk activity.  
Using the sequences of the related Tec family kinases, Tec and Btk, as a guide, 
we have solved a practical problem related to expression and purification of ItkPH.  
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Structural, biochemical and mechanistic studies can now proceed to elucidate what are 
likely numerous roles for the PH domain in controlling Itk function during T cell 
signaling.   
 
 
Materials and Methods 
Bacterial expression constructs.  We modified pET-20b expression vectors to 
incorporate N-terminal tags of either His6-GB1 or His6-MBP.  GB1 and MBP were 
PCR-amplified and subcloned into pET-20b at the NdeI and Xho1 restriction sites; 
overhangs of the primers were designed to incorporate the His6 tag, the restriction sites, 
as well as a BamH1 site C-terminal to the purification tag.  ItkPHTH (amino acids 1-
154), TecPHTH (amino acids 1-154), and BtkPHTH (1-176) were then PCR-amplified 
and subcloned into the BamH1 and Xho1 sites of the modified pET-20b vectors.  
Additionally, ItkPHTH and BtkPHTH were subcloned into the BamH1 and Xho1 sites of 
the pGEX-4T expression vector (GE Healthcare).   In all of these constructs, a Factor Xa 
cleavage site was engineered between the purification tag and the PHTH sequence by 
overhang primer design.  Wild-type sequences for all Itk, Tec, and Btk constructs used in 
this paper correspond to mouse (mus musculus) cDNA.  Chimeric Tec/Itk sequences were 
constructed by amplifying fragments of Tec and Itk that were then fused by overlap 
extension PCR and inserted into pET-20b-His6-GB1 at the BamH1 and XhoI restriction 
sites: TecPH/Itkβ1-4 consists of Itk amino acids 1-58 fused with Tec 58-154; 
TecPH/Itkβ5-7 consists of Tec 1-57 fused with Itk 59-90 and Tec 91-154; TecPH/ItkHα 
consists of Tec 1-94 fused with Itk 95-111 and Tec 112-154; TecPH/ItkTH consists of 
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Tec 1-111 fused with Itk 112-154; and ItkPH/TecHα consists of Itk 1-94 fused with Tec 
95-111 and Itk 112-154.  Point mutants were generated by site-directed mutagenesis 
(QuikChange II kit, Stratagene).  Sequences of all constructs were verified by the Iowa 
State University DNA Syndissertation and Sequencing Facility. 
 
Tests for soluble expression of PHTH constructs.  The plasmids described above 
were transformed into BL21(DE3) cells.  Cells were grown in LB media with 100µg/mL 
ampicillin at 37°C, 250 rpm until OD600 reached approximately 0.6, at which point 
temperature was lowered to 15°C and expression was induced with 0.1mM IPTG.  
Expression was carried out overnight (12-18 hours) at 15°C.  1mL of cells were 
centrifuged and cell pellets re-suspended in lysis buffer of 25mM Tris pH 7.5, 150mM 
NaCl, 20mM imidazole, and lysozyme.   Re-suspensions were stored overnight at -80 °C 
and then thawed at room temperature, lysing the cells, and DNAse and 1mM PMSF were 
added.  Lysates were centrifuged for 10 minutes at 14K rpm in a microcentrifuge at 4°C.   
Samples were then taken from the supernatant (S) and pellet (P) fractions, boiled for 5 
minutes in SDS-loading buffer, and analyzed by 12% SDS-PAGE and staining with 
coomassie brilliant blue. 
 
PI(3,4,5)P3 binding assay of full-length Itk.  Full-length Itk/TecHα was 
constructed using the same internal primers as for the ItkPH/TecHα construct and 
inserted into the pENTR/D-TOPOTM vector (Invitrogen) by TOPO cloning, with a C-
terminal FLAG tag.  Baculovirus was then generated and used to express the protein in 
insect cells, which was then purified via FLAG-affinity resin as described previously for 
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wild-type full-length Itk (13).  For both wild-type and Itk/TecHα, 300nM of purified full-
length enzyme was incubated for one hour at 4°C in 150μl of 20mM HEPES pH 7.4, 
150mM NaCl, 0.1% Nonidet P-40, with 15µl of PI(3,4,5)P3 coated agarose beads 
(Echelon Biosciences #P-B345a).  Beads were then washed 5 times in the same buffer, 
re-suspended in 2X SDS-loading buffer and boiled for 5 minutes.  Samples were run on 
8% SDS-PAGE gels and transferred to PVDF membranes by semi-dry western transfer 
and incubated overnight in primary antibody (1:1000 anti-FLAG).  Membranes were then 
washed 3 times in TBST, probed with secondary anti-Mouse-HRP, washed an additional 
3 times in TBST and imaged by chemiluminescence.   
 
Purification of soluble PH domains.  Protein was expressed, harvested, and lysed 
as described above (Tests for soluble expression of PHTH constructs).  Cleared lysate 
was passed over a Ni-NTA column equilibrated with lysis buffer (25mM Tris pH 7.5 at 4 °C, 150mM NaCl, 20mM Imidazole), washed and eluted with the same buffer containing 
40mM and 200mM Imidazole, respectively.  Protein was then concentrated and loaded 
onto Sephadex S300 or S100 size-exclusion columns, equilibrated in 25mM Tris pH 7.5, 
150mM NaCl, 2mM DTT, and sodium azide. 
For NMR studies, His6-GB1-ItkPH(C96E/T110I) was expressed in modified M9 
Minimal Media supplemented with 100μM ZnCl2 , 50µg/mL ampicillin, 15N ammonium 
chloride (1 g/l, Cambridge Isotope Laboratories) and either 13C glucose (2 g/l, Cambridge 
Isotope Laboratories) or un-enriched glucose as sole nitrogen and carbon sources.   Cells 
were induced with 0.1mM IPTG at OD600 = 0.7 and expression was carried out for 16 
hours for at 17°C.  Protein was then purified as described above with the following 
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additions: the His6-GB1 tag was cleaved with Factor Xa for 16 hours at room 
temperature; cleavage was stopped with 1mM phenylmethanesulfonylfluoride (PMSF) 
and once again passed over an Ni-NTA column, concentrated and loaded onto a 
Superdex-75 column equilibrated in 50mM potassium phosphate buffer pH 7.0, 150mM 
NaCl, 2mM DTT, and sodium azide; the protein was then concentrated to 600μM for 
NMR data acquisition. 
 
Circular Dichroism (CD) measurements.  CD measurements were performed on a 
Jasco J-715 spectropolarimeter (Jasco Inc.) for the far-UV region of 190-260nm, at 25 °C, as described previously (10) . 
 
NMR Spectroscopy.  NMR spectra were collected on a Bruker AVII 700 
spectrometer with a 5mm HCN z-gradient cryoprobe operating at a 1H frequency 700.13 
MHz.  Backbone chemical shifts of apo-ItkPH(C96E/T110I) are assigned using Sparky 
(41) and MARS (42) software programs, from the following pairs of triple-resonance 
experiments: HNCA and HN(CO)CA, HNCO and HN(CA)CO, and CBCA(CO)NH and 
CBCANH.  Spectra are referenced to DSS, directly in the 1H dimension and indirectly for 
the 13C and 15N dimensions, according to standard procedures.  Heteronuclear single 
quantum coherence (HSQC) spectra were also acquired for ItkPH(96E/T110I) in the 
presence and absence of 1 molar equivalent of inositol 1,3,4,5-tetrakisphophate (IP4, A.G. 
Scientific).  1D 1H NMR spectra were collected for wild-type His6-GB1-ItkPH and His6-
GB1-TecPH that was lyophilized and resuspended in 100% D2O.   All spectra were 
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acquired at 298K.  NMRPipe (43) and NMRViewJ (44) were also used for data 
processing, visualization, and analysis. 
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Figure Captions 
 
Figure 1.   ItkPH shows poor soluble expression compared to TecPH and BtkPH.  (A)  
Domain architecture of constructs used in this study: full-length Itk and three PH-TH 
domain constructs with N-terminal purification/solubility tags as indicated.  Numbering 
refers to the mouse Itk sequence.  (B-D) Itk, Tec and Btk PH-TH domain constructs with 
different N-terminal purification/solubility tags were expressed in BL21(DE3) cells, and 
the pellet (P) and soluble (S) fractions were analyzed by SDS-PAGE; the boxes indicate 
the bands corresponding to the PH-TH domain on each gel. (E) Superposition of one-
dimensional 1H NMR spectra for His6-GB1-TecPH (black spectrum) and His6-GB1-
ItkPH (red spectrum) in 100% D2O at identical concentrations (90uM).  The non-
exchangeable, aliphatic region is expanded for clarity. 
 
Figure 2.  A chimeric approach based on the TecPH sequence reveals that the α-helix of 
ItkPH is responsible for its poor expression behavior.  (A) Threaded structure of 
ItkPHTH onto the available BtkPHTH structures (14, 15) (PDB: 1BTK and 1B55); 
threading was performed using I-TASSER (45); the ribbon tracing the protein backbone 
is colored to indicate the four regions used in construction of the Tec/Itk chimeras.  
β strands	  1-4 are green, β strands	  5-7 are purple, the α-helix is cyan and the TH domain 
(or Btk motif) is dark blue.  The structural model of ItkPH was visualized in PyMOL (46) 
and is used in the subsequent Figures.  (B) Diagram describing the construction of the 
four Tec/Itk chimeras and the single Itk/Tec chimera.  Coloring for each of the regions 
matches that described in (A).   (C) Wild type (WT) and chimeric proteins were 
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expressed in BL21(DE3) cells and analyzed for soluble expression; pellet (P) and soluble 
(S) fractions were analyzed by SDS-PAGE and the boxes indicate the bands 
corresponding to the PHTH constructs; the arrows point to the chimeras in which the α-
helices of Tec and Itk have been swapped.  (D) Sequence alignment of the alpha-helices 
of ItkPH and TecPH, showing the residues that were swapped in the helix chimeras 
(amino acids 95-111); boxes highlight the eight amino acid differences between Tec and 
Itk in this region.  (E) Itk/TecHα retains canonical PIP3 binding activity in the context of 
full-length Itk; FLAG-tagged full-length wild-type Itk and full length Itk/TecHα are 
captured using PIP3-coated beads, washed, and analyzed by immunoblot (anti-FLAG):  
lanes correspond to total input (T), supernatant (S), and washed bead (B) samples. 
 
Figure 3.  Minimal sequence changes in ItkPH required to produce soluble protein. (A) 
Sequence alignment of the α-helices of ItkPH, TecPH, and BtkPH, with arrows indicating 
the most significant amino acid differences that were targeted for mutation. It is 
interesting to note that position 96 is not conserved between mouse and human Itk 
sequences; mutation of the mouse sequence to that of human (C96R) did not alter the 
expression and solubility behavior of ItkPH (data not shown). (B) Soluble expression 
analysis of single and double helix mutations; arrows point to the C96P/T110I and 
C96E/T110I mutations that rescue the poor expression of wild type ItkPH.  (C) Structural 
model of the Itk PH-TH domain: α-helix shown in cyan, positions C96 and T110 shown 
in red, N- and C-termini are labeled and the Zn2+ ion coordinated by the TH domain is 
shown in blue.  (D) Comparison of side-chain packing for threonine versus isoleucine at 
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position 110 in the threaded model of ItkPH reveals a significant cavity for T110, 
whereas I110 packs tightly against adjacent side-chains.  
 
Figure 4.  Characterization of purified PH domain proteins.  (A) Four different His6-
GB1 fusion proteins were purified and run through a Sephadex S300 sizing column; wild 
type ItkPH and ItkPH(C96P/T110I) show signs of aggregation, eluting in two peaks, 
whereas ItkPH/TecHα and TecPH WT each elute as a single peak corresponding to the 
size of the monomeric PH domain.  (B) Purified His6-GB1-ItkPH(C96P/T110I) and 
His6-GB1-ItkPH(C96E/T110I) were run through a Sephadex S100 sizing column.  
Unlike ItkPH(C96P/T110I), the ItkPH(C96E/T110I) mutant elutes as a single peak.  (C) 
After cleavage of the His6-GB1 tag, purified 13C/15N-labeled ItkPH(C96E/T110I) was 
passed over a Superdex-75 column on an Aktä	   FPLC	   system	   (solid	   black	   line).	   SDS-­‐PAGE	   analysis	   of	   the	   resulting	   fractions	   is	   shown	   above	   the	   FPLC	   trace.	   	   Protein	  standards	  (dashed	  purple	  and	  blue	  lines)	  are	  shown	  and	  indicate	  the	  major	  peak	  for	  
ItkPH(C96E/T110I) elutes in a manner consistent with its 19 kDa monomeric molecular 
weight.  	   Following	   completion	   of	   NMR	   data	   acquisition,	   the	   IP4-­‐bound	  ItkPH(C96E/T110I)	   was	   re-­‐injected	   onto	   the	   Superdex-­‐75	   column	   and	   run	   under	  identical	   conditions	   (solid	   red	   line).	   	   The	   slight	   shift	   in	   the	   elution	   profile	   of	   IP4	  bound	   ItkPH	   (compare	   red	   to	   black	   trace)	   is	   consistent	  with	   previously	   reported	  findings	   that	  PH	  domains	  exhibit	   restricted	  motions	  upon	  binding	   to	   IP4	   (47).	   (D)	  The	   two	   peaks	   (fractions	   24-­‐35	   and	   36-­‐41)	   from	   the	   initial	   ItkPH(C96E/T110I)	  Superdex-­‐75	   run	   (black	   trace	   in	   (C))	   were	   analyzed	   by	   circular	   dichroism	   (CD)	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spectroscopy.	   	   The	   two	   samples	   show	   no	   significant	   difference	   in	   secondary	  structure.   
 
Figure 5. Preliminary NMR characterization of apo- and IP4-bound ItkPH(C96E/T110I)  
(A) Complete 1H-15N HSQC spectrum of 600 µM ItkPH(C96E/T110I).  (B) 1H-15N 
HSQC spectrum of 600 µM ItkPH(C96E/T110I) in the presence of 600 µM IP4.  (C) 
Superposition of HSQC spectra acquired in the absence (black) and presence (red) of one 
molar equivalent of IP4.  Chemical shift changes of a subset of Itk resonances are shown.  
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CHAPTER 3.  THE ITK PH DOMAIN DIRECTLY 
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Abstract 
 We have identified a direct interaction between the Pleckstrin Homology (PH) 
domain and the kinase domain (KD) of Itk through a coimmunoprecipitation (CoIP) 
assay and NMR.  Using 1H-15N NMR backbone assignments of a solubilizing ItkPH 
mutant, ItkPHS, binding residues were mapped onto the Itk PH domain.  Mutagenesis 
studies were carried based on this mapping and revealed a subset of mutants that 
disrupted the ItkPH/ItkKD interaction in the CoIP assay.  These mutants were 
constructed in the context of full-length Itk using a baculovirus expression system.  
Preliminary results point to the ItkPH/ItkKD interaction playing a role in regulating 
activation-loop phosphorylation of the kinase domain at pY511, but have been 
complicated by activity assays that indicate the possible involvement of the subdomains 
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C-terminal to the PH domain: the Tec Homology (TH) and proline-rich-region (PRR).  
Future studies have been designed to build on the work presented here and clearly define 
the functional role of the ItkPH/ItkKD interaction.   Additionally, the PH domain of Itk 
specifically binds PI(3,4,5)P3 as an important step in co-localizing Itk to the T-cell 
Receptor (TCR), and I have shown that PI(3,4,5)P3 may out-compete ItkPH/ItkKD 
binding, suggesting a possible down-regulatory role for this interaction in the context of 
TCR recruitment. 
 
Introduction 
IL2-inducible T-cell kinase (Itk) is a Tec family kinase that fine-tunes signaling 
downstream of the T-Cell Receptor (TCR)1-3.  In this signaling pathway, Itk is co-
localized to the TCR through its Pleckstrin Homology (PH) domain specifically binding 
to phosphatidylinositol (3,4,5)-triphosphate (abbreviated as (PtdIns(3,4,5)P3, PI(3,4,5)P3, 
or PIP3).  Itk is involved in numerous protein-protein interactions, and is responsible for 
the phosphorylation and activation phospholipase C γ1 (PLCγ1)4-6, which catalyzes the 
hydrolysis of PI(4,5)P2 into the second messengers diacylglycerol (DAG) and IP3, which 
trigger calcium flux and other downstream signaling events that regulate immune 
response.  Itk’s role in this pathway has made it an appealing target for modulating the 
immune response in the context of disease states such as allergy and autoimmunity in that 
inhibiting Itk could dial down immune response without abolishing immune response 
altogether.   
Itk is a non-receptor tyrosine kinase that consists of five domains; the amino-
terminal Pleckstrin Homolgy (PH) domain, followed by the Tec Homology (TH) domain, 
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Src Homology 3 (SH3) domain, Src Homology 2 (SH2) domain and the catalytic kinase 
domain (KD) at the carboxy-terminus.  Previous work in our lab has characterized the 
structures and functional details of the SH3, SH2 and Kinase domains of Itk7-13; however, 
due to its poor expression and solution behavior, we have not previously been able to 
characterize the structure and function of the Itk PH domain.  Recent work has overcome 
this obstacle through the development of an ItkPH mutant, C96E/T110I, that increases 
soluble expression and remedies the poor solution behavior of wild-type ItkPH, without 
altering canonical PI(3,4,5)P3 binding14(Chapter 2 of this dissertation); this C96E/T110I 
mutant is hereafter referred to as ItkPHS, for solubilizing ItkPH. 
PH domains structures from many other proteins have been solved, including that 
of Bruton’s tyrosine kinase (Btk), the Tec family kinase expressed in B-cells15,16, and 
recently an NMR structure of the PH domain of the prototypical Tec kinase, Tec (PDB 
ID 2LUL, data not yet published).  All PH domains share a common fold consisting of a 
single α-helix adjacent to a 7-stranded β-barrel. Despite this conserved fold, PH domains 
have remarkably low sequence homology, with only a single tryptophan residue (W102 
in ItkPH) conserved across all PH domains17.  PH domains generally function to co-
localize their respective proteins to signaling complexes at the plasma membrane through 
phosphoinositide binding.  The PH domains of Tec kinases are part of a unique subset of 
PH domains that bind with high specificity and affinity to PI(3,4,5)P3.  PI(3,4,5)P3 is 
transiently produced by phosphoinositide-3-Kinase (PI3K) phosphorylating PI(4,5)P2 at 
its 3’-position, conferring tight control of the colocalization of Tec kinases to their 
respective signaling complexes.  In the Tec Family, this PI(3,4,5)P3/PH-domain 
interaction has only been structurally and biophysically characterized in BtkPH15,16.  
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Functional assays in cell lines have deduced that ItkPH, TecPH, and BmxPH are also 
colocalized upon PI3K signaling1,18-22; this result, coupled sequence conservation of key 
PIP3-binding residues, has led to the assumption that ItkPH, TecPH, and BmxPH also 
bind PI(3,4,5)P3 with high affinity and specificity, in the same orientation as BtkPH.  It 
should be noted that the fifth member of the Tec Family, Rlk, does not possess a PH 
domain. 
Recent studies have also elucidated many other functions of PH domains, in 
addition to their well-studied role of phosphoinositide binding and consequent 
colocalization to the plasma membrane23.   Some examples of these additional functions 
are binding to βγ-subunits of G Protein coupled receptors24, binding of filamentous 
actin25, and enzymatic regulation26,27.  Protein Kinase B (Akt/PKB) is an example of an 
enzyme that is regulated by its PH domain.  Akt/PKB is a kinase that contains an N-
terminal PH domain; like the PH domains of Tec kinases, AktPH has been shown to bind 
PI(3,4,5)P3 with high affinity and specificity28,29.  The PH domain of Akt regulates 
enzymatic activity by intramolecularly binding to its kinase domain, locking it into an 
inactive conformation and preventing phosphorylation on the activation loop27; the PH 
domain is released upon PI(3,4,5)P3 binding, freeing the kinase domain to be activated 
through phosphorylation on its activation loop at T308 by PDK126,30.  A similar 
mechanism has been suggested for Btk, based on the finding that the addition of PIP3 
vesicles to immunoprecipitated Btk, as well as deletion of its PH domain, each had a 
uniformly activating effect31.  A previous study also found evidence that the PH domain 
of Itk may play a role in regulating its enzymatic activity.  Ching et. al. found that PH-
domain deleted Itk (ΔPH Itk) prevented phosphorylation at pY511 by Lck in T-cells, thus 
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preventing activation of Itk.  In this study, to ensure that this effect was not simply due to 
ΔPH Itk not being properly colocalized within the proximity of Lck at the plasma 
membrane, the membrane-localization signal from Lck was added to the N-terminus of 
ΔPH Itk construct (referred to in that study as mΔPH Itk).  mΔPH Itk was shown to 
restore colocalization, but was unable to restore phosphorylation by Lck, suggesting a 
role for the Itk PH domain in regulating activation-loop phosphorylation at pY511. 
 In this work, we identify a direct interaction between the PH domain (ItkPH) and 
kinase domain (ItkKD) of Itk, and probe its functional significance in the context of full-
length Itk.  Preliminary results suggest that the ItkPH/ItkKD interaction regulates Itk by a 
different mechanism than that of Akt/PKB, but suggest a possible role for this interaction 
in regulation of kinase domain activation loop phosophorylation at pY511.  These results 
warrant further investigation and future experiments have been designed to build on the 
work presented here, with the aim of clearly defining the functional significance of the 
ItkPH/ItkKD interaction. 
 
Results 
1H-15N Backbone chemical shift assignments of ItkPHS.  We previously described 
the characterization of an ItkPH double mutant, C96E/T110I, referred to in this paper as 
ItkPHS, for “solubilizing” mutant of ItkPH.  ItkPHS rescues the poor expression and 
solution behavior of wild-type ItkPH without perturbing PI(3,4,5)P3 binding14.  Using a 
collection of pairs of triple-resonance NMR experiments, 1H-15N backbone chemical 
shifts were assigned to ~75% of ItkPHS (Figure 1).  The residues that were unable to be 
assigned with high confidence were due to missing peaks and irreconcilable breaks in the 
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chain of sequential assignments of α-carbon and β-carbon shifts from the triple resonance 
datasets.  
The Pleckstrin Homology domain of Itk (ItkPH) directly interacts with Itk Kinase 
domain (ItkKD).  To test whether the PH domain of Itk directly interacted with the kinase 
domain (KD), we developed a coimmunoprecipitation (CoIP) assay.  ItkPHS was 
immunoprecipitated with anti-Itk (aa 1-26 of the PH domain of Itk) in the presence of 
protein G beads and free Itk kinase domain (ItkKD) with a C-terminal FLAG tag.  The 
reverse CoIP was also performed, immunoprecipitating ItkKD-FLAG with anti-FLAG 
affinity resin in the presence of protein G beads and free ItkPHS.  All CoIP cases showed 
evidence of binding (Figure 2). 
NMR chemical shift mapping of the ItkPH/KD interaction.  To further corroborate 
the results of the CoIP assay and map the binding interface onto ItkPH, we performed an 
NMR titration of unlabeled His6-ItkKD into 15N-ItkPHS.  The starting concentration of 
15N ItkPHS was 200uM, and unlabeled His6-ItkKD was titrated into the sample at 0 µM, 
11 µM, 41 µM, and 82 µM titration points.  This concentration range was limited by low 
overall yields and instability at high concentrations of His6-ItkKD, which is expressed in 
an insect cell (High-Five) expression system.  In the titration, a subset of chemical shifts 
showed perturbations and differential loss of signal (Figure 3).  The peaks corresponding 
to the residues of the lone α-helix of ItkPH, which include the C96E and T110I 
solubilizing mutations in ItkPHS, show no change in chemical shift perturbations or loss 
of signal. 
The differential loss of signal observed upon binding in the ItkPH/KD interaction 
may indicate that the interaction is in the intermediate exchange regime; the size of the 
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bound complex (~52 kDa) and the fact that 5% glycerol was present in the buffer 
(necessary to stabilize ItkKD) may have exacerbated the loss of signal upon binding.  
Additionally, we were not able to assign 1H-15N chemical shifts for the residues that 
comprise the β1/β2-loop of ItkPH, which is adjacent to the mapped ItkPH/ItkKD 
interface; therefore, it is possible that this loop is also involved in the interaction with 
ItkKD.  This loop is involved in PI(3,4,5)P3 binding, and the preliminary results that 
indicate PI(3,4,5)P3 disrupts the ItkPH/ItkKD interaction suggests that this loop may 
indeed be involved in binding (Figure 4). 
PI(3,4,5)P3 out-competes the ItkPH/ItkKD interaction in the CoIP assay.  Based 
on the threaded model of ItkPH, the PI(3,4,5)P3 binding site is adjacent to the mapped 
interface of the ItkPH/ItkKD interaction (Figure 4, top), leading us to probe whether 
PI(3,4,5)P3 binding to ItkPH affected its ability to bind ItkKD.  CoIP results in which 
ItkPHS was pulled down with PI(3,4,5)P3 beads, in place of anti-Itk and protein G beads, 
showed that ItkKD did not bind (Figure 4, bottom).  A separate CoIP assay, which was 
performed with identical conditions to those of Figure 2 but in the presence or absence of 
soluble IP4, showed decreased binding of ItkKD in the presence of IP4 (Figure 4, 
bottom).  Together, these results suggest that PI(3,4,5)P3 out-competes the ItkPH/ItkKD 
interaction.  Further experimentation will be required to confirm this result (see Future 
Directions below). 
ItkPH/ItkKD interaction is disrupted by specific mutations.  Using the mapped 
residues from the NMR titration experiments, we probed for ItkPHS mutants at the 
interface that would disrupt the ItkPH/KD interaction.  A panel of His6-GB1-ItkPHS 
mutants was constructed and tested for binding via CoIP.  His6-GB1-ItkPHS was 
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immunoprecipitated with anti-His6 in the presence of ItkKD-FLAG for the entire panel 
of ItkPHS mutants (Figure 5).  Two mutants, F26Y/V28E and K48D/R49D, showed a 
significant loss of binding as compared to wild-type ItkPHS (Figure 5). 
K48D/R49D and F26Y/V28E/K48D/R49D mutants in the context of full-length Itk 
(ItkFL) affect activation loop phosphorylation at pY511 by Lck.  We next aimed to assess 
the functional affect of the K48D/R49D and F26Y/V28E/K48D/R49D disrupting 
mutations.  Baculovirus constructs for these two mutations were made in the context of 
full-length Itk (ItkFL) and then co-expressed with Lck in High-Five cells, as compared to 
full-length wild-type Itk (ItkFL WT).  Upon purification, the mutants showed no 
detectable phosphorylation by Lck at pY511, unlike wild-type Itk, which showed 
significant pY511 levels (Figure 6).  The following additional baculovirus constructs 
were made and co-expressed with Lck: ItkFL P158A/P159A, ItkFL K47D/K48D with 
residues 18-20 deleted, ItkFL PHS (C96E/T110I), ProKD (consisting of the Proline-rich 
region through the kinase domain; PRR-SH3-SH2-KD), and 32KD (consisting of the 
SH3 domain through the kinase domain; SH3-SH2-KD).  Like ItkFL WT, ItkFL PHS 
displayed significant phosphorylation at pY511 when co-expressed with Lck; however, 
all other constructs exhibited markedly reduced phosphorylation at pY511 (Figure 6). 
Together, these results suggest that the PH domain and proline-rich region (PRR) 
may act in a coordinated manner to control activation loop phosphorylation a pY511, and 
that the K48D/R49D and F26Y/V28E/K48D/R49D disrupt Lck’s ability to phosphorylate 
Itk at pY511, suggesting that the ItkPH/ItkKD interaction elucidated in this work may 
serve to positively regulate phosphorylation at pY511.  If this is indeed the case, it would 
suggest that the PH domain is binding the kinase domain in a manner that stabilizes the 
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kinase domain its activation loop “open” conformation and/or frees the activation loop 
from steric occlusion, promoting phosphorylations at pY511.  However, the analysis of 
these results is complicated by the possibly role of the PRR.  Future experiments will be 
required to tease out the effect of the ItkPH/ItkKD interaction and deduce a more sound 
functional conclusion. 
 
Discussion and Future Directions 
In this work, we have identified a direct interaction between the PH and kinase 
domains of Itk, as observed both by CoIP and NMR.  Using NMR chemical shift 
mapping, ItkPH mutants were constructed that specifically disrupt this interaction.  These 
disrupting mutations were then made in the context of full-length Itk and co-expressed 
with Lck in High-Five cells.  Unlike wild-type full-length Itk, the K48D/R49D and 
F26Y/V28E/K48D/R49D mutants were not phosphorylated on pY511 when co-expressed 
with Lck (Figure 6), suggesting a possible role for the PH domain and the ItkPH/ItkKD 
interaction in regulating activation loop phosphorylation on pY511.  Like the 
K48D/R49D and F26Y/V28E/K48D/R49D mutants, the ProKD construct was also 
unable to be phosphorylated at pY511 when co-expressed with Lck.  The 32KD 
construct, which lacks both the PH domain and PRR region, showed increased pY511 
levels from wild-type.  Cumulatively, these results suggest a mechanism in which the PH 
domain, ItkPH/ItkKD interaction, and PRR regulate activation loop phosphorylation at 
pY511 in a coordinated manner. 
Previous work in our lab showed that deletion of ItkPH and its subsequent linker 
resulted in altered enzyme kinetics using peptide B as a substrate, resulting in increases to 
 
 
 
57 
both kcat and km with respect to peptide B13.  This result, coupled with the finding that 
PI(3,4,5)P3 disrupts the ItkPH/ItkKD domain interaction, initially led us to hypothesize 
that ItkPH/ItkKD binding was a down-regulatory interaction.  Furthermore, Akt, like Itk 
posses an N-terminal PH domain that exhibits high affinity and specificity for 
PI(3,4,5)P3; Akt is down-regulated through an intramolecular interaction between its PH 
and kinase domains that is disrupted by the PH domain binding to PI(3,4,5)P3, releasing 
the kinase domain and allowing it to be phosphorylated on its activation at pT308 by 
PDK1, activating the enzyme.   
The results of this paper suggest that Itk is not regulated by an Atk-like 
mechanism, and that the ItkPH/ItkKD interaction may serve to regulate phosphorylation 
of Itk at pY511 by Lck (Figure 6).  A previous study found that PH domain deleted Itk 
(ΔPH Itk) was unable to be activated, showing no phosphorylation at pY511 by Lck in 
stimulated T-cells22; in this study ΔPH Itk (aa 136-620) was also found to affect 
colocalization of Itk to the TCR.  Ching et. al. then added the Lck membrane localization 
signal to the N-terminus of ΔPH Itk (referred to in their paper as mΔPH Itk), and 
interestingly, mΔPH Itk restored colocalization to the TCR, but it did not restore 
activation and phosphorylation at pY511 by Lck22.  The results we present here are in 
agreement with the results of Ching et. al., and suggests that the ItkPH/ItkKD interaction 
may regulate Itk’s ability to be phosphorylated by Lck, providing a mechanism to explain 
the results in Ching et. al. 22; however, additional experimentation is needed to evaluate 
the validity of this hypothesis.  
 Further investigation will be carried out to confirm the results presented in this 
chapter and to gain better insight as to the functional role of this ItkPH/ItkKD interaction, 
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and ItkPH’s role in regulating Itk catalytic activity.  Specifically, the NMR titration of 
unlabeled ItkKD into 15N-ItkPHS will be repeated, as well as performed with the 
disrupting mutants: 15N-ItkPHS K48D/R49D and 15N-ItkPHS F26Y/V28E/K48D/R49D.  
In repeating these titrations, we aim to obtain cleaner data to verify the mapping of the 
interaction onto ItkPH, as well as to verify the CoIP results and provide further evidence 
that K48D/K49D and F26Y/V28E/K48D/R49D specifically disrupt the ItkPH/ItkKD 
interaction.  If the NMR titrations support the disrupting effect of these mutants, we will 
further explore their effect on catalytic activity in the context of full-length Itk.  The Itk 
full-length K48D/R49D and F26Y/V28E/K48D/R49D mutants were unable to be 
phosphorylated by co-expression with Lck in High-Five cells; thus, in vitro kinase assays 
will be performed to test Lck’s ability to phosphorylate these Itk mutants at pY511 under 
in vitro conditions.  Itk “kinase dead” (K390R), which displays no activity in vitro, will 
be used as a negative control. 
 In this work, we have laid the groundwork for elucidating the structural basis for 
ItkPH’s affect on Itk catalytic activity, paving the way for future inquiry into role of the 
PH domain in regulating the Tec kinases.  However, much is yet to be determined, and 
future studies will be required to clarify the PH domain’s role with respect to regulating 
catalytic activity and activation loop phosphorylation.  In particular, questions of whether 
the PH domain acts independently, or in concert with the PRR and other regulatory 
domains, and if so, to what extent, will need to be further explored. 
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Materials and Methods  
Protein expression and purification.  ItkPHS (ItkPHTH C96E/T110I, amino acids 
1-154, mus musculus) was expressed and purified as in (1).  Briefly, a modified pET20b 
vector was used to express ItkPHS with an N-terminal His6-GB1 tag in (DE3)BL21 cells.  
Protein was purified using Ni-NTA chromatography, followed by Factor Xa cleavage of 
the His6-GB1 tag and size-exclusion chromatography on an FPLC system.  His6-ItkKD 
was expressed in High-Five cells and purified as described in Boyken et. al.14 (Chapter 2 
of this dissertation).  Baculovirus production, expression, and purification of full-length 
Itk constructs were carried out as described in (12,13), with the exception that in this 
work, suspension Hi-FiveTM cells (Invitrogen) were used in place of adherent Sf9 cells.  
The C-terminal SH2 domain of PLCγ1 was expressed and purified as in (12) for use as 
substrate for in vitro kinase assays.  All mutant constructs were generated by site-directed 
mutagenesis (Quikchange II kit, Stratagene). 
NMR Spectroscopy.  All NMR spectra were collected on a Bruker AVII 700 
spectrometer with a 5mm HCN z-gradient cryoprobe operating at a 1H frequency 700.13 
MHz, with a sample temperature of 298K.  1H-15N-backbone chemical shifts were 
assigned using Sparky (7) and MARS (8) software programs, utilizing the following pairs 
of triple-resonance experiments: HNCA and HN(CO)CA, HNCO and HN(CA)CO, and 
CBCA(CO)NH and CBCANH.  Spectra are referenced to DSS, directly in the 1H 
dimension and indirectly for the 13C and 15N dimensions, according to standard 
procedures. NMRPipe (9) and NMRViewJ (10) were also used for data processing, 
visualization, and analysis. 
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NMR Titrations.  NMR titrations were carried out as described previously (2). 
Unlabeled His6-ItkKD was added to 200 µM 15N-labeled ItkPHS and 1H-15N HSQC’s 
were acquired at the following concentrations of His6-ItkKD: 0 µM, 11 µM, 41 µM, and 
82 µM. 
 Coimmunoprecipitation experiments.  2 µM of purified ItkPHS or His6-GB1-
ItkPHS was first incubated with 30 µl (50% slurry) protein G beads and 3 µl anti-Itk 
(2F12) or anti-His6, respectively, for four hours or overnight at 4 °C with rocking in a 
CoIP buffer of 50mM Tris pH 7.4 at 4 °C, 150 mM NaCl, and 0.5% Nonidet P-40; 
protein G beads were then washed one time to remove ItkPHS and antibody not bound to 
protein G beads.  Purified ItkKD-FLAG or ItkLKD-FLAG was then added at 0.5 or 1.5 
µM and samples were incubated for 4 hours at 4 °C with rocking.  Samples were then 
washed 5 times with CoIP buffer, re-suspended in 2X SDS sample loading buffer, and 
boiled for 5 minutes.  Samples were analyzed by SDS-PAGE, semi-dry western transfer 
to PVDF, and blotting with anti-Itk or anti-His6 to detect ItkPHS, and anti-FLAG to 
detect ItkKD-FLAG.  CoIP assays in which ItkKD-FLAG was immunoprecipitated in the 
presence of free ItkPHS was performed as described above, with the following 
modifications:  ItkKD-FLAG was purified with anti-FLAG affinity resin, and during the 
final wash steps of the purification, the FLAG resin wash washed with CoIP buffer.  
Purified ItkPHS was then added 0.5 or 1.5 µM to the ItkKD-FLAG bound to the FLAG 
resin and incubated for 4 hours at 4 °C with rocking. 
Structural models of ItkPH.  Models of ItkPH were constructed with I-TASSER32 
and MODELLER33, using BtkPH (PDB ID’s 1BTK and 1B55) as the template.   
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In vitro kinase assays.  In vitro kinase assays and western blotting procedures 
were performed as in 13,34,35.  Activity was monitored with antibodes to α-pY783 on C-
terminal tail of PLCγ1-SH2C-linker and autophosphorylation of the activation loop of Itk 
(α-pY511).   The reactions were performed at room temperature for indicated time in a 
kinase reaction buffer of 20mM HEPES pH 7.0, 10mM MgCl2, 200µM ATP, 1mM DTT, 
1mM AEBSF, 1mg/mL BSA, and 0.5mM CaCl2.    
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Figure Captions 
 
Figure 1.  1H-15N Backbone chemical shifts of ItkPHS.  Shown is a 1H-15N HSQC of 
apo ItkPHS at 600 µM, peaks labeled with corresponding residue numbers. 
 
Figure 2.  Coimmunoprecipitation (CoIP) assay showing binding of ItkPH to ItkKD.  
(A) ItkKD-FLAG was immunoprecipitated with anti-FLAG affinity resin in the presence 
of free ItkPHS.  (B) ItkPHS was immunoprecipitated with anti-Itk (2F12, aa 1-26) in the 
presence of free ItkKD-FLAG.  (C) His6-GB1-ItkPHS was immunoprecipitated with anti-
His6 in the presence of ItkKD-FLAG.  All three CoIP cases, A, B, and C, show binding 
of ItkPH to ItkKD, with no binding to the antibody and protein G beads control (far right 
lane in all panels).  See Materials and Methods for details. 
  
Figure 3.  NMR mapping of the ItkPH/KD binding interface onto ItkPH.  (top)  1H-
15N HSQC of ItkPHS at 200 µM with the following concentrations of unlabeled ItkKD 
titrated in: 0 µM (blue), 11 µM (violet), 41 µM (red), and 82 µM (green).  (bottom) 
Threaded model of ItkPH, with mapped binding residues indicated in red.  
 
Figure 4.  PI(3,4,5)P3 disrupts the ItkPH/ItkKD interaction.  (top) ItkPH/ItkKD 
interfaced mapped onto the threaded model of ItkPH shows that the mapped residues 
(Figure 3) are adjacent to the PI(3,4,5)P3 binding site.  (bottom, left) 
Coimmunoprecipitation assay as in Figure 2, in the presence or absence of soluble IP4; 
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ItkKD shows decreased binding to ItkPHS in the presence of IP4.  (bottom, right) lanes 1-
3: coimmunoprecipitation assay as in Figure 2; lanes 4-6: same as lanes 1-3 except 
ItkPHS is pulled down with PI(3,4,5)P3 agarose beads instead of anti-Itk; no binding of 
ItkKD is observed when ItkPHS was pulled down using the PI(3,4,5)P3 beads. 
 
Figure 5.  Coimmunoprecipitation assay as in Figure 2 with panel of ItkPHS 
mutants.  Mutants F26Y/V28E and K48D/R49D show significantly reduced binding to 
ItkKD. 
 
Figure 6.  Purfied full-length Itk constructs purified from High-Five insect cells 
after co-expression with Lck.  Purified preps were assessed for purity and relative 
concentration by SDS-PAGE (8%) and coomassie staining.  Purified preps were assessed 
for activation loop phosphorylation on pY511 by western transfer and blotting with anti-
pY511.  The same sample preps that were assessed by coomassie staining were used for 
pY511 analysis, loading proportional amounts of sample across both gels.  32KD and 
full-length Itk WT (ItkFL WT), and ItkFL PHS all display significant pY511 levels, 
whereas all other constructs display markedly reduced pY511 levels; two independent 
preps of ItkFL F26Y/V28E/K48D/R49D, and ItkFL K48D/R49D, display no detectable 
levels of pY511. 
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CHAPTER 4. IDENTIFICATION AND 
CHARACTERIZATION OF A DIRECT INTERACTION 
BETWEEN THE PLECKSTRIN HOMOLOGY (PH) 
DOMAIN OF ITK AND CALMODULIN 
 
This chapter consists of my contribution to a collaborative project with Dr. Yina Huang 
and Xinxin Wang at Washington University in St. Louis, MO. 
 
Abstract 
 With collaborators Dr. Yina Huang and Xinxin Wang, I helped identify and 
characterize a positive-regulatory interaction between Itk and Calmodulin (CaM) in T-
cells.  I have mapped this interaction to the Pleckstrin Homology (PH domain) of Itk via 
NMR.  The interaction between ItkPH and CaM is under intermediate exchange, resulting 
in extensive line-broadening and loss of NMR signal upon binding, making it difficult to 
clearly map the interaction.  I overcame this challenge by performing NMR titrations 
with isolated individual domains of CaM (N-lobe and C-lobe), which resulted in fast-
exchange, linear chemical shift perturbations, as well as a reduced molecular weight of 
the complex, resulting in greater signal/noise.  Through these experiments, I was able to 
clearly map the binding interface, show that the binding is Ca2+-dependent, that there is 
differential specificity and affinity between the N and C-lobes of CaM for ItkPH, and that 
PI(3,4,5)P3 (the canonical ligand of ItkPH) competes with CaM binding.  Additionally, I 
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identified a mutation in the PH domain that disrupts the PH/CaM interaction without 
affecting canonical PI(3,4,5)P3 binding, and the Huang group is currently using this 
mutant in T-Cell experiments to further probe the biological significance and finish this 
work.  I also measured the affect of CaM binding on Itk activity in vitro. 
 
Introduction 
Calmodulin (CaM) plays an important role in T-cell Receptor (TCR) signaling 
and subsequent immune response.  Activation of the TCR sets off a phosphorylation 
cascade inside the T-cell.  In this cascade, the Src Family Kinase Lck phosphorylates 
IL2-inducible T-cell kinase (Itk), activating it; Itk in turn phosphorylates pY783 of 
PLCγ1, activating it, and PLCγ1 then hydrolyzes PI(4,5)P2 into the second messengers 
Inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG).  IP3 binds its receptor on the 
endoplasmic reticulum (ER), resulting in calcium flux.  This release of calcium allows 
Ca2+ to bind CaM, changing its conformation and allowing it to interact with many 
binding partners, particularly calmodulin kinases (CAMKs) and calcineurin (CN).  Once 
activated by CaM, CN dephosphorylates the SRR-region of transcription factor NFAT, 
facilitating its nuclear transport through exposure of its nuclear localization signal.  Once 
in the nucleus, NFAT contributes to regulating the expression of various genes critical for 
immune response, including cytokine production in T-cells.  Calmodulin has also been 
implicated in PI3K signaling1, which plays an important role in TCR signaling and 
regulates the colocalization of Itk through binding of its Pleckstrin Homology (PH) 
domain to PI(3,4,5)P3. 
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With our collaborators, Dr. Yina Huang and Xinxin Wang, we have identified a 
novel, positive-regulatory interaction between CaM and the PH domain of Itk.  In this 
work, I have mapped the interaction to the PH domain of Itk and performed extensive 
NMR experiments to thoroughly characterize this interaction.  Wild-type ItkPH cannot be 
purified for NMR due to its unstable, aggregation-prone solution behavior; however, I 
previously identified a double mutant, C96E/T110I (ItkPHS), that overcomes this poor 
expression and solution behavior2(Chapter 2 of this dissertation).  ItkPHS is used 
throughout this paper, and results show that the solubilizing mutantions, which are both 
located on the lone α-helix of ItkPH, are not at the binding interface of the ItkPH/CaM 
interaction. 
 
Results and Discussion 
 Mapping of the CaM/ItkPH interaction using NMR.  To map the binding residues 
involved in the CaM/ItkPH interaction onto the surfaces of both ItkPH and CaM, I 
performed a series of NMR titrations, utilizing the 1H-15N-backbone chemical shift 
assignments for ItkPHS that were detailed in Chapter 3 of this dissertation, as well as 
publically available backbone chemical shifts for CaM.  First, to map the ItkPH side of 
the binding interface, unlabeled full-length CaM (CaM-FL) was titrated into 300µM 15N-
ItkPHS.  Binding was observed, but the interaction between ItkPHS and CaM-FL is in the 
intermediate exchange regime, resulting in extensive line-broadening and loss of NMR 
signal upon binding, making it difficult to clearly map the interaction (Figure 1).  The 
reverse titration of unlabeled ItkPHS into 15N-CaM-FL also showed significant loss of 
signal due to intermediate exchange (Figure 4).   
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 I overcame this challenge by performing NMR titrations with isolated individual 
domains of CaM, CaM-N and CaM-C (N-terminal domain and C-terminal domain), 
which resulted in fast-exchange, linear chemical shift perturbations, as well as a reduced 
molecular weight of the complex, resulting in improved spectral qualities throughout the 
titration.  In addition to overcoming the intermediate exchange issues, these titrations 
provided valuable data as to the differential binding preferences of the two CaM domains.  
As has been found in other CaM-binding interactions3,4, isolated CaM-C binds with high 
affinity, whereas isolated CaM-N exhibits no detectable binding for both apoCaM-N and 
Ca2+CaM-N cases (Figure 9); however, 15N-CaM-FL titrations with unlabeled ItkPHS 
showed chemical shift perturbations in the N-terminal domain of CaM (Figure 4), and 
15N-ItkPHS titrations with CaM-FL resulted in additional chemical shift changes than the 
titration with CaM-C (Figure 10), suggesting that the N-lobe does bind in the context of 
full-length calmodulin (CaM-FL), but requires the presence of the C-terminal domain for 
binding.  The affect of Ca2+ was also measured, and 11 titrations were performed in total 
(Table 1).  Binding was found to be Ca2+-dependent (Figures 1, 2, 3, and 4).  Titrations of 
15N-CaM-FL, both Ca2+-bound and apo, with unlabeled ItkPHS were also performed to 
identify residues in CaM that display significant chemical shift perturbation upon binding 
of ItkPHS (Figure 4). 
 Estimation of dissociation constants (Kd) for the CaM/ItkPH interaction.  Kd’s 
were estimated by fitting of binding curves to plots of average chemical shifts vs. ligand 
concentration for the NMR titrations.  A Kd of 42 µM was determined for apo-CaM-C 
binding to ItkPHS.  The fit of the binding curve for Ca2+CaM-C estimates a Kd of ~13 
µM; however; this estimation is not reliable due to the linear binding curve that results 
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from the ligand concentration at all titration points exceeding the Kd.  For titrations with 
CaM-FL, a Kd could not be precisely determined using NMR due to the extensive line-
broadening and loss of signal; however, because the interaction is under intermediate 
exchange and likely greater than or equal to the affinity of CaM-C, we estimate that the 
Kd for ItkPH/CaM-FL is in the low µM-range.  To accurately determine Kd’s for 
Ca2+CaM-C and CaM-FL, a technique other than NMR that does not require such high 
protein concentrations will be required. 
 Binding of IP4 (the soluble head group of PI(3,4,5)P3) to ItkPHS out-competes the 
CaM/ItkPHS interaction.  To probe the affect of IP4/PIP3 on the CaM/ItkPHS interaction, 
at the end of each of the aforementioned titrations, soluble IP4 was titrated into sample.  
In all titrations, the addition of IP4, rescued any signal that was lost due to intermediate 
exchange, and resultant chemical shifts were indicative of the unbound conformation 
(Figure 5).  For all 15N-apoCaM and 15N-Ca2+CaM titrations, the final chemical shifts 
after addition of IP4 overlayed the chemical shifts of unbound CaM, and for the 15N-
ItkPHS titrations, the endpoints of the titration after addition of IP4 were identical for IP4-
bound to ItkPHS in the absence of CaM (Figure 5). 
Intrinsic disorder likely explains the specificity of PH domains that can bind CaM 
and the mechanism by which CaM binds.  Based on computational predictions using the 
Calmodulin Target Database5, we found that numerous other PH domains can likely bind 
CaM, and I have proposed that this binding may be dependent upon some degree of 
intrinsic disorder in the binding region.  PH domains that bind CaM show regions of 
predicted disorder that overlap with, or are adjacent to, their predicted CaM binding 
residues, particularly near the C-terminal end of the binding site; for example, Itk-PH, 
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Veph1-PH, and cdc42bp-PH were all shown to bind CaM (Figure 1) and all regions of 
predicted disorder near their predicted CaM-binding site (Figure 6).  Caps2-PH and 
Phlpp2-PH showed no binding in pull-down assay, despite having predicted CaM binding 
regions; interestingly, these two PH domains have markedly less predicted disorder near 
their predicted CaM-binding sites (Figure 6).  Btk-PH, despite having very similar 
sequence to the ItkPH CaM-binding region, showed much weaker affinity for CaM than 
ItkPH (data not shown).  Itk-PH shows predicted disorder in the region of CaM-binding, 
whereas Btk-PH shows less predicted disorder in this region.  Furthermore, the ItkPH(Btk 
β3/β4-loop) mutant that disrupts the ItkPH/CaM interaction is also predicted to decrease 
the disorder in the CaM-binding region of ItkPH (Figure 7). 
For all PH domains predicted to bind CaM, the predicted binding residues span 
regions of β-sheets, and the region of ItkPHS that binds CaM, as mapped via NMR, 
corresponds primarily to a β-sheets.  No structure exists for CaM bound to a β-sheet and 
most canonical CaM-binding events involve binding of helices, however, recent work has 
shown CaM binding to disordered regions in proteins6,7.  It is likely that for CaM-binding 
to PH domains, these β-strands and their encompassing loops become partially disordered 
upon binding of CaM.  CaM has been shown to bind to a beta-sheet region of the 
Pleckstrin Homology (PH) domain of Akt1/PKB, and it was shown that the region of 
Atk1-PH primarily responsible for this binding consisted of amino acids 1-42 of the Akt1 
PH domain8; this work also showed that CaM competed with the canonical PIP3 binding 
of Akt1-PH (for which the key binding residues are also in this region), suggesting a 
down-regulatory role for the Akt1-calmodulin interaction8.  But the structural basis of 
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this Akt1-PH/CaM interaction remains poorly understood, and to the best my knowledge, 
no other PH domains have been shown to bind to CaM prior to this study. 
 
 
Materials and Methods 
Structural models of ItkPH.  Models of ItkPH were constructed with I-TASSER9 
and MODELLER10, using BtkPH (PDB ID’s 1BTK and 1B55) as the template.   
In vitro kinase assays.  Kinase assays and western blotting procedures were 
performed as in (12,13,14).  Activity was monitored by anti-pY783 on the C-terminal 
SH2 domain of PLCγ1 and autophosphorylation of the activation loop of Itk (anti-
pY511).  Full-length Itk was expressed using baculovirus and purified using FLAG-
affinity resin as described in (12,13), with the exception that in this work, suspension Hi-
FiveTM cells (Invitrogen) were used in place of adherent Sf9 cells.  The C-terminal SH2 
domain of PLCγ1 was expressed and purified as in (12).  Ca2+CaM was dialyzed into 
HEPES NMR Buffer (see below) and added at indicated concentrations, along with 
corresponding buffer controls to ensure equal buffer composition across all reactions.  
The reactions were performed at room temperature for 30 minutes in 20mM HEPES pH 
7.0, 10mM MgCl2, 200µM ATP, 1mM DTT, 1mM AEBSF, 1mg/mL BSA, and 0.5mM 
CaCl2.    
Protein expression and purification for NMR studies.  The stabilizing double 
mutant, ItkPHS (ItkPHTH C96E/T110I, amino acids 1-154, mus musculus) was expressed 
and purified as in (1).  Briefly, a modified pET20b vector was used to express ItkPHS 
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with an N-terminal His6-GB1 tag in (DE3)BL21 cells.  Protein was purified using Ni-
NTA chromatography, followed by Factor Xa cleavage of the His6-GB1 tag and size-
exclusion chromatography.  The following rat calmodulin constructs were expressed and 
purified as in (3): CaM-FL (1-148), CaM-C (76-148), CaM-N75 (1-75), CaM-N80 (1-
80).  For NMR titrations, proteins were dialyzed into 50mM HEPES pH 7.4, 150mM 
NaCl, 2mM DTT, 0.02% NaN3 (and 1mM CaCl2 for Ca2+CaM experiments).  For apo-
CaM titrations, CaM was treated with EGTA or EDTA and then dialyzed into calcium-
free NMR buffer  (it should be noted that ItkPHTH binds a Zn2+ ion that is likely 
necessary for the proper fold of this domain; hence, EDTA/EGTA needs to be dialyzed 
away).  For Ca2+CaM experiments, a five-fold excess of CaCl2 was added to the CaM 
prep, which was then dialyzed into 1mM CaCl2 NMR buffer. 
NMR Spectroscopy.  All NMR spectra were collected on a Bruker AVII 700 
spectrometer with a 5mm HCN z-gradient cryoprobe operating at a 1H frequency 700.13 
MHz, with a sample temperature of 298K.  1H-15N-backbone chemical shifts were 
assigned using Sparky (7) and MARS (8) software programs, utilizing the following pairs 
of triple-resonance experiments: HNCA and HN(CO)CA, HNCO and HN(CA)CO, and 
CBCA(CO)NH and CBCANH.  Spectra are referenced to DSS, directly in the 1H 
dimension and indirectly for the 13C and 15N dimensions, according to standard 
procedures. NMRPipe (9) and NMRViewJ (10) were also used for data processing, 
visualization, and analysis. 
NMR Titrations.  NMR titrations were carried out as described previously (2).  
For each titration, unlabeled ligand was added to 15N-labeled protein and 1H-15N HSQC’s 
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were acquired for each of the following molar ratios: 0.07:1, 0.25:1, 0.5:1, 0.75:1, 1:1, 
1.2:1, and 1.5:1.   For titrations of individual CaM domains, additional titration points 
were collected to ensure saturation of binding.  After saturation was reached, IP4 was 
titrated into the sample, up to a 2:1 ratio of IP4:ItkPH.  Table I lists the 11 titrations 
performed.  Titrations with CaM-FL experienced extensive line-broadening; this problem 
was circumvented by utilizing the individual domains of CaM, which yielded crosspeaks 
undergoing fast exchange that could be monitored until saturation, allowing for 
determination of dissociation constants.  The differential line-broadening in CaM-FL 
titrations matched well with the peaks showing significant chemical shift perturbations in 
the CaM-C titrations, allowing for mapping of the binding interface onto the structural 
models of ItkPH.  The 1H and 15N chemical shift changes were combined into a 
weighted-average chemical shift: 
 
Dissociation constants (Kd) were determined using an in-house MATLAB script to fit Ka-
1 and δmax in the following equation: 
 
where Δδ is the weighted-average chemical shift change and [P]0 and [L]0 are the total 
concentrations of protein and ligand, respectively.  Ka-1 (equal to 1/Ka) is the dissociation 
constant, Kd 
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Table I.  NMR Titrations performed and their corresponding Kd 
 15N-labeled     (initial conc.) Unlabeled Kd 
1 apo-CaM-FL  (150µM) ItkPHS * 
2 Ca2+CaM-FL  (150µM) ItkPHS * 
3 Ca2+CaM-FL  (300µM) ItkPHS * 
4 ItkPHS            (300µM) apo-CaM-FL * 
5 ItkPHS            (300µM) Ca2+CaM-FL  * 
6 ItkPHS            (300µM) apo-CaM-C 42 µM 
7 ItkPHS            (300µM) Ca2+CaM-C ~13 µM** 
8 ItkPHS            (300µM) apo-CaM-N75 *** 
9 ItkPHS            (300µM) Ca2+CaM-N75 *** 
10 ItkPHS            (300µM) apo-CaM-N80 *** 
11 ItkPHS            (300µM) Ca2+CaM-N80 *** 
*   Kd could not be determined precisely due to extensive line-broadening 
** Kd is not precise due to [ligand] >> [Kd] and resultant linear binding curve 
*** Kd not determined due to lack of binding 
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Figure Captions 
 
Figure 1.  Mapping of binding interface by titration of 15N-ItkPHS with unlabeled 
Ca2+CaM-C (A) and Ca2+CaM-FL (B); initial concentration of 15N-ItkPHS is 300µM and 
colors correspond to the molar ratio of 15N-ItkPHS:Ca2+CaM at each titration point, for 
which a 1H-15N HSQC was acquired: 1:0 (red), 1:0.07 (magenta), 1:0.25 (blue), 1:0.5 
(cyan), 1:0.75 (turquoise); 1:1 (lime green); 1:1.2 (green); 1:1.5 (dark green).  Peaks 
showing changes indicative of binding are labeled: residue labels in red correspond to 
peaks that show changes in both titrations (fast exchange chemical shifts upon addition of 
CaM-C, and differential line-broadening upon addition of CaM-FL); residue labels in 
black correspond to peaks that show differential line-broadening upon addition of CaM-
FL, but no change upon addition of CaM-C, indicating the putative binding interface for 
the N-terminal domain of Ca2+CaM-FL (See Figure S10).  (C) Most peaks showing 
significant chemical shift perturbation in CaM-C titration match peaks experiencing line-
broadening in CaM-FL titration.  (D) Sequence of ItkPHS: residues showing significant 
shifts upon binding to Ca2+CaM are colored in red; residues for which backbone 
assignments could not be made with high confidence are colored in blue; the stabilizing 
mutations, C96E and T110I are in orange; numbers below the sequence indicate residues 
predicted to bind CaM, with contiguous 8’s and 9’s predicted to bind with high affinity, 
according to the Calmodulin Target Database5.  (E) Binding residues mapped onto a 
structural model of ItkPHS, with coloring as in (D); the Zn2+ ion is shown as a gray 
sphere and IP4 is shown in yellow. 
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Figure 2.  NMR titrations of 15N-ItkPHS with unlabeled Ca2+CaM-C (A) and apo-CaM-C 
(B) show calcium-dependence of the ItkPH/CaM interaction.  Residues showing 
significant chemical shift change are labeled in red; residues that show significant 
chemical shift upon addition of Ca2+CaM-C, but not apo-CaM-C are labeled in black in 
(B).  It is interesting to note that many more residues show significant shifts for Ca2+CaM 
than apo-CaM.  Shifts are also bigger and saturate at lower concentration for Ca2+CaM, 
indicative of higher affinity (see Figure 3). 
 
Figure 3.  Kd estimation by NMR titrations of 15N-ItkPHS and unlabeled CaM-C shows 
calcium-dependence of ItkPH/CaM interaction: (left) Ca2+CaM-C, Kd ~ 13µM, (right) 
apo-CaM-C, Kd = 42µM.   Resonances showing chemical shift perturbations greater than 
two standard deviations above the mean were used to determine Kd by parameter 
estimation, fitting Kd and δmax, where δmax is the final chemical shift value (see Materials 
and Methods).  Plots show the change in the weighted-average chemical shift for 
corresponding concentrations of CaM-C (in mM), colored by residue.  For the purposes 
of comparison, δmax for each residue was normalized to 1.  The reported Kd is the average 
of the fitted Kd’s for the individual residues (represented by the thick black line in the 
plots). 
 
Figure 4.  Mapping of binding interface onto CaM by titrations of unlabeled ItkPHS into 
15N-apo-CaM-FL (A) and 15N-Ca2+CaM-FL (B); initial concentration of 15N-CaM is 
150µM in both titrations and colors correspond to the molar ratio of 15N-ItkPHS:Ca2+CaM 
at each titration point; 1:0 (red), 1:0.07 (magenta), 1:0.25 (blue), 1:0.5 (cyan), 1:0.75 
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(teal); 1:1 (lime green); 1:1.2 (green); 1:1.5 (dark green).  Residues showing differential 
line-broadening were mapped onto structures of CaM in (C) and (D).  It is interesting to 
note that for apo-CaM, only the C-terminal domain shows shifts indicative of binding, 
whereas Ca2+CaM shows participation of both the N-term and C-term domains.  It should 
be noted that CaM often undergoes significant conformational changes during binding 
and that changes in the NMR spectra may be indicative of this conformational change 
and not necessarily directly contacting ItkPH.  It should also be noted that the 1H-15N 
backbone chemical shift assignment for the exact rat-CaM construct used in this study are 
not publically available.  Most residues assignments were able to be deduced with high 
confidence from assignments of related CaM datasets; however, these will have to be 
confirmed before publication of these results. 
 
Figure 5.  IP4/PIP3 competes with ItkPH/CaM Interaction.  (A) Endpoint of 15N-
Ca2+CaM-FL titration with 1.5 molar equivalent of unlabeled ItkPHS before (left) and 
after (right) addition of IP4 (1.5 molar equivalent to ItkPHS) is shown in black.  After 
addition of IP4, Line-width is restored to that of the monomer and peaks closely match 
the unbound 15N-Ca2+CaM-FL spectrum, which is shown in red.  (B) Endpoint of 15N-
ItkPHS titration with Ca2+CaM-FL before (left) and after (right) addition of IP4 (1.5 molar 
equivalent to ItkPHS) is shown in black.  Addition of IP4 alleviates line-broadening and 
peaks closely match those of 15N-ItkPHS bound to IP4 in the absence of CaM, which is 
shown in red. 
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Figure 6.  Intrinsic disorder may explain specificity and affinity of PH domain 
binding of CaM.  Sequences of six PH domains are shown, all of which have sequences 
predicted to bind CaM; the numbers below the amino acid sequence indicate predicted 
CaM-binding residues, according to the Calmodulin Target Database5; contiguous 
sequences of 8’s and 9’s are predicted to bind with high affinity.  The plots below the 
sequences represent predicted regions of disorder, according to the prediction servers 
PreDisorder (red)11 and DisEMBL 1.5 (green)12; the y-axis is probability of disorder and 
the x-axis is the residue numbers for that PH domain.  The black rectangles outline the 
residues predicted to bind CaM. 
 
Figure 7.  The ItkPH(Btk β3/β4-loop) mutant alters predicted CaM-binding residues and 
predicted regions of disorder.  Residues colored in red are actual binding residues as 
mapped via NMR.  The β3/β4-loop residues mutated are highlighted in yellow.  All other 
labeling is an in Figure S5. 
 
Figure 8.  1H-15N TROSY Spectrum of 300µM 15N-Ca2+CaM before (red) and after 
addition of 1.5 molar equivalent ItkPHS.  TROSY does not improve line-broadening and 
loss of signal, indicating that the interaction is in intermediate exchange and/or the 
CaM:ItkPHS complex is larger than a 1:1.  Due to the fact that the line-broadening is non-
uniform (with binding residues experience more line-broadening), that TROSY does not 
alleviate the broadening, and the estimated affinity of the interaction, it is most likely that 
the line-broadening is due to the interaction falling into the intermediate exchange with 
respect to the NMR timescale. 
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Figure 9.  The N-terminal domain of CaM alone shows no binding to ItkPHS, even 
in the presence of Ca2+.  1H-15N HSQC NMR titrations of 15N-ItkPHS with unlabeled N-
terminal CaM domains: (left) CaM-N75 and (right) CaM-N80. 
 
Figure10.  Titration of 15N-ItkPHS with Ca2+CaM-C shows saturation of binding at a 
1:1.5 molar ratio of ItkPHS:CaM, as shown by the exact overlaps of peaks between 1:1.5 
(dark green) and 1:1.8 (black). 
 
Figure 11.  Putative binding site on the surface of ItkPHS for the N-terminal domain of 
Ca2+CaM-FL.  Images corresponding exactly to those of figure 3, with the putative N-
terminal domain binding residues of ItkPHS labeled in black in (A) and in magenta in (B) 
and (C). 
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CHAPTER 5.  THE BTK TRANSFORMING MUTANT E41K 
ACTS BY MODULATING PHOSPHOINOSITOL 
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Abstract 
 Bruton’s tyrosine kinase (Btk) and the Tec family tyrosine kinases contain N-
terminal Pleckstrin Homology (PH) domains that are part of a small subset of PH 
domains that exhibit high specificity and affinity to the transiently produced 
phospholipid, PI(3,4,5)P3.  This specificity is essential for the co-localization and tight 
regulation of the Tec kinases, which play key roles in signaling related to lymphocyte 
activation and development; Btk functions in signaling downstream of the B-cell 
Receptor (BCR).  A mutant in the PH domain of Btk, E41K, has been shown to render 
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Btk constitutively membrane-bound and active; however, the mechanism by which this 
mutant confers its constitutive activation has remained elusive.  Similar glutamate to 
lysine mutations have been identified in the PH domains of Akt and Grp1, for which the 
mechanisms of constitutive membrane binding and activity have been elucidated; these 
Akt and Grp1 mutants increase affinity for PI(4,5)P2, which is more prevalent and less 
transient than PI(3,4,5)P3.  In this work, we demonstrate that Btk E41K also increases 
affinity for PI(4,5)P2.  But Btk-PH structures show differences from Akt1-PH and Grp1-
PH structures that suggests a unique mechanism by which Btk E41K binds PI(4,5)P2: 
through induced dimerization at the plasma membrane, and through a second PIP binding 
site that is dependent upon dimerization and exhibits affinity for PI(4,5)P2.  We 
experimentally probe this mechanism via biochemical assays, Surface Plasmon 
Resonance (SPR), and nuclear magnetic resonance (NMR).  In vitro kinase assays of 
wild-type (WT) Btk also indicate potential induced dimerization at the plasma membrane 
upon PI(3,4,5)P3 binding, showing increased Btk activity as evidenced by higher levels of 
phosphorylation at pY551 in the activation loop (A-loop) of Btk.  E41 in BtkPH is 
conserved across all of the PH domains of the Tec family kinases.  Thus, we also 
investigate E42K (analogous to E41K in Btk) in the Tec kinases Itk and Tec; 
interestingly, E42K in Itk-PH and Tec-PH does not increase affinity for PI(4,5)P2,  
suggesting that the affect of this glutamate to lysine mutation is unique to Btk. 
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Abbreviations 
Pleckstrin Homology (PH); Bruton’s tyrosine kinase(Btk); IL-2 inducible T-cell kinase 
(Itk); Protein Kinase B (PKB); General Receptor for Phosphoinositides 1 (GRP1); 
Phosphoinositide-3-Kinase (PI3K);phosphatidylinositol (3,4,5)-trisphosphate 
(PI(3,4,5)P3, PIP3); phosphatidylinositol (4,5)-bisphosphate (PI(4,5)P2, PIP2); X-linked 
agammaglobulinemia (XLA). 
 
Introduction 
Btk and Tec family kinases, as well as Akt/PKB and Grp1, all contain Pleckstrin 
Homology (PH) domains that are part of a unique subset of PH domains that exhibit high 
specificity and affinity for phosphatidylinositol (3,4,5)-trisphosphate (PIP3)1.  This 
property is essential to the functionality of these enzymes, allowing for tightly regulated 
activation and co-localization to their respective signaling complexes, mediated by 
Phosphoinositide-3-Kinase (PI3K) signaling; PI3K phosphorylates PI(4,5)P2 on its 3ʹ′-
position, yielding PI(3,4,5)P3 and subsequently recruiting these PH domains to the 
plasma membrane.  The Tec family kinases (Btk, Itk, Tec, Bmx, and Rlk) are found 
primarily in hematopoietic cells and regulate key signaling events in lymphocyte 
activation, differentiation, and development.  Btk is found primarily in B-cells and 
contributes to proper B-cell Receptor (BCR) signaling and antibody production.  
Mutations in Btk are responsible for X-linked agammaglobulinemia (XLA)2-4, and Btk is 
a current drug target for certain autoimmune diseases, such as Rheumatoid Arthritus5,6.  
Akt/PKB is a member of the AGC family of kinases and is primarily involved in 
apoptosis-related signaling, having important implications for cancer7,8.  General 
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Receptor for Phosphoinositides 1 (GRP1) is an Arf6 guanidine-nucleotide exchange 
factor involved in the activation of Arf6-GDP9. 
The PH domains of Btk, Grp1, and Akt have a conserved arginine residue (R28 in 
Btk) that interacts with the 3ʹ′phosphate of PI(3,4,5)P3 and is responsible for the high 
specificity and affinity to this transiently produced phospholipid (Figure 1).  Mutation of 
this arginine significantly disrupts phosphoinositide binding and downstream 
signaling8,10-12. Mutations at this position in Btk have been found in humans with XLA, 
and R28C results in x-linked immunodeficiency (xid) in mice11.  High specificity to 
PI(3,4,5)P3 is equally important in that it is necessary for these PH domains to 
discriminate against the more ubiquitous PI(4,5)P2, which is over a hundred-fold more 
prevalent than PI(3,4,5)P3, even at maximum levels of PI(3,4,5)P3 during PI3K 
signaling13,14.  Akt catalytic activity is regulated by its PH domain, which binds 
intramolecularly to its C-terminal kinase domain (KD), locking it into an inactive 
conformation15.  The PH domain is released through PIP3-binding, which simultaneously 
co-localizes and activates Akt; the release of the PH domain frees the activation loop (A-
loop) of the kinase domain to be phosphorylated on T308 by PDK1 at the signaling 
complex, resulting in an activated Akt16.  A similar mechanism has been proposed, but 
not verified, for Btk, based on the findings that the addition of PIP3 vesicles to 
immunoprecipitated Btk, as well as deletion of its PH domain, each had a uniformly 
activating effect17.   
A mutation in Akt, E17K, has been shown to cause aberrant signaling that has 
been linked to numerous cancers, particularly breast cancer7,8,16,18.   The structural 
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mechanism by which E17K acts was recently elucidated15,16:  Akt E17K increases affinity 
for PI(4,5)P2 through interaction with the 5ʹ′-phosphate, and is also located at the PH/KD 
interface, resulting in a constitutively membrane bound and constitutively active Akt.  
This glutamate was hence coined a “sentry” glutamate in that it “guards” the specificity, 
particularly at the 5ʹ′-phosphate position, restricting high-affinity binding to 3ʹ′-
phosphorylated PIPs16.  The charge reversal of E17K goes from an unfavorable 
electrostatic interaction (negatively charged glutamate with negatively charged 
phosphate) to a favorable, closer proximity (lysine side-chain is longer), electrostatic 
interaction between the positively charged lysine and the 5ʹ′-phosphate.  Grp1 has also 
been shown to have a “sentry” glutamate residue, E345, that when mutated to lysine, also 
increases affinity for PI(4,5)P219, although not by level that E17K does, which is thought 
to be due to the different locations of the sentry glutamates on the respective PH domains 
– Grp1 E345K cannot interact as readily with the 5ʹ′-phosphate, and possibly does not 
allow for alternate binding conformations of PI(4,5)P2 in the pocket16,19(Figure 1).   
An activating glutamate to lysine mutation has also been identified in the PH 
domain of Btk: E41K.  Li et. al. identified this mutation in 199520, and the hyper-activity 
and transforming potential of this mutant has since been verified in other studies21-23; 
however, to our knowledge, no work has investigated the mechanism by which E41K 
confers this increased signaling activity.  E41K was shown to be constitutively membrane 
bound21,23, and it was speculated that this was due to increased affinity for PI(3,4,5)P321, 
or possibly even broadened specificity to include PI(4,5)P212,24, but to our knowledge, 
this has never been directly tested. 
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It is thus tempting to conclude that E41K is also a sentry glutamate; however, 
unlike Akt-PH and Grp1-PH, E41 in Btk-PH is not within reach of the 5ʹ′-phosphate of 
inositol 1,3,4,5-tetrakisphosphate (IP4, the soluble head group of PI(3,4,5)P3) in the 
crystal structure (Figure 1).  Even when taking into account the flexibility of the β3/β4-
loop that contains E41, utilizing a recently solved NMR structure of the PH domain of 
Tec (a close homologue of Btk), it is unlikely that it can reach the 5ʹ′-phosphate of the 
ligand (Figure 2).  However, unlike Akt1-PH and Grp1-PH structures, which are 
monomeric, all structures of Btk-PH are dimers25,26; and the structure of Btk E41K binds 
two IP4 molecules per Btk PH domain, through a unique PIP binding pocket at the dimer 
interface that is not seen in the structure of wild-type Btk-PH (Figure 1, bottom right). 
In this work, we show that Btk E41K does exhibit increased affinity for PI(4,5)P2, 
and given the structural differences between Btk-PH and Akt1-PH/Grp1-PH, we propose 
a novel mechanism – that Btk E41K binds PI(4,5)P2 through induced dimerization at the 
plasma membrane, and through a second PIP binding site that is prerequisite on 
dimerization.  We also probe whether wild-type Btk undergoes similar induced 
dimerization at the plasma membrane in the presence of PI(3,4,5)P3.  Both Btk-PH WT 
and E41K crystalized as a dimer25,26, with Btk E41K showing two IP4 molecules bound 
per PH domain.  Some speculated that this second IP4 binding site might increase 
affinity/avidity for IP4/PI(3,4,5)P321, but  ITC experiments of Baraldi et. al are in conflict 
with that hypothesis25.  The secondary IP4 molecules span the dimer interface in the Btk 
E41K crystal structure, with contributing binding contacts coming from both monomers 
of Btk-PH; additionally, the K41 of each monomer contacts the 5ʹ′-phosphate their 
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respective bound IP4(Figure 1, bottom).  Thus, we hypothesize that E41K acts as a sentry 
glutamate, but only in the context of this second, non-canonical, PIP-binding site that is 
dependent upon PH domain dimerization. 
  
Results 
 Btk-PH E41K broadens PIP specificity.  To probe the affect of E41K on PIP 
specificity, we first incubated 0.5 µg/mL of Btk PH domain and mutants on PIP StripsTM 
(hydrophobic membranes spotted with 15 different phospholipids).  Btk-PH WT shows 
binding primarily to PI(3,4,5)P3, with slight binding to PI(3)P and PI(5)P;  Btk-PH E41K 
binds several additional PIPs as compared to WT, indicating a broadening of specificity, 
and unlike WT, shows significant binding to PI(4,5)P2 (Figure 4).  As a negative control, 
we also tested Btk-PH R28C, as expected, this mutant displayed no significant binding to 
any phospholipid.  Btk-PH R28C+E41K was also tested to gauge the affect of E41K in 
the absence of R28, and weak binding was detected to PI(3)P and PI(5)P.  D43R, another 
mutant that was shown to render Btk constitutively membrane- bound21, was also tested; 
a broadening of specificity similar to E41K was observed, but overall binding signal was 
significantly weaker than WT and E41K (Figure 4).  To probe whether these affects 
observed in Btk are conserved across other Tec kinase PH domains, we also performed 
the PIP-stripTM assay with Itk PH domain wild-type and corresponding mutants.  Itk-PH 
WT bound specifically to PI(3,4,5)P3 as expected; the negative control, Itk-PH R29C 
disrupted binding, also as expected  (Figure 4).  However, Itk-PH E42K (analogous to 
Btk E41K) did not show a similar trend to Btk E41K.  The specificity of Itk-PH E42K 
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was slightly broadened, but only to include weak binding to PI(3)P and PI(5)P, and 
increased binding to PI(3,4)P2; unlike Btk E41K, Itk E42K displayed no detectable 
binding to PI(4,5)P2 and showed reduced binding to PI(3,4,5)P3. 
 Btk E41K increases affinity for PI(4,5)P2.  To further probe the specificity and 
affinity these PH domain mutants, relative binding was analyzed via Surface Plasmon 
Resonance (SPR) using streptavidin chips loaded with either biotin-PI(4,5)P2 or biotin-
PI(3,4,5)P3, and the results largely matched that of the PIP StripsTM (Figure 5).  Btk E41K 
showed a significant increase in affinity for PI(4,5)P2 (Figure 5, bottom).   Itk-PH E42K 
showed a slight increase in PI(4,5)P2 binding as compared to Itk-PH WT, but markedly 
less than Btk-PH E41K (Figure 5, bottom).  Tec-PH, a close homologue of both Btk and 
Itk and the namesake of the Tec Family Kinases, was also tested and displayed a similar 
trend to Itk-PH (Figure 5).  To further confirm Btk E41K’s increased affinity for 
PI(4,5)P2, binding was also tested using full-length Btk enzyme from insect cell preps 
(High-Five cells).  Purified full-length Btk WT and E41K were each incubated with 
agarose beads coated with either PI(3,4,5)P3, PI(4,5)P2, or no PIP (control).  Btk E41K 
showed increased binding to PI(4,5)P2 as compared to WT (Figure 6). 
 Btk displays increased affinity in the presence of PI(3,4,5)P3 beads, but not in the 
presence of soluble I(1,3,4,5)P4, the head-group of PI(3,4,5)P3.  A previous study 
showed increased Btk activity in the presence of PI(3,4,5)P3 liposomes, using Btk 
immunoprecipitates17.  To test the affect of PI(3,4,5)P3 binding on activity, we performed 
in vitro kinase assays (IVK) in presence of PI(3,4,5)P3, PI(4,5)P2, or control agarose 
beads, as well as soluble IP4, with gentle agitation to keep the beads suspended in 
solution.  Interestingly, Btk displayed increased activity (due to increased 
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phosphorylation on its activation loop at pY551) in the presence of PI(3,4,5)P3, but not 
IP4 or any of the other conditions (Figures 7 and 9).  This affect was much less drastic 
when Btk enzyme preps were co-expressed with Lck (A Src kinse that will phosphorylate 
Btk on its activation loop) or pre-incubated with ATP before addition of PIP agarose 
beads (Figure 8).  We speculate that the activating effect of activation loop 
phosphorylation is due to induced dimerization on the surface of the PIP3 agarose beads.  
To confirm the induced dimerization and rule out the possibility that the increased 
activity is simply due to an increased local concentration (bound to the beads), we are 
currently developing a split-YFP assay (see “Discussion and Future Directions” below 
for details). 
 
Discussion and Future Directions 
We have proposed and experimentally probed a new mechanism to elucidate the 
molecular details of how the hyperactive Btk E41K mutant achieves its constitutive 
membrane localization and subsequent increased signaling: through induced dimerization 
at the plasma membrane, and through a second PIP binding site that is dependent upon 
dimerization and exhibits affinity for PI(4,5)P2.  Initial results show that Btk E41K does 
increase affinity to PI(4,5)P2 (Figure 4, Figure 5).  Future experiments have been 
designed to more directly probe the dependence of this increased affinity on dimerization.  
We also provide evidence that wild-type Btk undergoes similar induced dimerization at 
the plasma membrane in the presence of PI(3,4,5)P3, resulting in an increase in catalytic 
activity (Figure 7). 
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Baraldi et. al. measured the affinity to IP4 in solution via ITC to be 40nM for 
BtkPH WT and 87nM for BtkPH E41K25.  Another study, using PIP3-coated agarose 
beads found that Btk E41K displayed increased PIP3 binding over WT27.   Though these 
two results appear contradictory at first glance, they both support our proposed 
mechanism of E41K gaining affinity through induced dimerization and clustering at a 
PIP-presenting surface, but not in solution. 
 It is interesting that Btk E41K+R28C rescues PI(3,4,5)P3 binding somewhat 
(Figure 4, Figure 5).  This result makes sense given structural modeling shown in Figures 
1 and 2.  We infer that E41K can reach the 3ʹ′-phosphate of the IP4 in the canonical 
binding pocket, which presumably has little consequence in context of wild-type Btk-PH, 
in which R28 mediates interaction with the 3ʹ′-phosphate; however, in its absence, E41K 
likely compensates, favorably interacting with the 3ʹ′-phosphate and restoring binding. 
 It is also interesting that Itk-PH E42K and Tec-PH E42K do not exhibit an 
increased affinity for PI(4,5)P2.  Based on the close homology of these PH domains and 
conservation of the glutamate residue, we initially expected them to behave like Btk-PH 
E41K.  The fact that they don’t is consistent with a study that found TecPH E42K 
displayed decreased signaling and binding to PI(3,4,5)P3 as compared to wild-type Tec 27.  
A similar result was also found for Bmx E42K, in which this mutation also showed 
decreased in vivo activity as compared to wild-type28; Bmx is also a member of the Tec 
Family kinases. 
There exists no evidence of Btk-PH dimerization in solution; however, all solved 
structures of Btk-PH have crystalized as a dimer, leading to speculation that dimerization 
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may be functionally relevant, induced by clustering and PIP3 binding at the plasma 
membrane25.  Our proposed mechanism would support this speculation. 
 To confirm our hypothesis that dimerization is induced through PIP binding at the 
plasma membrane (and PIP-presenting surfaces in vitro), a split-YFP (Yellow 
Fluorescent Protein) assay has been devised, in which the N-terminal half of YFP is 
covalently attached to one copy of Btk-PH, and the C-terminal half to another copy of 
Btk-PH.  If Btk-PH self-associates, the two halves of YFP will be brought together, 
yielding measureable changes in fluorescence.  Fluorescence anisotropy and nuclear 
magnetic resonance (NMR) are also being investigated as orthogonal approaches to probe 
the binding kinetics in solution.  If our hypothesis correct, in solution, Btk E41K will not 
show an increased affinity for PI(4,5)P2; as observed with the surface-immobilized PIP 
binding experiments via SPR. 
 Measure affinity of WT and E41K to PI(4,5)P2 and PI(3,4,5)P3.  Affinity of Btk 
for IP4/PI(3,4,5)P3 has been measured in the literature, but reported results vary widely, 
from 40nM-800nM.  Additionally, no affinity measurements have been made for Btk WT 
or E41K for PI(4,5)P2, nor in the context of a lipid-coated surface that would mimic the 
plasma membrane.  Furthermore, Btk’s two closest homologues in the Tec Family, Itk 
and Tec, have also been shown to co-localize through specificity to PIP3; however, this 
interaction has not been directly characterized for Itk and Tec, and no affinity 
measurements exist in the literature.  Surface Plasmon Resonance (SPR) would be, in 
theory, the ideal technique to measure precise affinity, as it allows for the phospholipids 
to be immobilized onto a flat surface at variable concentrations, and can even be attached 
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to a chip coated with a lipid surface to mimic the topology of the plasma membrane; 
however, initial attempts have been hindered by non-specific binding of the Btk and Itk 
PH domains to the SPR chips, presumably due to their high isoelectric point (pI ~ 9.6), 
yielding data that is too noisy for reliable fitting and calculation of binding constants.  We 
are currently investigating strategies to overcome this non-specific binding, as well as 
alternative techniques. 
 NMR to map residues and dynamics.  Depending on the results of the above 
experiments, as well as the ability to obtain quality NMR spectra of Btk-PH, our 
proposed mechanism could be further elucidated via NMR approaches.  A similar 
approach to reference 29 could be used to map which residues contact lipid in addition to 
PIP3 for Btk-PH and Itk-PH.  Additionally, the residue mapping and protein dynamics of 
the β3/β4-loop, which contains the E41K mutation, could be investigated.  One possible 
explanation for why Itk and Tec E42K do not exhibit the same effects as Btk E41K is that 
the dynamics of the β3/β4-loop are different across these different PH domains; this loop 
does show amino acid differences between Btk, and Itk and Tec, and a recently solved 
NMR structure of Tec-PH (PDB entry 2LUL) shows significant conformational 
heterogeneity in the region of this β3/β4-loop. 
 Another question is: do Btk WT and E41K have different activity levels in vitro?  
E41K was identified as hyperactive from the observation of increased activity and 
signaling in vivo.  It is unclear whether this increased in vivo activity is due solely to the 
constitutive membrane binding of E41K, or if the E41K mutant increases baseline Btk 
enzymatic activity through additional mechanisms as well.  Thus, the in vitro kinase 
activity of full-length Btk WT and E41K should be tested side-by-side. 
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 In this work, we have begun to elucidate the mechanism by which E41K renders 
Btk constitutively membrane-bound and active.  We have shown that Btk E41K displays 
an increased affinity for PI(4,5)P2.  This result makes sense in light of previous studies 
that show that Btk E41K is constitutively membrane-bound in various cell-lines; 
PI(4,5)P2 is much more prevalent and ubiquitous than PI(3,4,5)P3.  We have proposed, 
based on crystal structures of Btk-PH, that Btk E41K achieves its increased affinity for 
PI(4,5)P2 through a unique PIP binding pocket and induced dimerization at the plasma 
membrane.  Future work will continue to probe this mechanism, utilizing NMR, SPR, 
and a split-YFP assay. 
  
 
Materials and Methods 
Protein expression and purification.  Btk-PH (aa 1-176), Itk-PH (aa 1-154), and 
Tec-PH (aa 1-154) were expressed in a modified pET-20b vector with an N-terminal 
His6-GB1 tag.  All mutants were constructed using site-directed mutagenesis 
(Quikchange II kits, Stratagene).  PH domain constructs were expressed and purified as 
in 30.  Briefly, proteins were lysed by freeze/thaw and lysozyme in 25mM Tris pH 7.5 at 4 
°C, 150mM NaCl, and 20mM imidazole; cleared lysate were run over Ni-NTA resin and 
resin was then washed and eluted with the same buffer conditions with 40mM and 
250mM imidazole respectively.  FLAG-tagged full-length Btk and Itk were expressed in 
Hi-Five cells using a baculovirus expression system and purified using anti-FLAG 
affinity resin (SIGMA) as described in 30.  Protein concentrations were normalized within 
each experiment based on absorbance at A280 and densitometric analysis of coomassie-
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stained SDS-PAGE gels. 
 Phosphoinositide specificity by PIP StripTM blotting.  PIP StripsTM (Echelon 
Biosciences, P-6001) were used according to manufacturer’s instructions.  Briefly, PIP 
StripTM membranes were blocked in blocking buffer of TBST (0.1% w/v Tween-20) and 
1% non-fat dried milk for 1 hour at room temperature (RT) with gentle agitation.  Protein 
was then added to the membrane at a concentration 0.5 µg/mL in TBST and incubated for 
1 hour at RT.  Membranes were then washed in TBST three times for ten minutes each at 
RT, followed by incubation with primary antibody (anti-Itk, anti-Btk, or anti-His6) for 1 
hour at RT or overnight at 4 °C.  Membranes were then washed 3 times, incubated for 1 
hour at RT with secondary anti-mouse-HRP, washed a final 3 times, and binding was 
detected by chemiluminescence.  It should be noted that blocking in TBST and 3% BSA 
resulted in higher backgrounds and decreased specificity of blots. 
Surface Plasmon Resonance.  All SPR work was performed on a Biacore T-100 
instrument, using a running buffer of 20 mM Tris pH 8.0, 150 mM NaCl, BSA at 5 
mg/ml, and 5% glycerol.   PI(4,5)P2 and PI(3,4,5)P3 with a biotin tag was obtained from 
Echelon Biosciences. The streptavidin Chip (SA-chip) was obtained from GE Healthcare 
and labeled with PIP2 in flowcell (Fc)-2 and PIP3 in flowcell FC-4. The FC1 and FC3 
flowcells were left blank to be used as references. The protein samples were injected at a 
flow rate of 100ul/min, for 1 min followed by dissociation phase for 1min.  The RU at 
equilibrium were used to determine extent of binding/plotting the graph and all the runs 
were double reference using Scrubber so as to normalize the binding.  PLCδ1-PH and 
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Grp1-PH domains were used for positive controls for PI(4,5)P2 and PI(3,4,5)P3 
respectively. 
PI(3,4,5)P3 agarose beads to assay binding of full-length Btk.  Full-length Btk 
wild-type (wt) and Btk E41K incubated for two hours at 4 °C at a concentration of 
300nM in 150µl of 20mM HEPES pH 7.4, 150mM NaCl, 0.1% Nonidet P-40, with 15ml 
of PI(3,4,5)P3 coated agarose beads (Echelon Biosciences #P-B345a).  Beads were then 
washed 5 times in the same buffer, re-suspended in 2X SDS-loading buffer and boiled for 
5 minutes.  Samples were run on 8% SDS-PAGE gels and transferred to PVDF 
membranes by semi-dry western transfer and incubated overnight at 4 °C in primary 
antibody (1:1000 anti-FLAG).  Membranes were then washed 3 times in TBST at RT, 
probed with secondary anti-Mouse-HRP for 1 hour at RT, washed an additional 3 times 
in TBST and imaged by chemiluminescence.  
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Figure Captions 
 
Figure 1.  Unlike Grp1-PH and Akt-PH, Btk-PH WT does not have a glutamate within 
reach of the 5’-phosphate of PI(3,4,5)P3.  Shown are the crystal structures of Btk-PH WT 
(PDB ID 1B55, green), Grp1-PH WT (sand), Akt1-PH WT (cyan), and Btk-PH E41K 
(PDB ID 1BWN, green), all complexed with IP4, the soluble head group of PI(3,4,5)P3, 
shown in yellow.  The arginines that mediate 3’-phosphate specificity are labeled and 
colored in magenta, sticks representation.  The “sentry” glutamates are labeled and 
colored in red, sticks representation.  Unlike Btk-PH WT, Btk-PH E41K binds 2 IP4 
molecules per PH domain; the second IP4 molecules span the dimer interface, contacting 
K41 through the 5’phosphate (bottom right). 
Figure 2.  Using the NMR ensemble of Tec-PH (PDB ID 2LUL) as a model to account 
for β3/β4-loop flexibility provides further evidence that E41K cannot reach the 5’-
phosphate of PI(3,4,5)P3 in its canonical binding position.  Btk-PH E41K (PDB ID 
1BWN) is shown in green, with its bound primary IP4 molecule shown in yellow, sticks 
representation; Tec-PH is shown in white, with the backbone conformation of the first 
NMR structure in the ensemble shown in cartoon representation.  (left) K41 of Btk-PH 
E41K, as well as the conserved glutamate in Tec-PH (E42), are shown in red, sticks 
representation, for all 20 ensemble structures of Tec-PH.  (right) Same as (left) with the 
entire β3/β4-loop shown for all 20 ensemble structures of Tec-PH. 
Figure 3.  SDS-PAGE (12%) of purified His6-GB1-PH mutants used for PIP StripsTM 
assays and Surface Plasmon Resonance (SPR) experiments. 
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Figure 4.  Btk E41K broadens PIP specificity.  0.5 µg/mL of each PH domain was 
incubated on PIP StripTM membranes and assayed for binding.  (left) PIP StripTM diagram 
(Echelon Biosciences) with spots labeled according to the PIPs that they contain (for 
clarity, only spots showing binding in this study are labeled).  (middle) Btk PH domain 
mutants.  (right) Itk PH domain mutants. 
Figure 5.  Relative binding affinity of Btk-PH, Itk-PH, and Tec-PH domain mutants 
as determined by Surface Plasmon Resonance (SPR).  On a Biacore T-100 SPR 
machine, the indicated PH domains were ran over streptavidin chips with bound 
biotynilated phosphoinositides: PIP3 (top) and PIP2 (bottom).  Binding for each PH 
domain was measured at three independent concentartions, the relative degree of binding 
is shown in normalized Response Units (RU’s). 
Figure 6.  Full-length Btk E41K shows increased binding to PI(4,5)P2.  Full-length 
Btk WT or E41K was incubated for 2 hours at 4 °C in the presence of PI(3,4,5)P3, 
PI(4,5)P2, or control agarose beads (Echelon Biosciences).  Beads were then washed and 
samples were analyzed for binding by western transfer (see Materials and Methods for 
details).  The lanes correspond to the total input (Tot), supernatant (S/N) after initial spin 
down of beads and before washing, and the boiled PIP beads (B) after 5 wash steps.   
(top) Full-length Btk E41K.  (bottom) Full-length Btk WT. 
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Figure 7.  Btk shows increased in vitro catalytic activity in the presence of 
PI(3,4,5)P3 beads, but not soluble IP4 nor PI(4,5,)P2 beads.  Purified full-length Btk 
(that was no co-expressed with Lck or pre-incubated with ATP) was incubated in kinase 
assay reaction buffer, with exogenous PLCg1-SH2C-linker as the substrate, for 30 
minutes at room temperature.  All reactions were identical except for the addition of 
different PIPs.  Samples were analyzed by western blot analysis, incubation with the 
indicated antibodies, and chemiluminescence.  In the presence of PI(3,4,5)P3, Btk showed 
markedly increased activity as measured by phosphorylation of pY783 on PLCg1-SH2C-
linker, as well as autophosphorylation at pY551 on its activation loop.  
 
Figure 8.   To test whether the increased activity in Figure 7 was due to primarily to 
increased activation loop phosphorylation, or if there were other activating factors 
independent of pY551, we compared a prep of purified Btk that was co-expressed with 
Lck (known to phosphorylate pY551 on the activation loop of Btk), the same prep from 
Figure 7 (which was not co-expressed with Lck), only this time the prep from Figure 7 
was allowed to pre-incubate in kinase reaction buffer for 15 minutes prior to the addition 
of PLCg1-SH2C-linker substrate.  Samples were analyzed by western blot analysis, 
incubation with the indicated antibodies, and chemiluminescence.  Lanes 7 and 8 are 
controls: no ATP, and no PLCg1-SH2C-linker substrate, respectively.  Neither prep 
showed increased ability to phosphorylate pY783 in the presence of PIP3; however, both 
preps showed a slight increase in activation loop phosphorylation at pY551 in the 
presence of PIP3 as compared to the other PIPs, suggesting that the presence of PIP3 
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promotes activation through phosphorylation of pY551. 
 
Figure 9.  Control experiment for experiments in Figures 7 and 8.  The same enzyme 
prep that was used in Figure 7, under identical conditions to Figure 7, was separated into 
Bead (B) and supernatant (S/N) fractions for both PI(3,4,5)P3 and PI(4,5,)P2 agarose 
beads.  The beads were washed three times and then the B and S/N samples were 
analyzed by western blot, incubation with the indicated antibodies, and imaged by 
chemiluminescence.  Btk showed binding to PI(3,4,5)P3, but not PI(4,5)P2 beads.  The 
PIP3-bound Btk showed significantly increased levels of activation loop phosphorylation 
at pY551, and a correlated increase in activity as measured by its ability to phosphorylate 
pY783 of PLCg1-SH2C-linker and pY223 of Btk. 
 
Figure 10.  PIP StripTM (Echelon Biosciences).  Diagram of all of the phospholipid 
species present on the PIP StripTM, available from Echelon Biosciences, which was used 
in this study. 
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Abstract 
 The Tec and Src families of non-receptor tyrosine kinases play key roles in 
signaling events related to lymphocyte activation and development, and cell growth, 
respectively.  Despite high sequence and structural homology, the kinase domains of the 
Src and Tec families exhibit markedly different baseline activity levels.  Isolated Tec 
kinase domains exhibit very weak activity and require interactions with their N-terminal 
regulatory domains for activation.  This is in sharp contrast to Src kinases, which have 
fully active isolated kinase domains and require their N-terminal regulatory domains to 
down-regulate activity.  Kinase activity can be thought of in terms of a conformational 
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equilibrium between active and inactive conformations, and the structural features 
necessary for catalysis that define the active kinase domain fold have been well 
established and are highly conserved across all eukaryotic protein kinases.  These 
conserved hallmarks are necessary but not sufficient for activity in that some kinase 
domains, such as Src, adopt the active conformation much more readily than others in 
ways that are not currently well understood.  Thus, there must exist sequence/structure 
differences outside of these hallmarks that underlie the difference in activity between the 
Tec and Src families.  We employ molecular dynamics simulations totaling 0.85 µs, 
coupled with rigorous computational analysis, to drive experiment and identify novel N-
lobe packing motifs that influence conformational dynamics and explain activity 
differences across these two families, using Btk (Tec family) and Lck (Src family) as our 
model systems.  Most notably, an isoleucine (Tec family) to leucine (Src family) 
mutation activates the Tec family kinase Btk, altering the dynamics of the αC-Helix and 
serving to stabilize the active conformation.  This isoleucine is conserved in other kinases 
that require factors external to the kinase domain for activation, such as Csk and Cdk, 
suggesting evolutionary pressure at this position to delegate activation to regions outside 
the kinase domain. 
 
Introduction  
Multi-domain protein tyrosine kinases transfer the gamma-phosphate of ATP to a 
tyrosine side chain of a substrate molecule, serving as important regulators of cell 
signaling pathways.  Numerous conserved structural features within the kinase domain 
have been shown to be essential for catalysis and accepted as hallmarks of an active 
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kinase: the P-loop and Lys-Glu salt bridge, which bind ATP in the proper orientation for 
catalysis; the Regulatory and Catalytic spines, which consist of networks of hydrophobic 
residues that are distant in sequence but come together in tertiary structure to stabilize the 
active kinase fold1,2; the αC-Helix must be in its αC-in conformation to allow for 
formation of the Lys-Glu salt bridge, which serves to orient ATP, and assembly of the 
Regulatory spine; and the activation loop (A-loop), which is often phosphorylated as a 
requisite step for activation, stabilizes the active kinase fold with the A-loop in its “open” 
conformation.  The high sequence conservation of these hallmarks is necessary but not 
sufficient for kinase activity; different kinase domains more readily adopt an active 
conformation than others.  Dephosphorylation, disassembly of the regulatory spine and 
loss of the Lys-Glu salt bridge upon movement of the αC-Helix away from the active site 
all accompany inactivation of kinase function, and switching between inactive and active 
conformational states is controlled by distinct mechanisms for different kinases.  For 
many kinases, the structural features outside of these conserved hallmarks that govern 
conformational equilibrium, and hence activity, are poorly understood. 
Our previous studies have focused on the Tec family of non-receptor tyrosine 
kinases, in particular Itk and Btk, enzymes that are expressed in T cells and B cells, 
respectively, and regulate key signaling events in lymphocyte activation and 
development3,4.  For this family of tyrosine kinases, we find that the non-catalytic 
regulatory regions outside of the kinase domain are required for full activation of the 
adjacent kinase domain5.   In fact, the isolated kinase domains of Itk and Btk exhibit 
extremely low levels of enzymatic activity toward a range of substrates regardless of the 
phosphorylation status of the activation loop6,7.  Extension of the Itk or Btk kinase 
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sequence to include additional non-catalytic domains (in particular the linker between the 
SH2 and kinase domains) increases kinase activity.  A conserved tryptophan residue in 
this linker sequence makes direct contacts with residues in the N-terminal lobe of the 
kinase domain stabilizing the αC-Helix and regulatory spine in their active 
conformations7,8.  A Btk construct containing this conserved tryptophan (W395), as well 
as an A-loop phosphomimetic mutation (Y551E), has been crystalized in its active 
conformation (PDB entry 3K548), with all active hallmarks, such as the Lys-Glu salt 
bridge and regulatory spine, intact (Fig. 1c). Other Tec family kinase domain structures 
have been solved for Btk, Itk, and Bmx, and most of these adopt inactive conformations 
in which the αC-Helix is in its αC-out conformation.  Some of these inactive structures 
are in the conserved “Src-like inactive” conformation with the A-loop coiled inwards 
(Fig. 1c), whereas others adopt a unique conformation where the A-loop is in its active 
“open” conformation, despite the αC-out conformation (Fig. S2a).  The high number of 
Tec kinase domain structures with this αC-out conformation is consistent with 
biochemical studies showing that these isolated kinase domains exhibit extremely low 
activity5,7,9.  However, these structures are not enough to illuminate why Tec kinase 
domains are averse to their active conformation.  The isolated kinase domains of closely 
related kinase families, such as Src, exhibit high activity and readily adopt the αC-in 
conformation in crystal structures10-12.    
The Src kinases (Src, Lck, Lyn, Fyn, Yes, Fgr, Hck, Blk, Frk) are the only family 
of non-receptor tyrosine kinases larger than the five-membered Tec kinase family.  
Expression of Src family kinases is more widespread than the Tec kinases and the nine 
Src kinases play a variety of important roles in signaling pathways related to cell growth 
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and differentiation.  The namesake of the family, Src, was in fact the first tyrosine kinase 
to be described13,14 and as a result, a great deal of attention has been focused on the 
mechanisms that control Src kinase activity during signaling.  Of particular note, in the 
context of our studies of the Tec family kinases, is the observation that the non-catalytic 
regulatory domains of the Src kinases negatively regulate kinase activity15.  Unlike the 
Tec kinases, isolated Src kinase domains exhibit maximal activity; association of the 
kinase domain with regulatory regions outside of the catalytic domain leads to reduced 
kinase activity.  Src kinases, like Tec kinases, have a conserved tryptophan in the linker 
region between their SH2 and kinase domains; however, in the Src kinases this 
tryptophan is not required to activate the kinase domain as it is in Tec kinases, but 
allosterically mediates the down-regulatory interaction of the SH3 and SH2 domains with 
the kinase domain. 
In spite of the sharply different activity levels of the Src and Tec kinase domains, 
these catalytic domains exhibit a significant level of sequence homology; the kinase 
domains of Lck (Src family) and Btk (Tec family) are 43% identical and 66% similar 
(BLOSUM62).  Furthermore, the salient regulatory features (activation loop, C-helix, 
regulatory spine, Lys/Glu salt bridge), are quite similar in the available crystal structures 
of Src and Tec kinases (Fig. 1 a,c).  Given what appear to be very closely related kinase 
domain structures, we set out to determine the molecular features that favor stabilization 
of the active Src conformation and favor the inactive Tec conformation. There must exist 
key sequence/structural differences outside of the conserved hallmarks of the active 
kinase that influence the conformational preferences of the catalytic core differently in 
the Tec and Src family kinase domains.  We approach this hypothesis using 
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computational methods, combined with experiment, and focus on Btk (Tec family) and 
Lck (Src family) as our model systems.  Understanding the atomistic details that account 
for the stark difference in Btk and Lck kinase domain activity is important for fully 
understanding the regulatory mechanisms that govern these kinases. 
 
Results 
Lck and Btk kinase domains are structurally similar yet exhibit drastically 
different levels of catalytic activity. To directly compare the kinase activity of Lck and 
Btk we expressed and purified both kinase domains and carried out autophosphorylation 
kinase assays.  Using the anti-phosphotyrosine antibody 4G10, we probed for levels of 
autophosphorylation on Lck and Btk.  As shown in Fig. 1b, Lck autophosphorylation is 
significantly more efficient than that of Btk.  This finding is not limited to the results 
shown here but extends to phosphorylation of exogenous substrates and has been shown 
been for multiple Src and Tec family members.  For example, the isolated Src kinase 
domain was found to have a kcat of 50 min-1 and kcat/km of 18.5 min-1µM-1 with respect to 
a Src-specific peptide substrate10, whereas the isolated Itk (Tec family) kinase domain 
exhibited a kcat of only 0.02 min-1 and kcat/km of 0.0002 min-1µM-1 with respect to  peptide 
B5, a peptide substrate with high specificity for Tec kinases16.  Given the difference in 
Lck and Btk mediated catalysis it is surprising to note the high level of sequence and 
structural conservation between these two kinase domains (Fig. 1a,c).  Crystal structures 
of the Lck and Btk kinase domains in their active states have been solved8,11. Comparing 
these structures reveals nearly identical backbone conformations (Fig. 1a) and, perhaps 
more importantly, the amino acids that make up the catalytic and regulatory spines as 
 
 
 
128 
well as specific residues in each active site are all conserved (Fig. 1c).  These static 
crystal structures, however, provide little information about the conformational equilibria 
the kinase domains are sampling in a more physiological solution environment.   
 
Molecular Dynamics simulations reveal key differences in the dynamics of the Lck 
and Btk kinase domains. To probe for differences in the dynamics and conformational 
preferences between the kinase domains of Lck and Btk, we performed all-atom 
molecular dynamics simulations starting from the active conformation of each kinase 
(PDB entry 3LCK for Lck, and PDB entry 3K54 for Btk).  3LCK is phosphorylated on its 
activation loop (pY394) and the 3K54 has a phosphomimetic mutation (Y551E) on its 
activation loop; thus, we performed simulations of these structures with these residues 
phosphorylated (see Materials and Methods for details). We performed multiple 100 ns 
equilibrium simulations in the NPT ensemble, with three replicates for Btk and two 
replicates for Lck.  Table I summarizes all simulations performed in this study.  
Throughout the simulations, we monitored RMSD from the starting structure for the 
hallmarks of the active catalytic core, as well as distances between specific residues 
involved in electrostatic interactions in and around the active site: K430-E445 and E445-
R544 in Btk; and K273-E288 and E288-R387 in Lck.  As depicted in Fig. 1c, the active 
site salt bridge, K430-E445(Btk)/K273-E288(Lck), is intact in the active 
conformation17,18; whereas in the inactive conformation E445(Btk)/E288(Lck) on the C-
Helix forms a salt bridge with an arginine on the A-loop (R544(Btk)/ R387(Lck) and the 
distance between the Lys and Glu in the active site is increased.   
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The results of the Lck and Btk simulations starting from their active 
conformations differ significantly, reflecting the known activity differences between 
these kinases.  Early in the simulations, Btk shows deviations from its active structure, 
whereas the Lck kinase domain remains locked into its active conformation, with all 
hallmarks of the catalytic core remaining intact for the entire 100 ns in both replicates 
(Fig. 2).  For both Btk and Lck, the C-lobe remains rigid during the course of the 
simulations.  The majority of the observed structural changes in Btk can be attributed to 
movement in the N-lobe of the kinase, particularly in the αC-Helix.  Within the first 10-
20 ns of the Btk simulations, the αC-Helix begins to move out towards its αC-out 
position, breaking the active K430-E445 salt bridge and disassembling the R-spine, 
characteristic of an inactive state (Fig. 2b).  It is interesting to note that during these 
simulations Btk is sampling the unique inactive conformations observed in numerous Tec 
family kinase domains crystal structures, in which the αC-Helix is in its inactive αC-out 
position but the A-loop is in its active “open” position (Fig. S2a).  Additionally, the 
outward movement of the αC-Helix facilitates formation of the E445-R544 salt bridge 
that is observed in many inactive kinase structures, which was observed in all three Btk 
replicates to varying degrees; in replica 1, E445-R544 remains intact for approximately 
50ns, or half of the simulation (Fig. 2a).  Btk simulations also showed significant 
movement away from the active conformation in the A-loop, P-loop, C-spine, and R-
spine (Fig. 2a-b).  A more detailed view of the snapshots from Btk simulations is 
provided in Fig. S1.  To further probe for differences between Btk and Lck, we also 
performed 100 ns simulations starting from inactive conformations, expecting that Lck 
would be more prone to deviate from its inactive conformation than Btk.  The differences 
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between Lck and Btk in these inactive simulations were less pronounced than the active 
simulations (Fig. S3); however, the αC-Helix of Lck showed significantly greater 
movement than in Btk, which was the opposite of what was observed in the simulations 
starting from the active conformations (Fig. S3b-c).  Together, these results suggest that 
the αC-Helix preferentially adopts the active αC-in conformation in Lck and the Src 
kinases, but preferentially adopts the inactive αC-out position in the Tec kinases, 
consistent with the known activity differences of these kinase domains. 
 
“Frustration” analysis of snapshots from the Lck and Btk kinase domain 
simulations identify regions outside of conserved active hallmarks that contribute to 
stabilization/destabilization of the active kinase.  The Lck and Btk simulation results 
recapitulate the activity differences observed for these kinases in experiment and point to 
the αC-Helix as root of these differences.  Simulations of the more active Lck kinase 
domain show that the αC-Helix locks into its active αC-in position, whereas in Btk, the 
αC-Helix readily adopts an inactive αC-out conformation, consistent with the poor 
activity of Tec kinase domains.  To begin to identify the sequence/structural differences 
between Btk and Lck that give rise to these observed differences, we looked at packing 
interactions involving the αC-Helix and performed “frustration” analysis on snapshots 
from the simulations in Fig. 2 using the Frustratometer server19 (Fig. 3a,c).  Mutational 
frustration analysis takes into account all pairwise contacts in a structure, iteratively 
mutating each amino acid to all other 19 amino acids, utilizing a coarse-grained energy 
potential.  If the majority of mutations at a position result in a more stable interaction for 
the pairwise contact, that contact is characterized as highly frustrated20.  Conversely, if 
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the native residue is most energetically favorable, that contact is said to be minimally 
frustrated.  Single-residue frustration values were also calculated, in which residues were 
mutated individually, not pairwise.  The lower the Frustration Index score for a given 
residue or pairwise contact, the more frustrated it is.  As was established in previous 
studies, a Frustration Index greater than 0.78 is considered minimally frustrated, and less 
than -1.0 highly frustrated20.  Mutational frustration analysis for the Btk and Lck active 
structures (0 ns timepoint in the simulations) reveals differences in the αC-Helix and 
surrounding region.  During the course of the Btk simulation, the highly frustrated 
contacts become less frustrated as the αC-Helix moves out toward its inactive αC-out 
state, suggesting that the stabilization of these contacts drive the kinase domain of Btk 
towards its inactive conformation (Fig. 3a,c).   
Comparing this region across Src and Tec kinases revealed three residues that 
showed significant differences between the families in terms of both mutational 
frustration (Fig. 3a,c) and sequence conservation (Fig. 3d): Btk residues E439, E441, and 
I432, which packs against a phenylalanine (F442) that is conserved across both Src and 
Tec families, but adopts different structural conformations between the two families (Fig. 
3b).  We mutated these three positions in Btk to their corresponding amino acids in Lck 
(I432L, E439P, and E441A) in silico as a triple mutant and performed a short 20 ns 
simulation, using the same starting conformation and parameters as the simulations in 
Fig. 2.  Unlike the simulations of wild-type Btk, this triple mutant remained in the active 
conformation during the entire 20ns (Fig. 3e), giving us the impetus to go forward and 
experimentally measure the activity of these mutants via an in vitro kinase assay, 
measuring autophosphorylation of Btk at pY551.   E439P showed little change in 
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activity, E441A showed no detectable activity, but remarkably, the I432L mutation 
showed a significant increase in activity (Fig. 3f).  We also experimentally tested these 
three positions as a combined triple mutant, but this mutant did not show a further 
increase in activity from the I432L single mutant (data not shown).  It is particularly 
interesting that this isoleucine is conserved in other kinases, such as C-terminal Src 
Kinase (Csk) and Cyclin-dependent kinases (Cdk’s), which also possess kinase domains 
that exhibit weak catalytic activity by themselves and rely on external factors for 
activation (Fig. 3d).   
 
Btk I432L increases activity by stabilizing the αC-Helix in its active αC-in 
position.  To further probe the mechanism by which I432L confers this increase in 
activity, we mutated I432L in silico and performed two independent 50 ns MD 
simulations, starting from the active conformation with identical conditions to the Btk 
wild-type simulations shown in Fig. 2.  Btk I432L stabilized the catalytic core in both 
simulations: in one replicate, the active K430-E445 salt bridge remained intact during the 
entire simulation, and in the second replicate K430-E445 only started to break in the last 
10 ns (Fig. 4a).  In both replicates, the αC-Helix remained in its active αC-in position 
during the entirety of the simulations (Fig. 4a-b).   
Remarkably, within the first few nanoseconds of these simulations, L432 and 
F442 adopted a packing conformation that is nearly identical to that of Lck (Fig. S4).  
The αC-Helix rotates, moving the F442 sidechain from its exposed starting position to a 
more buried environment, sandwiched between L432 and I472, which is conserved in 
Lck and all Src kinases.  In Btk wild-type simulations, F442 only moved inward to this 
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buried position after the αC-Helix started moving out to its inactive position.  Starting 
structures of both Btk wild-type and Btk I432L show high levels of frustration in the N-
terminal end of the αC-Helix and its preceding loop.  In both Btk wild-type and Btk 
I432L simulations, these highly frustrated residues become substantially less frustrated 
during the course of the simulations, albeit through different motions; in wild-type Btk, 
these residues are stabilized by the outward movement of the αC-Helix to its inactive αC-
out position, whereas in Btk I432L, these residues are stabilized by rotation of the αC-
Helix and subsequent packing of F442 and L432 in a manner that maintains the active 
αC-in position (Fig. S4). 
We also tested the reverse mutation, L275I, in Lck.  Both in simulations and in 
vitro kinase assays, Lck L275I did not significantly affect kinase activity, yielding similar 
results to wild-type Lck (Fig. S5).  Also, I432L activates Btk, but not to the level of 
activity seen in wild-type Lck (Fig. S5).  Together, these results suggest that I/L432 and 
its packing interactions play an important role in regulating the dynamics of the αC-
Helix, but that additional differences exist between Src and Tec kinases that serve to 
stabilize the active conformation in Lck and the Src kinases. 
 
Discussion 
 Much progress has been made in characterizing the structural anatomy of kinases 
and the molecular mechanisms that govern their activation.  The elucidation of structural 
hallmarks, such as the αC-Helix, Lys-Glu salt bridge, and R-spine, is vital for 
understanding kinase activity and regulation, but it is far from the full story.  These 
residues are conserved across almost all non-metabolic, eukaryotic protein kinases; it is 
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the distinct motions and conformational equilibria of these conserved hallmarks, 
governed by features outside of these hallmarks, that result in the diverse mechanisms of 
regulation and activity differences across the kinome.  For many kinases, much work 
remains in illuminating these governing features.  This is especially true for the Tec 
kinases, for which we do not yet understand the basis of their inactive isolated kinase 
domains, and for which no multi-domain structures exist.  And the x-ray resolved crystal 
structures only capture the low-energy, static states of the kinase domain, and thus not 
surprisingly, the backbones for the active conformations of kinases in the Protein Data 
Bank (PDB) are highly similar.  These crystal structures do not offer a clear picture of the 
dynamics and alternate conformations these kinases are sampling, nor do they give 
information about the equilibrium of these conformational ensembles.  In this work, we 
employed molecular dynamics simulations, coupled with rigorous computational analysis 
and experimental validation, to interrogate these problems using the Btk (Tec family) and 
Lck (Src family) as model systems that represent two extreme examples in the kinome 
with respect to the baseline activity of their isolated kinase domains. 
Simulations of wild-type Lck and Btk effectively recapitulated the known 
disparity in activity between Lck and Btk, revealing motions present in Btk (but absent 
from Lck) that to contribute to the weak activity of Btk kinase domain (Fig. 2).  The most 
notable difference is in the dynamics of the αC-Helix, which readily moves away from its 
active αC-in position towards its inactive αC-out position, sampling αC-Helix 
conformations nearly identical to those observed in inactive crystal structures of Tec 
kinases (Fig. S2).  To investigate the sequence/structure differences driving these 
differences in dynamics between Btk an Lck, we looked at packing interactions 
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throughout the simulations and performed mutational “frustration” analysis, focusing on 
interactions involving the αC-Helix.  Highly frustrated residue positions have been shown 
to be associated with cancer hotspot mutations in Abl and EGFR kinases, with the 
oncogenic mutants altering the states of local frustration to stabilize the active 
conformations of these kinases21.  Differences in energetic frustration were also shown to 
be important for the conformational transitions of adenylate kinase22. Frustration analysis 
of snapshots from our simulations revealed key amino acid differences between Lck and 
Btk that displayed dissimilarities in the energetic favorability of their contacts, 
particularly in the region involving contacts with the N-terminal end of the αC-Helix 
(Fig. 3, S4). We next tested mutations at these residue positions both in silico and in 
vitro, revealing key differences in the dynamics and activity.   
Most notably, the Btk I432L mutation offers interesting insight into N-lobe 
packing motifs that stabilizes the αC-Helix through the removal of the bulky β-branched 
methyl group of Ile.  Previous studies by Shokat and colleagues identified an activating 
mutant in kinases referred to as the “gatekeeper,” which has been linked to certain 
cancers and drug recently, primarily in Abl kinase23,24.  Some kinases were unable to 
tolerate mutation at this gatekeeper position; however, if they introduced a second-site 
suppressor mutation that involved the addition of a β-branched methyl group (i.e. 
mutation to valine, isoleucine, threonine), the kinase could be activated and the 
gatekeeper mutation tolerated.  It is interesting that in case of our Btk I432L mutant, we 
do the opposite and remove a β-branched methyl group in order to stabilize N-lobe 
packing and increase activity (Figure 3-4). 
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 Other kinases also have an isoleucine at the same position as Btk I432 (Figure 
3b,d).  One example is C-terminal src kinase (Csk).  Csk is a tyrosine kinase that is 
related to both the Tec and Src families, and like Tec kinases, the isolated kinase domain 
of Csk displays very weak activity, requiring its N-terminal regulatory domains to 
stabilize its kinase domain in the active conformation25-29.  Structures of isolated Csk 
kinase domain show the αC-Helix in the inactive αC-out position (PDB entry 1BYG30), 
whereas structures of full-length Csk show the αC-Helix stabilized in its active αC-in 
position through an intramolecular interaction with its SH2 domain (PDB entry 1K9A, 
chain B31).  Interestingly, in this active Csk structure, the conserved isoleucine (I224) and 
phenylalanine (F233) adopt nearly identical configurations to their corresponding 
residues in Btk, I432 and F442 (Fig. 3b).  F233 in Csk, like F442 in Btk, is in an exposed 
position, pointing away from I224.  Biochemical studies show an activating role for the 
SH2 domain in Tec kinases as well5; it is possible that Tec kinases undergo a similar 
mechanism to Csk, with the SH2 domain docking onto the N-lobe to stabilize the αC-
Helix in its active conformation.  This conserved isoleucine is also found in Cyclin-
dependent kinases (CDKs), another example of a kinase domain with low baseline 
activity.  CDKs consist only of a kinase domain and are activated through an 
intermolecular interaction with Cyclin; the interface of this interaction involves direct 
contacts between the αC-Helix and Cyclin, stabilizing the αC-Helix (PDB entry 1FIN32).  
In these kinases, the presence of isoleucine at this specific position may reflect 
evolutionary pressures leading to a regulatory mechanism that prevents the αC-Helix 
from adopting its active “in” conformation, delegating activation to factors external to the 
kinase domain. 
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 A previous study used Src:Csk chimeras to identify regions responsible for the 
activity difference between Src and Csk kinase domains, finding that activity levels could 
be transferred between the two by swapping large regions in the N-lobe33, but did not 
specifically test the effect of the isoleucine we present here (Btk I432, Csk I224).  Large 
sequence changes were required for large changes in activity, but it is interesting to note 
that tow of the positions found to be most important for activating the Csk kinase domain 
in that study (I255 and L262) are insertions in the β-4.5 turn that are not conserved 
between Csk and the Tec kinases33.  Rather, these positions in Tec kinases are more 
similar to Src kinases than Csk, suggesting that additional features responsible for the 
inactivity of Tec kinase domains may be unique from those in Csk.  Indeed, we found 
that Btk I432L does not activate Btk to levels comparable to wild-type Lck (Figure S7).  
Future efforts will aim to elucidate additional structural features that account for the 
remaining activity difference between Tec and Src kinases. 
 The increasing power of molecular dynamics simulations, tightly coupled with 
experiments, offers a promising approach to continue the investigation of these 
differences in kinase domain activity and regulation.  A recent study demonstrated this 
power by elucidating new mechanistic understanding in EGFR kinases, particularly the 
role of intrinsic disorder in the αC-Helix and its stabilization through dimerization and 
oncogenic mutations34.  Simulations in that study revealed that monomeric EGFR kinase 
domain is unstable in its active conformations due to αC-Helix dynamics; these authors 
were able to perform simulations on the order of several microseconds, but the outward 
movement of the αC-Helix and consequent break in the conserved Lys-Glu salt bridge 
were observed within the first 50 ns34, similar to our simulations of Btk kinase domain 
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(Fig. 2).    Intrinsic disorder in the αC-Helix of Btk has not directly been probed; 
however, the crystal structure of Btk in its active conformation (PDB entry 3K548) has 
residues at the N-terminus of the αC-Helix and its preceding loop missing from the 
electron density, as is the case in some EGFR structures (PDB entry 2RF9).  After 
carefully modeling in these residues and performing extensive minimization and 
equilibration, these residues were highly frustrated, only becoming energetically 
stabilized upon the outward movement of the αC-Helix towards its inactive αC-out 
position (Fig. 3).  Numerous other molecular dynamics studies of Src kinases have been 
performed, several of which utilize enhanced sampling methods and/or biased molecular 
dynamics (BMD) to gain a better picture of the conformational transitions between the 
active and inactive conformations in Src kinases35-40.  To the best of our knowledge, the 
work we present here represents one of the first extensive computational studies of the 
dynamics of Tec kinases.  Future work will explore these enhanced sampling methods, as 
well as hydrogen-deuterium exchange mass spectrometry and experimental dynamics 
measurements from nuclear magnetic resonance (NMR), to further investigate the 
dynamics and regulatory mechanisms of the Tec kinases. 
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Materials and Methods 
 
Simulation systems 
All simulations used the CHARMM2741 protein and nucleic acid force field in 
NAMD 2.842 and were equilibrated and performed in the NPT ensemble at 310 K and 1 
atm, using Particle-Mesh Ewald for long-range electrostatics.  For simulations starting in 
the active kinase conformation, phosphotyrosine in the A-loop (pY551 in Btk, pY394 in 
Lck) was parameterized with the TP2 patch in the CHARMM27 force field41.  Hydrogen 
bonds were kept rigid using SHAKE and a time-step of 2 fs.  Simulation systems were 
prepared using VMD43, solvated in a periodic water box using the standard TIP3P model 
for water, with at least 15 Å buffer between protein surface and the box.  Na+ and Cl- ions 
were added to charge-neutralize the system, with a final molar concentration of 
approximately 150mM.  Simulation systems were first minimized and equilibrated for 50 
picoseconds (ps) holding the protein rigid, allowing only water molecules and Na+ and 
Cl- ions to move.  Next, the entire system was minimized, gradually releasing harmonic 
constraints on all protein heavy-atoms.  The temperature of the system was then gradually 
raised from 200 K to 310 K with harmonic constraints on all protein heavy-atoms, in 5 K 
increments over a total of 90 ps.  Subsequently, the harmonic constraints were gradually 
released and the system was equilibrated for a total time of approximately 1 ns.  
Initial coordinates for the simulation systems were obtained from the Protein Data 
Bank (PDB) entries indicated in Table I.  Regions of the structures missing from the 
electron density of the PDB files were modeled using MODELLER44.  For the Btk active 
conformation structure (PDB entry 3K54), residues 435-441 were modeled using the 
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active conformations of Lck (PDB entry 3LCK) and Csk (PDB entry 1K9A, chain B) as 
templates; residues 542-558 of the A-loop were modeled using structures of Btk (PDB 
entry 1K2P) and Lck (PDB entry 3LCK), which have A-loops in the “open” active 
conformation.  For the Inactive simulation of Lck, a homology model was constructed in 
MODELLER based on the inactive structure of the Src kinase Hck (PDB entry 1QCF); 
Lck and Hck sequences are 77% identical and 89% similar (BLOSUM62).  For the 
Inactive Btk structure (PDB entry 3GEN), only three residues were missing and were 
modeled using MODELLER with no user-defined template.  All other structures in this 
study were complete with no other missing residues.  Mutants were generated using 
MODELLER44 and SCWRL 445.  
 
Analysis of simulation trajectories 
 Analysis of molecular dynamics trajectories was carried out using VMD43 and 
MATLAB (The Mathworks, Inc.).  For RMSD calculations, superposition was based on 
the backbone atoms of the C-lobe, which in all simulations showed minimal movement 
(Fig. 2, 4, S3), using the minimized starting structure for that simulation as the reference.  
RMSD was calculated using all backbone atoms for the region of interest, except for the 
R-Spine and C-Spine, which was calculated using all heavy atoms.  Salt bridge distances 
were measured in VMD using the angstrom distance between the center of mass of the 
oxygens in the negatively charged sidechain and the center of mass of the nitrogens in the 
positively charged sidechain.  Snapshots taken at every 10 ns were submitted to the 
Frustratometer server19, according to the methods developed in Ferreiro, et. al20.  As we 
were interested in sequence differences accounting for the dynamics and activity 
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differences in these kinases, we utilized the mutational frustration scores, both pairwise 
and single-residue, from this analysis.  Mutational frustration analysis is based on free 
energy landscape theory and estimates the energetic change from iteratively mutating 
each amino acid to all other 19 amino acids, utilizing a coarse-grained energy potential20.  
As in these previous studies, we considered a Frustration Index (or z-score) > 0.78 to be 
minimally frustrated and < -1.0 to be highly frustrated.  All PDB structures in this study 
were of human sequences; the simulation systems consisted of the isolated kinase 
domains (aa 396-659 for Btk, aa 239-501 for Lck). 
 
Protein Expression and Purification 
 His6-tagged Btk and Lck kinase domains were expressed in Arctic Express 
BL21(DE3) cells (Stratagene) and purified as previously described46.  Briefly, proteins 
were express for 24 hours at 12 °C.  Pellets were resuspended in lysis buffer (Tris pH 7.8 
at 4 °C, 150mM NaCl, 20mM imidazole and lysozyme) and stored at -80 °C.  Cells were 
lysed by thawing and lysozyme; 3000 U DNAse I (Sigma) and 1 mM PMSF were added 
to the lysate, which was spun at 16,000 rpm for 45 minutes at 4 °C.  The supernatant was 
incubated in Ni-NTA resin (QIAGEN), washed with Tris pH 7.8 at 4 °C, 75 mM NaCl, 
40 mM imidazole, and eluted in 50 mM HEPES pH 7.5, 150 mM NaCl, 250 mM 
Imidazole, and 10% glycerol.  Eluted protein was immediately aliquoted and flash frozen 
in liquid nitrogen and stored at -80 °C.  The Btk and Lck kinase domain constructs used 
for in vitro kinase assays were of mouse sequence (mus musculus); the human and mouse 
sequences for Btk kinase domain only differ by 3 amino acids, and the human and mouse 
sequences for Lck kinase domain only differ by 7.  The Lck construct consists of aa 239-
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509.  The domain cutoffs for Btk identically corresponded to those used in the molecular 
dynamics study: aa 396-559. 
 
In vitro kinase assays 
In vitro kinase assays were performed as in Joseph et. al7.  Briefly, purified kinase 
domains were incubated for one hour at room temperature in a kinase reaction buffer of 
20mM Hepes pH 7.0, 10 mM MgCl2, 1 mM  DTT, 1mg/mL bovine serum albumin 
(BSA), 1 mM Pefabloc, and 200 µM ATP.  Samples were analyzed by western blot and 
activity detected with either anti-Btk pY551, or a generic phosphotyrosine antibody (anti-
pY 4G10).  Mutants were generated by site-directed mutagenesis (Quikchange II kit, 
Stratagene). 
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Table 1. Equilibrium Simulations in this study 
Simulation Starting Conf. Mutation PDB ID Length 
1a.   BtkKD  Active wt 3K54 100 ns 
1b.   BtkKD  Active wt 3K54 100 ns 
1c.   BtkKD  Active wt 3K54 100 ns 
2.     BtkKD  Inactive wt 3GEN 100 ns 
3a.   BtkKD  Active I432L 3K54 50 ns 
3b.   BtkKD  Active I432L 3K54 50 ns 
4a.   LckKD Active wt 3LCK 100 ns 
4b.   LckKD Active wt 3LCK 100 ns 
5.     LckKD  Inactive wt 1QCFhm 100 ns 
6.     LckKD  Active L275I 3LCK 50 ns 
Total Simulation Time:                        850 ns 
   hm = homology model based on PDB ID given 
   KD = Kinase Domain 
   LKD = Linker Kinase Domain (includes N-terminal linker-Trp) 
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Figure Captions 
 
 
Figure 1.  The differences in baseline activity levels between the Tec family kinases 
and Src family kinases is not clear from crystal structures alone. (a) The active 
crystal structures of Btk (white, PDB entry 3K54) and Lck (salmon, PDB entry 3LCK) 
reveal nearly identical backbone conformations; the N-lobe, C-lobe, activation loop (A-
loop), αC-Helix, catalytic spin (C-spine), and regulatory spine (R-spine) are labeled.  (b) 
Autophosphorylation kinase assay with His6-tagged Btk kinase domain His6-tagged Lck 
kinase domain shows the disparity in activity between these two isolated kinase domains; 
activity is measured with a generic phosphotyrosine antibody (4G10).  (c) The catalytic 
core of the active and inactive structures used for simulations for Btk (white) and Lck 
(salmon), showing conserved structural hallmarks: the catalytic spine (C-spine) is shown 
in yellow and the regulatory spine (R-spine) in orange, both anchored onto the αF-Helix; 
the activation loop (A-loop) is open in the active conformation, exposing 
pY551(Btk)/pY394(Lck), whereas it is coiled inward in the inactive conformation; the 
αC-Helix moves from it’s “in” position in the active conformation to its “out” position in 
the inactive conformation, facilitating an “electrostatic switch” (residues in the salt 
bridges colored by charge and labeled).   
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Figure 2.  Molecular dynamics simulations reveal key differences between Btk and 
Lck that explain their sharp differences in baseline activity.  100 nanosecond (ns) 
equilibrium simulations were performed for Lck and Btk, starting from their active 
conformations, and key structural features monitored (see Materials and Methods for 
details).  (a) The bottom two panels monitor salt bridge distance for the active salt bridge 
(K273-E288 in Lck; K430-E445 in Btk) and inactive salt bridge (E288-R387 in Lck; 
E445-R544 in Btk); all other panels measure RMSD for the indicated structural features; 
three 100 ns simulations were performed for Btk and 2 100 ns simulations for Lck; 
replica 1 is shown in black, 2 in dark gray, and 3 in light gray.  (b) Snapshots of the 
catalytic core during the simulations from replica 1 of Btk and replica 1 of Lck: shown 
are 0ns, 10ns, 20ns, 30ns, 40ns, 50ns, and 100ns; coloring and structural representation is 
as in Fig. 1c.  Lck exhibits a remarkably steady catalytic core, whereas Btk shows 
significant perturbations of its catalytic core, most notably an outward movement of the 
αC-Helix towards its inactive position, indicated by the arrow. 
 
Figure 3.  Analysis of packing interactions involving the αC-Helix reveal I432L as a 
key position in regulating the dynamics of the αC-Helix.  (a) Single-residue 
mutational frustration analysis for the residues of the αC-Helix in Btk (top) and Lck 
(bottom), showing the Frustration Index at 0 ns, 100 ns, and the change in frustration (100 
ns – 0 ns); For both Btk and Lck, snapshots from replicate 1 in Fig. 2 (black) was used 
for the frustration analsysis shown here; many residues in the αC-Helix of Btk are highly 
frustrated initially but become less frustrated during the course of the simulation, whereas 
frustration levels of the αC-Helix of Lck stays constant throughout the 100ns simulations.  
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(b) The αC-Helix from the crystal structures of active conformations in Btk (white, PDB 
entry 3K54), Lck (salmon, PDB entry 3LCK), and Csk (blue, PDB entry 1K9A, chain B); 
shown in sticks representation are the isoleucine (I432 in Btk, I224 in Csk) that is 
conserved in Tec kinases, which is a leucine in Src kinases (L275 in Lck), and the 
phenylalanine that is conserved across both Tec and Src families, as well as Csk, but 
adopts different sidechain conformations in Btk and Csk than in Lck and Src kinases.  (c) 
Pairwise mutational frustration analysis of Btk wild-type at 0 ns and 10 ns (from replicate 
one of Fig. 2) shows that highly frustrated contacts involving the αC-Helix become less 
frustrated during the first 10 ns of the simulation as the αC-Helix moves out towards its 
inactive position; highly frustrated contacts are shown in red, minimally frustrated 
contacts in green, and neutral contacts are not shown. (d) Multiple sequence alignment of 
the αC-Helix and preceding loop for the 9 Src kinases, the 5 Tec kinases, and Csk and 
Cdk2; the conserved Lys-Glu salt bridge is colored with the lysine in red and glutamate 
in blue; the phenylalanine (F442 in Btk) that is conserved across the Src and Tec families, 
as well as Csk, is highlighted in black with white font; resides that were selected for 
mutations based on differences in both mutational frustration and amino acid identity 
between the two families are highlighted and color-coded.  These three mutants – Btk 
I432L, E439P, and E441A – were simulated as a triple mutant for 20 ns starting from the 
active conformation (d) and tested for in vitro kinase activity (e).  The triple mutant, 
unlike wild-type Btk, maintains the active conformation during the course of the 20 ns 
simulation (d).  In the autophosphorylation kinase assay (measured by anti-pY551), 
I432L exhibits a significant increase in activity. 
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Figure 4.  Btk I432L stabilizes the αC-Helix in the active conformation.  Two 
independent 50 ns simulations of Btk I432L were performed starting from the active 
conformation, using the same conditions and parameters as the Btk wild-type simulations 
shown in Fig. 2.  (a) The of the two I432L simulations are shown in black (replica 1) and 
gray (replica 2).  The bottom two panels monitor salt bridge distance for the active salt 
bridge (K430-E445 in Btk) and inactive salt bridge (E445-R544 in Btk); all other panels 
measure RMSD for the indicated structural features.  Unlike the wild-type Btk 
simulations, Btk I432L maintains the active αC-in position of the αC-Helix, stabilizing 
the active conformation in these 50 ns simulations (b) Snapshots of the catalytic core 
during the simulations of Btk I432L: shown are 0ns, 10ns, 20ns, 30ns, 40ns, 50ns, and 
100ns; coloring and structural representation is as in Fig. 1c, 2b.   
 
Figure S1.  Snapshots of catalytic core from Btk wild-type simulations at 0, 10, 20, 
30, 40, 50, and 100 ns, for replicas 1 and 2 (Fig. 2).  Coloring and representation is as 
in Figure 1.  In both replicas, the αC-Helix move outwards towards its inactive position, 
breaking the R-spine and the K430-E445 salt bridge.  The E445-R544 salt bridge, 
hallmark of the inactive conformation, also forms during both simulations. 
 
Figure S2.  In Btk wild-type simulations starting from the active conformation, the 
αC-Helix readily adopts conformations seen in unique inactive crystal structures of 
Tec kinases.  (a) Crystal structures of Tec kinases that adopt a unique inactive 
conformation in which the αC-Helix is out, breaking the the Lys-Glu salt bridge and R-
spine, but the A-loop is in an active “open” conformation (or is missing from the electron 
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density map, indicating conformational heterogeneity and flexibility); these structures are 
unique from canonical “Src-like” inactive conformations, in which the A-loop is coiled 
into the catalytic core and the Lys-Glu salt bridge is further apart (Fig. 1c); the Lys-Glu 
salt bridge is colored by charge and the Lys-Glu distance is labeled.  (b) and (c) 
Representative snapshots from simulations of wild-type Btk (replica 1) are shown in 
white, overlaid with structures from (a), shown in green, demonstrating that as the αC-
Helix moves away from its active position in Btk, it readily adopts the unique 
conformation observed in these inactive Tec kinase domain structures; αC-Helix RMSD 
is reported. 
 
Figure S3.  Simulations of Btk and Lck kinase domains starting from inactive 
conformations.  (a) The bottom two panels monitor salt bridge distance for the active 
salt bridge (K273-E288 in Lck; K430-E445 in Btk) and inactive salt bridge (E288-R387 
in Lck; E445-R544 in Btk); all other panels measure RMSD for the indicated structural 
features.  Overall, the simulations starting from the inactive conformation show fewer 
differences than the simulations starting from the active states (Fig. 2a).  It is interesting 
to note that the inactive salt bridge (E288-R387 in Lck; E445-R544 in Btk) remains intact 
during the entire Lck inactive simulation, but in the Btk inactive simulation, this salt 
bridge is not necessary to stabilize the inactive conformation.  (b) In the inactive 
simulations, the αC-Helix of Lck shows greater RMSD variation than Btk (top), whereas 
in the active simulations, the opposite is true and the Btk αC-Helix shows much greater 
RMSD variation than Lck (bottom). 
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Figure S4.  Btk I432L simulations reveal that I432L and F442 adopt packing 
conformations nearly identical to that of Lck, allowing for stabilization of the αC-
Helix in its active αC-in position.  (A) Starting points of these simulations for Btk 
I432L (white), Btk wild-type (Btk WT)(white), and Lck wild-type (Lck WT)(salmon); 
the phenylalanine and isoleucine/leucine residues monitored are labeled and colored in 
red, sticks representation.  10, 20, 30, 40, and 50 ns snapshots are shown for the 
simulations of Btk I432L (b), Btk WT (c), and Lck WT (d).  Within the first 10 ns, the 
leucine and phenylalanine residues of Btk I432L adopt a similar conformation to that of 
Lck, with F442 moving inward; conversely, in Btk WT simulations, the phenylalanine 
only moves inward to this position once the αC-Helix has moved outward towards its 
inactive conformation. 
 
Figure S5.  Lck L275I (reverse of Btk I432L) does not alter the dynamics or activity 
of Lck.  (a) A 50 ns simulation was performed for Lck L275I, starting from the active 
conformation; the top panel shows αC-Helix RMSD and the bottom panel shows the 
distances for the active (K273-E288) and inactive salt bridge (E288-R387);  during the 50 
ns simulations Lck L275I remains in its active conformation with the Lys-Glu active salt 
bridge intact and the αC-Helix in its active αC-in position.  (b) Autophosphorylation 
kinase assay with His6-tagged Btk kinase domain His6-tagged Lck kinase domain as in 
Fig. 1b; Lck L275I shows no difference in activity from Lck wild-type (WT).  Though 
there are difficulties directly comparing Lck and Btk activity in this assay (due to the 
possibility of different substrate affinities and differing numbers tyrosines that are 
spuriously phosphorylated and detected by the generic anti-pY antibody (4G10)), it is 
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clear that Lck activity is far greater than Btk wild-type (WT) and I432L; the Lck and Btk 
lanes were run on the same gel but in between lanes have been removed for clarity. 
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CHAPTER 7.  GENERAL CONCLUSIONS 
 
Summary 
 This dissertation investigates the regulation of IL-2 inducible T-cell kinase (Itk) 
and its related Tec family kinases, using a combination of experimental and 
computational approaches.  All of the chapters of this dissertation share the same goal of 
improving understanding of the molecular mechanisms that regulate Itk, Btk and the Tec 
Family kinases, and the lymphocyte signaling pathways they are a part of.  Before we can 
fully understand these pathways and develop drugs to manipulate them, we need a deep 
understanding the structures and mechanisms of these signaling enzymes. 
 Itk is found primarily in T-cells and fine-tunes signaling downstream of the T-cell 
receptor (TCR).  Itk is needed for a proper immune response, and plays key roles at 
stages in T-cell development1,2; however, deletion of Itk is not fatal and still allows for 
some immune response, as evidenced in double-knockout Itk-/- mice3,4.  Btk plays a 
similar role to Itk, but in B-cell receptor (BCR) signaling.  These properties make Itk and 
Btk attractive drug targets for allergies and autoimmune disease, cases where immune 
response needs to be scaled back and prohibited from attacking things that it should not, 
without entirely destroying immune response.  Efforts to develop drugs have been 
hindered by a lack of structural understanding for Itk and the Tec kinases.  Structures for 
each of the individual domains present in these kinases have been solved5-9, but there are 
no multi-domain structures for Tec kinases, leaving gaps in our understanding of the 
mechanisms that regulate activity in these kinases.  My dissertation work aims to further 
this understanding, primarily addressing two questions: 1) What is the role of the N-
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terminal Pleckstrin Homology (PH) domain in regulating Itk activity, in addition to its 
canonical role of PIP3-binding which aids in the colocalization of Itk?  2)  What are the 
structural features that render the isolated Itk Kinase Domain inactive in the absence of 
the SH2 and subsequent linker? 
 In Chapter 2, I described development of a solubilizing and stabilizing mutant that 
overcomes the poor expression and solution behavior of wild-type Itk PH domain, which 
prior to this work was intractable for biophysical characterization in vitro.  Through a 
strategic chimeric approach, I identified the lone α-helix as responsible for the poor 
expression and solution behavior, and found that mutating the α-helix at its two end 
positions, to their corresponding amino acids in Itk’s homologues Btk and Tec, rescued 
the poor behavior without perturbing canonical PI(3,4,5)P3 binding, or affecting catalytic 
activity in the context of the full-length Itk enzyme.  I was able to assign 1H-15N 
backbone chemical shifts for this double mutant, Itk C96E/T110I, referred to as ItkPHS 
(for “stabilizing” or “solubilizing”) and use it throughout the work described in this 
dissertation to better understand important questions of Itk regulation. 
 In Chapter 3, I used the ItkPHS construct developed in the Chapter 2 to 
characterize a direct interaction between ItkPH and the Itk kinase domain (ItkKD).  Using 
the ItkPHS 1H-15N NMR assignments, I was able to map the binding surface of this 
interaction onto ItkPH and identify mutants that specifically disrupt the binding.  I then 
produced baculoviral constructs of these mutants in the context of full-length Itk and 
performed various in vitro kinase assays to measure the affect of disrupting this 
interaction on the catalytic activity of Itk.  Preliminary results point to ItkPH and the 
ItkPH/ItkKD interaction playing a role in regulating phosphorylation of the activation 
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loop at pY511 by Lck.  Experiments have been planned to further characterize the 
functional effects of this interaction. 
 Together with our collaborator, Dr. Yina Huang at Washington University in St. 
Louis, we have identified a positive regulatory interaction between Itk and calmodulin 
(CaM) in T-cells.  In Chapter 4, I described my contribution to this collaboration, using 
ItkPHS to thoroughly characterized a direct interaction between CaM and ItkPH, using 
NMR to map binding-induced chemical shifts onto both molecules, and gain the 
following insights into the functional role of this interaction: I showed that IP4, the 
soluble head-group of PI(3,4,5)P3 (ItkPH’s canonical ligand), out-competes the 
ItkPH/CaM interaction; additionally, evidence was shown for a possible mechanism of 
CaM-binding, through intrinsic disorder of the β3/β4-loop region of ItkPH. 
 In Chapter 5, I investigated the mechanism by which BtkPH E41K confers 
constitutive activation.  Btk E41K has been in the literature since 1995 as a hyper-
activating, transforming, mutant, but the mechanism has remained elusive.  The related 
PH domain of Atk1/PKB has a similar glutamate to lysine mutation, E17K that is 
oncogenic, and it was found that Akt1 E17K renders Akt constitutively active by 
broadening specificity to include increased for PI(4,5)P2, in addition to its canonical 
PI(3,4,5)P3 binding.  In Chapter 5, we propose and provide experimental evidence for a 
novel mechanism by which Btk E41K confers constitutive activation: through an 
increased affinity for PI(4,5)P2 at a second, non-canonical PIP binding site that is 
prerequisite upon induced dimerization at the plasma membrane. 
 In Chapter 6, a computationally driven approach was used to identify novel 
packing motifs in the N-lobe of the Tec kinase domains that contribute to the inactivity of 
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their isolated kinase domains.  Tec and Src kinases, despite sharing similar domain 
architecture, represent two extreme ends of the kinome with respect to the baseline 
activity of their isolated kinase domains.  Using molecular dynamics simulations coupled 
with rigorous computational analysis and in vitro kinase assays, I identified structural 
features of the N-lobe of these kinases contribute to this sharp difference in activity 
between the kinase domains of Tec and Src families. 
 This dissertation advances the understanding of the complex molecular-level 
regulation of the Tec family of tyrosine kinases.  The primary contributions of this 
dissertation are: 1) the development of the C96E/T110I Itk PH domain mutant, or ItkPHS, 
that overcomes the limitations of working with wild-type ItkPH, opening the door to 
being able to probe the functional role of this regulatory domain; 2) the implementation 
of computational techniques to complement and drive experiment in a way that improves 
our understanding of Tec kinase domain dynamics and regulation.  To the best of my 
knowledge, extensive computational work has never before been performed for Tec 
kinases.  In absence of multi-domain crystal structures for these kinases, creative 
approaches will be required to elucidate the structural basis of activity and regulation in 
these systems.  The increasing power of molecular dynamics simulations, tightly coupled 
with rigorous computational analysis and experiment, offers a promising approach to 
further address the complex regulation of the Tec kinases. 
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APPENDIX A.  CROSSLINKING MASS SPECTROMETRY 
STUDIES OF FULL-LENGTH ITK WILD-TYPE 
 
Scott Boyken 
In collaboration with Dr. Young-Jin Lee and Adam Klein 
 
This work was originally done to probe self-association of the Pleckstrin 
Homology (PH) domain of Itk.  Subsequent work has suggested that the Itk PH domain 
may not self-associate, at least not under in vitro conditions, and that early signs of ItkPH 
self-association may have been due to the insoluble, aggregation prone nature of wild-
type ItkPH (See CHAPTER 2 of this dissertation).  In CHAPTER 3 of this dissertation, I 
identified a direct interaction between the PH domain and Kinase Domain (KD) of Itk.  
The cross-linking mass-spec results have been re-interpreted in light of this finding, and 
three pairs of cross-linked lysines identified that span ItkPH and ItkKD: K47/K48 were 
shown to cross-link with K496, K522, and K596 on ItkKD (Figure 1).  K47/K48 were 
shown to be at the PH/KD interface by NMR chemical shift mapping, as well as by a 
K48D/R49D mutant that disrupts binding in a CoIP assay (see CHAPTER 3 of this 
dissertation).  The three lysines identified on ItkKD are not spatially close, suggesting 
that ItkPH is possibly docking onto multiple sites on the KD, or that the crosslinking was 
not specific enough to deduce the actual binding site.  Additionally, this crosslinking data 
may shed light on other intramolecular contacts across domains in the full-length Itk 
molecule.  No multi-domain or full-length structures have been solved for any of the Tec 
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Family Kinases, leaving large gaps in our current understanding of the structure/function 
relationships for these enzymes. 
 
Methods 
Cross-linking was accomplished with DSS or DSG, both of which cross-link 
lysine residues, with spacer arm lengths of 11.4 Å and 7.7Å respectively (purchased from 
Thermo Scientific, #21658  and #20593).  Crosslinking reactions were carried out with 1 
uM purified ItkFL WT and DSS or DSG, according to manufacturer’s instructions.  
Briefly, the protein was prepared at a concentration of 1uM in a conjugation buffer of 
20mM HEPES, pH 7.5, 150mM NaCl, and 100mM bicarbonate.   DSS or DSG stock 
solutions were prepared in dimethyl formamide (DMF) at 50mM and added to the protein 
sample at a 10-, 25-, or 50-fold molar excess to the protein.  Crosslinking reactions were 
carried out for 30 minutes at room temperature or for 2 hours on ice and then quenched 
with 50mM Tris for 15 minutes at room temperature with a stock quenching buffer of 1M 
Tris-HCl, pH 7.5.   Samples were then given to Adam Klein who performed trypsin 
digestion and analyzed the samples by mass spectrometry. 
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Table I.  ItkFL Sample used for crosslinking 
Full-length Itk (murine)(1 uM) 
619 amino acids 
C-terminal FLAG tag: DYKDDDDK 
mnnfilleeq likksqqkrr tspsnfkvrf fvltkaslay fedrhgkkrt lkgsielsrikcveivksdi sipchykypf qvvhdnylly 
vfapdcesrq rwvltlkeet rnnnslvskyhpnfwmdgrw rccsqlekpa vgcapydpsk naskkplppt pednrrsfqe 
peetlvialydyqtndpqel alrcdeeyyl ldsseihwwr vqdknghegy apssylveks pnnletyewynksisrdkae kllldtgkeg 
afmvrdsrtp gtytvsvftk aiisenpcik hyhiketndspkryyvaeky vfdsiplliq yhqynggglv trlrypvcsw rqkapvtagl 
rygkwviqpseltfvqeigs gqfglvhlgy wlnkdkvaik tiqegamsee dfieeaevmm klshpklvqlygvcleqapi clvfefmehg 
clsdylrsqr glfaaetllg mcldvcegma ylekacvihrdlaarnclvg enqvikvsdf gmtrfvlddq ytsstgtkfp vkwaspevfs 
fsryssksdvwsfgvlmwev fsegkipyen rsnsevvedi stgfrlykpr laschvyqim nhcwkekpedrppfsqllsq 
laeiaeaglDYKDDDDK 
 
TRYPSIN CLEAVAGE (74 sites): 
14 18 19 20 27 29 35 44 47 48 49 52 59 61 67 77 99 101 107 111 119 129 131 150 154 165 166 193 210 
214 229 242 246 248 251 258 265 268 280 290 295 302 303 309 332 334 341 343 351 354 384 386 390 
411 416 447 450 474 480 485 496 504 518 522 533 537 555 561 575 580 595 622 627 
 
Number of amino acids: 627 
Molecular weight: 72568.6 
Theoretical pI: 6.35 
 
Amino acid composition:  
Ala (A) 30 4.8% Arg (R) 33 5.3% Asn (N) 24 3.8% Asp (D) 33 5.3% Cys (C) 18 2.9% Gln (Q) 25 4.0% 
Glu (E) 51 8.1% Gly (G) 31 4.9% His (H) 15 2.4% Ile (I) 28 4.5% Leu (L) 56 8.9% Lys (K) 46 7.3% Met 
(M) 12 1.9% Phe (F) 27 4.3% Pro (P) 32 5.1% Ser (S) 51 8.1% Thr (T) 25 4.0% Trp (W) 13 2.1% Tyr (Y) 
34 5.4% Val (V) 43 6.9% Pyl (O) 0 0.0% Sec (U) 0 0.0% (B) 0 0.0% (Z) 0 0.0% (X) 0 0.0% 
 
Extinction coefficients: 
Extinction coefficients are in units of  M-1 cm-1, at 280 nm measured in water. 
 
Ext. coefficient   123285 
Abs 0.1% (=1 g/l)   1.699, assuming all pairs of Cys residues form cystines 
 
Ext. coefficient   122160 
Abs 0.1% (=1 g/l)   1.683, assuming all Cys residues are reduced 
 
The N-terminal of the sequence considered is M (Met). 
 
The estimated half-life is: 30 hours (mammalian reticulocytes, in vitro). 
                            >20 hours (yeast, in vivo). 
                            >10 hours (Escherichia coli, in vivo). 
Instability index: 
The instability index (II) is computed to be 47.67 
This classifies the protein as unstable. 
 
Aliphatic index: 76.92 
Grand average of hydropathicity (GRAVY): -0.48
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Table II.  Crosslinking mass-spec analysis of ItkFL WT 
X-­‐link	  mass	  :	  96.02113	  
	  
	  
	  
	   	   	   	   	   	   	   	   	   	   	   	   	  
Intensity	  Threshold	  :	  relative	  :	  0.001	  absolute:	  
0.1	   	   	   	   	   	   	   	   	   	   	   	   	  
Parent	   tolerance	   :	   10.0(MC=2)	   5.0(MC=3)	  
3.0(MC=4)	  	   	   	   	   	   	   	   	   	   	   	   	   	  
Fragment	  tolerance	  :	  0.6	   	   	   	   	   	   	   	   	   	   	   	   	   	  
Protein	   sequence	   file	   :	  
Itk.fasta	   	   	   	   	   	   	   	   	   	   	   	   	   	  
Data	  file	  :	  20100318_Itk_Cross.mgf	   	   	   	   	   	   	   	   	   	   	   	   	  
	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
Scan#	   Peptide1	   Peptide2	   aa	  #	  K-­‐>K	   Z	   Error(PPM)	   m/z)cal	   #_AA	   #fragement/#AA	   Evalue	  
5869	   QKAPVTAGLR	   LLLDTGKEGAFMVR	   343,	  258	   4	   0.274111715	   672.124344	   24	   1.375	   0.01644994	  
5019	   HGKKR	   MNNFILLEEQLIK	   47/48,	  13	   3	   4.0655483	   775.7630798	   18	   0.833333333	   0.063028269	  
3251	   DKVAIK	   QKAPVTAGLR	   386,	  343	   3	   0.939898123	   603.6912465	   16	   1.5	   0.100838876	  
5833	   NASKK	   ASLAYFEDRHGKK	   154,	  48	   3	   4.049461104	   722.0430098	   18	   0.611111111	   0.162490406	  
2546	   HGKK	   EKPEDR	   47/48,	  596	   3	   7.092644517	   446.5650998	   10	   1	   0.167267066	  
4249	   ETNDSPKR	   RTLKGSIELSR	   302,	  52	   4	   6.523731513	   576.0593715	   19	   1.052631579	   0.190202083	  
2234	   DKAEK	   QKAPVTAGLR	   248,	  343	   4	   1.075888908	   432.242784	   15	   0.933333333	   0.248870306	  
6280	   SQQKR	   HYHIKETNDSPK	   18,	  295	   3	   9.564847305	   737.3697931	   17	   0.411764706	   0.479554961	  
5287	   NASKK	   HYHIKETNDSPKR	   154,	  295	   3	   9.244586319	   756.3890731	   18	   0.444444444	   0.56844705	  
6464	   DKAEK	   HYHIKETNDSPKR	   248,	  295	   3	   9.722407093	   770.7205965	   18	   0.5	   0.749604846	  
3420	   DKAEK	   SISRDKAEK	   	   3	   6.688144231	   573.6354698	   14	   0.571428571	   0.756059422	  
4705	   EKPEDR	   HGKKRTLK	   597,	  48	   3	   5.738112302	   612.6743698	   14	   0.857142857	   0.763236434	  
6883	   KSQQKR	   FPVKWASPEVFSFSR	   13/18,	  522	   3	   4.162082354	   885.1343398	   21	   0.333333333	   0.805207532	  
6834	   HYHIKETNDSPK	   SISRDKAEKLLLDTGK	   295,	  251	   4	   3.103073919	   835.1901015	   28	   0.464285714	   0.856899126	  
6528	   ETNDSPKR	   PAVGCAPYDPSKNASKK	   302,	  150	   3	   8.80153544	   925.4519565	   25	   0.52	   0.872826762	  
3705	   KR	   WVLTLKEETR	   ?,	  105	   3	   7.942606757	   558.3175265	   12	   0.583333333	   1.303596742	  
5628	   HGKKR	   NCLVGENQVIKVSDFGMTR	   47/48,	  496	   4	   4.140083147	   708.3667115	   24	   0.958333333	   0.19708246	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Figures 
 
Figure 1.  Lysines that cross-linked between Itk Kinase Domain (ItkKD) and Itk PH 
domain (ItkPH).  (A,B, and C) Itk Kinase Domain (PDB ID 3MJ2) is shown in surface 
representation at different angle rotations along the y-axis, to show the three cross-linked 
lysines, labeled in red: K496, K522, and K596; negatively charged residues are colored in 
blue.  (D) Threaded model of ItkPH, with the mapped PH/KD interface shown in red; 
K47/K48, shown to crosslink with K496, K522, and K596 of ItkKD, are labeled in red. 
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APPENDIX B.  DATA-DRIVEN DOCKING TO MODEL THE 
STRUCTURE OF CUSB/CUSA COMPLEX 
 
Based on the paper: 
Long, F., Su, C.-C., Zimmermann, M. T., Boyken, S. E., Rajashankar, K. R., Jernigan, R. 
L., & Yu, E. W. (2010). Crystal structures of the CusA efflux pump suggest methionine-
mediated metal transport. Nature, 467(7314), 484–488. 
 
Summary 
 Dr. Ed Yu’s lab solved the individual structures of CusA and CusB in the 
CusCBA efflux system in E. Coli, part of the resistance-nodulation-cell division (RND) 
family of tripartite efflux pumps.  CusCBA spans the inner and outer membrane and is 
responsible for extruding Cu(I) and Ag(I) ions, both of which are toxic to E. Coli.  
Understanding the structures of these efflux pumps has important implications for better 
understanding gram-negative bacteria and the mechanism by which some of these 
bacteria confer resistance to toxic particles and drugs.  Based on a lysine-lysine cross-
linking restraint between CusA and CusB, I performed extensive data-driven protein-
protein docking to predict the structure of the CusA/CusB complex (Figure 1).  From 
early docking experiments, it was clear that a good fit between CusA and CusB could not 
be obtained without taking into account flexibility of CusB.  Incorporating flexibility into 
protein-protein docking is a difficult problem and can exponentially enlarge the search 
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space.  To overcome this issue, Mike Zimmermann and I developed a plan to dock the 
subdomains of CusB onto CusA individually, and then performed steered molecular 
dynamics and energy minimization calculations to fit the full-length CusB structure onto 
the docked individual subdomains.  The docking of the individual subdomains yielded 
higher scoring poses than the initial attempts to dock full-length CusB (Figures 2 and 3). 
It should be noted that Dr. Yu’s lab has since solved the CusA/CusB co-cyrstal 
structure[6]; unexpectedly, the structure of the CusA/CusB complex exhibits 1:2 
CusA:CusB binding.  For the computational work presented here, we were working under 
the assumption that binding was 1:1. 
 
Methods 
Docking structures of CusB onto CusA. Initial rigid-body docking of the crystal 
structures of CusA and CusB did not reveal any feasible complexes that satisfied the 
CusA-K150/CusB-K95 crosslinking constraint, indicating that docking most probably 
requires a conformational change in one or both molecules. As previously mentioned, it 
has been speculated that the PN2 and PC1 subdomains may move to accommodate CusB. 
For CusA, the normal modes from the Anisotropic- Network-Models (ANMs)[1] were 
calculated but did not reveal any appropriate structures. For CusB, ANM revealed 
significant hinge motions between domains 1 and 2. And, following this lead for a 
dominant transition, these two domains were docked individually onto CusA. Steered 
molecular dynamics simulations were then used to drive the CusB into a docked form 
agreeing with the individually docked fragments, thus allowing for the flexibility of the 
PC1, PN2 and TM2 domains of CusA. 
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Data-driven docking of domains 1 and 2 of CusB. Rigid-body docking was 
performed using the three-dimensional (3D)-dock software suite40, which uses the 
Katchalski–Katzir algorithm[3]. For all runs, 10,000 conformations were gen- erated and 
filtered by using the following data-driven constraints: transmembrane helices were 
masked from docking interactions, and side-chain amines of CusA- K150 and CusB-K95 
were within 25 Å [2]; CusB was oriented so that its domains were free to interact with 
CusC and its N terminus was directed towards the inner membrane.  
Steered molecular dynamics and energy minimization. An initial conformation 
was calculated by aligning CusB with the two individually docked fragments. To relax 
CusB from this conformation, we used steered molecular dynamics to guide the centre of 
mass of domains 1 and 2 into the corresponding docked position. Energy minimization 
was used to alleviate steric clashes. During the simulation CusA was taken to be rigid 
with the exception of TM2, PN2 and PC1, which make up most of the CusB-binding 
region. All calculations were performed with NAMD[4] and the CHARMM27 force 
field[5]. 
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Figure Captions 
 
Figure 1. Docking of CusB to CusA. (a) Side view of the docked complex of CusBA. 
The three CusB protomers are shown in green ribbons. The trimeric CusA is in gray 
surfaces. Sub-domains PN2 and PC1 of CusA are in red and blue, respectively. Specific 
interaction is found to occur between Domain 2 of CusB and the groove formed between 
DN and DC sub-domains of CusA to further stabilize the complex. (b) Top view of the 
docked complex of CusBA. 
Figure 2.  Top-scoring docking result for the data-driven docking of sub-domain 1 of 
CusB.  Coloring and structural representation is same as in Figure 1. 
Figure 3.  Top-scoring docking result for the data-driven docking of sub-domain 2 of 
CusB.  Coloring and structural representation is same as in Figure 1. 
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Figure 1 
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Figure 2 
 
 
 
Figure 3 
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APPENDIX C.  COMPUTATIONAL STRUCTURAL WORK 
ON IGF1: A BCB LAB PROJECT 
 
This project was carried out through my involvement with the Bioinformatics and 
Computational Biology Lab (BCB Lab), a graduate-student run consulting group at Iowa 
State University, and contributed to the following publication: 
 
Sparkman, A. M., Schwartz, T. S., Madden, J. A., Boyken, S. E., Ford, N. B., Serb, J. 
M., & Bronikowski, A. M. (2012). Rates of molecular evolution vary in vertebrates for 
insulin-like growth factor-1 (IGF-1), a pleiotropic locus that regulates life history traits. 
General and Comparative Endocrinology, 178(1), 164–173.  
 
Description of Problem 
Amanda Sparkman has characterized IGF1 sequences in various reptiles, yielding 
important evolutionary implications.   No structures exist for any reptilian IGF1s.  To 
gain insight as to how these reptilian IGF1s differ from their mammalian counterparts, I 
predicted the structures of these reptilian IGF1s and compared the structural features of 
these models. 
Furthermore, she has been utilizing an antibody that binds IGF1 (insulin-like 
growth factor) to monitor IGF1levels in various species of snakes.  Through sequencing, 
she has shown that there is a high level of variability in IGF1 across different species of 
snakes.  Any given mutant only has one to several mutations, but most species have 
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mutations unique to them, and there is a large total number of observed mutations (see 
tables 1 and 2).  Many of these mutations prevent the antibody from binding IGF1.  
Another question is then: what is happening structurally in these mutants that prevents 
the antibody from binding? 
 
Results 
The most notable amino acid change is the IGF-2R binding residue R55, which is 
conserved across mammals, birds, and turtles, but is isoleucine in the snake species 
sequenced and threonine in the lizard species A. carolinensis and A. sagrei.  Isoleucine 
and threonine are the only two beta-branched amino acids, short and bulky compared to 
the long sidechain of arginine.  In addition to the change in shape, isoleucine, threonine, 
and arginine all differ greatly in their hydrophobicity, charge, and polarity.  R50Q, also 
implicated in IGF-2R binding is another significant change between mammals and the 
other species in this study. 
The C-domain, which is critical for IGF-1R binding and is the most flexible 
region of the protein [1][2], is also distinctly different (Figure 1).  The difference in 
amino acid composition and hydrophobicity could have a significant impact on the 
dynamics and binding properties of this loop.  It is particularly interesting that proline, 
present in the other species, is absent in squamates and two of the lizards in this study, as 
proline has significant implication for flexibility and fold space. 
Together, these amino acid changes are substantial and would be expected to alter 
the affinity and specificity of IGF1 binding to IGF-1R and IGF-2R, which suggests two 
possible hypothesis: either there are correlated amino acid changes in the receptors of 
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these species that maintain binding, or the affinity and specificity of these interactions is 
distinctly different between mammals and reptiles, suggesting different physiological 
roles for IGF1.  These amino acid differences would not be expected to alter the overall 
fold of IGF1 but could have key implications for the function and dynamics of the 
protein.   
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Workspace: A web-based environment for protein structure homology modelling. 
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Figures 
Figure 1.  Structural differences between mammalian and reptilian IGF1.  The 
structure of snake IGF1 (left) was modeled by threading the sequence of T. elegans onto 
the crystal structure of human IGF1, PDB ID 1GZR (right) using SwissModel [3].  The 
eleven amino acids of the C domain (30-41) are colored in magenta, side-chains shown 
and labeled; note that amino acids 36-38 are missing from the human structure due to 
missing electron density, indicative of the highly flexible nature of this loop.  The 
differences in key IGF-2R binding residues, R50Q and R55I, are highlighted in red.  
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APPENDIX D.  COMPUTATIONAL REDESIGN OF THE 
ITK SH3/SH2 INTERFACE: A TOOL TO PROBE T-CELL 
RECEPTOR SIGNALING 
 
Boyken, S.E., Schmitt, L., Cutler., M., Joseph, R.E., Andreotti A.H. 
  
 Itk has been shown to self-associate through an intermolecular interaction 
between its SH3 and SH2 domains, and our lab has solved the structure of this complex 
via NMR (PDB ID 2K79).  The binding affinity of the individual domains is quite weak 
(~600uM); however, in the context of the full-length protein, in vivo and in vitro 
functional assays suggest this interaction down-regulates the catalytic activity of Itk, and 
that post-translation modifications to these domains may regulate Itk by altering the 
affinity of this interaction.  To create a tool to further probe the affect of this interaction, I 
set out to computationally design mutants that would increase the affinity of this 
interaction.  I used Rosetta and a similar approach to work out of Dr. Brian Kuhlman’s 
lab [1,2].  We experimentally measured dissociation constants for 12 of the predicted 
mutants and found that 5 increased binding affinity.  The increase in affinity is modest 
(only ~5-10-fold) and ongoing work aims to increase this further, possibly through 
double mutants; however, predicting double mutants is more difficult, and our search 
space is limited, as the interface is somewhat small and we have restricted ourselves by 
182 
 
avoiding residues of known functional importance.  I have put two of best single mutants 
into full-length Itk and am now measuring their effects on in vitro kinase activity.  I have 
mentored two undergraduate researchers in carrying out this project: Laura Schmitt 
performed much of the protein expression and purification and helped with NMR titration 
experiments (to measure binding affinity and map residues).  Maureen Cutler was a 
summer student that came to our lab from Purdue as part of a summer REU program here 
in computational biology. 
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Figure Captions 
 
Figure 1. (A) Example NMR titration curve for S284F, which increases binding affinity 
~5-fold.  (B) Computational alanine scanning correctly identifies energetically important 
residues: W208, V227, and Y180 had three of the highest predicted ddG’s upon mutation 
to Ala, and all three of these mutants have been shown to disrupt the interaction upon 
mutation. 
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